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Early Lichenologists at Work 
Title vignette of 
Descriptio et adumbratio plantarum e classe cryptogamica Linnaei. Quae lichens dicuntur. 
Georg F. Hoffmann (Lipsiae, 3 volumes, 1790 - 1801) 
/ 
Nothing is so lovely as spring lichen across the face of crisp rock, cracking it 
into sand. Fungi shattering the earth into chips of marble has never failed to 
amaze me with its power. Thus does beauty become soil. 
Graffiti at the entrance of Riverside Park, 
Milwaukee, Wiscousin, USA 
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Lichens are queer things. For a long time there didn't seem to be any use 
for them except that one kind is the reindeer's food ... 
John Wyndham 
Trouble with Lichen ( 1960) 
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Abstract 
This thesis describes the chemical investigation of five different species of lichenized 
fungi collected from Australasia and North America. In addition, the total syntheses of 
three lichen-derived p-terphenyls (6.16) - (6.18) and a p-terphenyl (6.59) not yet 
identified in Nature were successfully completed. 
A novel bisnaphthazarinoid pentacycle, hybocarpone ( 2. 8) [ 12a, l 2b-diethy 1-1,3, 
4,5a,6a,8,9, 11-octahydroxy-2, 10-dimethyl-5a,6a, 12a, 12b-tetrahydro-5aH,6aH, 12aH, 12 
bH-dinaphtho[2,3-b:2,3-d]furan-5,7,12,13-tetraone], was isolated from the cultured 
mycobiont of Lecanora hybocarpa (Tuck.) Broda. The structure of the metabolite 2. 8 
was established by spectroscopic methods and its relative configuration predicted by 
molecular modelling. Single crystal X-ray analysis was used to confirm the proposed 
structure and stereochemistry. Hybocarpone (2.8) was found to exhibit potent 
cytotoxicity against the murine P815 mastocytoma cell line. 
The foliose lichen Flavoparmelia euplecta (Stirt.) Hale was found to contain two new 
y-naphthopyronoid ·pigments. The molecular structures of euplectin [5, 1 l-dihydroxy-2-
methylindeno[5,6-h]4H-chromene-4,10-dione] (3.3) and coneuplectin [5,l 1-dihydroxy-
2-methylindano[5,6-h]4H-chromene-4,10-dione] (3.4) were established using 
multidimensional NMR spectroscopic methods. Highfield (600 MHz) gHMBC and gNOE 
experiments were particularly informative in the characterisation of these metabolites. The 
cytotoxicity of the more abundant y-naphthopyrone 3. 3 against the murine P815 
mastocytoma cell line was also examined. 
The reddish-purple pigment characteristic of the Australasian lichen Pseudocyphellaria 
coronata (Mtill. Arg.) Malme, was reinvestigated and identified as a new 
pyranonaphthazarin, coronatoquinone [lS,5,8, 10-tetrahydroxy-7-methoxy-3-methyl-
6,9-dihydro-1H-naphtho[2,3-c]pyran-6,9-dione] (4.1). The structure of the pigment 
4.1 was established by spectroscopic methods and its absolute configuration determined 
from chiroptical measurements. The antiproliferative capacity of coronatoquinone ( 4.1) 
against the murine P815 mastocytoma cell line was also evaluated. 
X 
Myeloconone A2 (5.1), the bright yellow pigment found in the lichen Myeloconis 
erumens P. M. McCarthy & Elix, was isolated and identified as a new phenalenone 
derivative. The structure of 5 .1 was established as 6,7,9-trihydroxy-3,8-dimethoxy-4-
methyl-lH-phenalen-1-one ( or an equivalent isomer) primarily using spectroscopic 
methods. 
The total syntheses of three pentasubstituted p-terphenyls, previously isolated from the 
lichen Relicina connivens (Kurok.) Hale, were achieved. Butlerin A [3,4,4" ,6'-
tetramethoxy[l,1':4',1 "-terphenyl]-2'-yl acetate] (6.16) was successfully prepared from 
readily available 2,5-dichloro-1,4-benzoquinone in a six step sequence. The isomeric 
butlerin B [3,4,4" ,5'-tetramethoxy[ 1, 1 ':4', 1 "-terphenyl]-2'-yl acetate] ( 6.17) was 
synthesised via two independent routes from 1,4-benzoquinone. The synthesis of 
butlerin C [3,4,4"-trimethoxy[l, 1 ':4', 1 "-terphenyl]-2',6'-diyl diacetate] ( 6.18) was 
accomplished in seven steps from 1,4-benzoquinone and confirmed the structure 
originally proposed. The isomeric p-terphenyl [3,4,4"-trimethoxy[l,1':4',1 "-terphenyl]-
2',5'-diyl diacetate] (6.59) was also successfully prepared. 
A reinvestigation of the lichen Xanthoparmelia scabrosa resulted in the unambiguous 
structural revision of the four scabrosin esters (7 .5) - (7 .8). The scabrosins 7 .5 - 7. 8 . 
were found to comprise a family of epidithiopiperazinedione derivatives. The structural 
and stereochemical elucidation was carried out using two dimensional NMR 
spectroscopy, including 15N NMR spectroscopy, CD spectroscopy and X-ray 
crystallography. A new scabrosin ester, scabrosin butanoate hexanoate (7 .9) was also 
isolated and characterised. The cytotoxicities of several scabrosin esters were evaluated 
against the murine PS 15 mastocytoma cell line (IC50 ca. 0.5 µM) and the human breast 
MCF7 carcinoma cell line (IC50 ca. 1 nM). 
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Chapter 1 2 
1.1 Metabolism and Metabolites 
The chemical processes essential for life are said to comprise an organism's pnmary 
metabolism. These biochemical pathways provide the energy and macromolecules (e.g. 
proteins, polysaccharides, nucleotides and fatty acids) necessary for the growth, 
maintenence and reproduction of living cells and are remarkably similar across all known 
living systems.1,2 
In addition to the ubiquitous intermediates of primary metabolism, a significantly greater 
body of natural substances are found sporadically throughout the natural world. These 
'secondary metabolites' are particularly prevalent in the lower forms of life, such as 
bacteria, fungi, plants and lower animals, and are often specific to individual genera, 
species or strains. Unlike the products of primary metabolism, secondary metabolites 
appear to have no clear role in the internal economy of the producing organism. 3-7 
The importance of secondary metabolites to their producer has been the subject of 
considerable debate and numerous conflicting views for their existence have been 
proposed.3,6,8 Some fifty years ago Muller propounded that secondary metabolites might 
act as a 'reservoir of nonfunctional variety out of which new functional processes (could) 
emerge' at some future time.9 Secondary compounds have also been viewed as 'shunt 
metabolites', formed in order to reduce abnormal concentrations of normal cell 
constituents, or simply as waste or detoxification products. 3,6 It was even suggested that 
secondary metabolites might arise from mutations, neither beneficial nor harmful, and 
possess no useful role at all. Io 
Although the precise role of many secondary metabolites is not known, evidence that their 
presence benefits the producer organism is now overwhelming.5,6,8,11,12,13 ,14 Williams 
and co-workers observed that the biosynthesis of secondary metabolites often involved 
dozens of discrete enzyme-catalysed conversions. 6,8 Furthermore, the formation of the 
' 
catalytic enzymes often required coding by several tens of kilobases of DNA. Williams 
concludes that, if the evolutionary fitness of the producing organism was not improved by 
the production of secondary metabolites then, 'the pressures of Darwinian natural 
selection would have precluded the expenditure of so much metabolic energy in the 
development of such complexity'.6 
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It is now recognized that secondary metabolites may improve the survival fitness of the 
producer organism in a multitude of ways. 5, 11 -15 A large number of secondary 
metabolites are thought to possess physiological functions in the processes of growth, 
development and reproduction. Examples of such roles include the strengthening of cell 
membranes, the solubilization and uptake of minerals needed for growth, the activation 
and inhibition of sporulation ( and germination) and the detoxification of excess or waste 
products.5,11 Other secondary metabolites act as intraorganismic signals, regulating the 
co-operation of specialized cells in multicellular organisms. Included amongst these 
substances are the hormones of higher plants and animals and the neurotransmitters of 
higher animals. 5 
While the number of secondary metabolites serving such physiological functions is large, 
a far greater quantity are involved in the complex interactions between their producers and 
other organisms. 13 Some of these natural products can improve the evolutionary fitness 
of the producer by exerting an adverse effect on predators, parasites or competitors. 
Others . provide benefit by coercing other organisms into participation in activities 
advantageous to the producer. 
Secondary metabolites are derived from a relatively small number of key pnmary 
intermediates (Figure 1.1). Despite their restricted biosynthetic origins, a vast array of 
these natural substances have been isolated and characterised. The chemical structures of 
secondary metabolites are astoundingly diverse and many of these naturally occurring 
compounds possess molecular frameworks of extraordinary structural complexity. 5 
1.2 Lichens and Lichen Secondary Metabolism 
Lichens are a specialized group of fungi intimately associated with one or more algal 
partners in a relationship of mutual benefit (symbiosis) (Figure 1. 2). The algal 
component (photobiont), typically a green alga or cyanobacterium, provides its symbiotic 
partner with the carbohydrate and energy necessary for the organism's metabolic 
processes through photosynthesis. In turn, the fungal component (mycobiont) protects 
the photobiont from adverse environmental conditions, such as strong sunlight and a 
shortage of water.16 
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Figure 1.1: The major biosynthetic pathways of secondary metabolism17 
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Approximately 18, 000 lichen species are currently recognized with the majority classified 
as Ascomycotina, the largest group of fungi. 16 Almost 50% of the Ascomycotina are 
lichenized - an indication of the value of the symbiosis association to the fungal partner. 
I\ i:'\_ Y.~ 'v 
·,¥ 
{"' 
~
. 
\ ~t. 
\_/\;: 
r'. , 
',".1 
\ ""· ::;,~~ 
~ ~ 
(j/jJ@ (iJ/) c;;;J; 
(mycobiont) 
Alga 
(photobiont) 
I > 
symbiosis 
Lichen 
Figure 1.2: The lichen symbiosis (Pseudocyphellaria homoeophylla drawn by W. M. 
Malcolm) 18 
In most species of lichen, the structure and form of the lichen thallus is determined by the 
mycobiont and it is this component which is referred to in the lichen's scientific name. 
Lichens have traditionally been divided into three main growth forms. Crustose lichens 
grow in very close contact with their substrata which is generally rock or wood. Foliose 
lichens are characterized by a leaf-like thallus formed by flattened lobes. Considerable 
variation in thallus size and shape has been observed. Fruticose lichens are more shrub-
like in shape than foliose lichens and typically display stem, branch and/or leaf-like 
structures. 
Over seven hundred lichen-derived secondary metabolites are known to Science.19 More 
than 90% of these compounds are unique to lichens and have not been identified in other 
fungi or higher plants. 20 Interestingly, the secondary products so typical of lichens are 
entirely of fungal origin. Furthermore, the experimentally produced combination of a 
mycobiont with foreign photobionts has been shown to generate the same lichen products 
as the mycobiont in a natural thallus with its usual partner. For example, Culberson and 
co-workers found that the biosynthesis of the depside cryptochlorophaeic ( 1.1 ) and 
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depsidone grayanic ( 1.2) acids in Cladonia chlorophaea was not affected by the 
replacement of the natural photobiont with Trebouxia erici. 21 
It is worth noting that laboratory cultivation of the separated mycobiont, as well as the 
simultaneous cultivation of both symbiontic partners, has also resulted in metabolic 
profiles with substantial qualitative and quantitative differences. 19 For example, while the 
lichen Lecanora dispersa is known to contain the xanthone 2,7-dichlorolichexanthone 
(1.3), the cultured mycobiont has been found to produce the depsidones pannarin (1.4) 
and dechloropannarin (l.5).22 
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The secondary metabolites produced in lichen-forming fungi are not evenly distributed 
throughout the lichen thallus and accumulate in specific regions within the organism. At 
the cellular level, secondary metabolites are deposited on the outer surf ace of the fungal 
hyphae ( extracellular) in contrast to the intermediates of primary metabolism which are 
confined within the producing cell (intracellular).20 
1. 2 .1 Functions of Lichen Secondary Metabolites 
Numerous biological roles have been mooted for lichen-derived secondary metabolites. 
For example, a number of lichen depsidones, such as norstictic (1.6) and psoromic (1.7) 
acids, are known to chelate strongly to metal ions [e.g. 1.8] and are thought to supply the 
producer lichen with essential minerals from the lichen's substrate.23,24 
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Many lichen substances absorb UV light and, in some lichen species, a direct relationship 
has been observed between the thallus concentration of pigments such as usnic acid ( 1. 9) 
(absorbance maxima at 232 and 282 nm in methanol) or parietin (1.10) (absorbance 
maxima at 220, 254, 264 and 286 nm in methanol) and the intensity of available light in 
natural habitats. It has been proposed that these substances are formed as a response to 
high levels of visible light in order to protect the photobiont from radiation damage. 25 
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Other proposed functions include antimicrobial, allelopathic and antifeedant activities, 
maintenance of continual gas exchange across the lichen's surface, regulation of the 
symbiotic equilibrium and modulation of the cell wall permeability of the photobiont.19,26 
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1. 2. 2 Chemotaxonomy 
Chemical analysis of the secondary products of lichenised fungi has become an integral 
part of lichen systematics, in conjunction with consideration of the organism's 
1norphological characteristics, ecology and geography. In fact, chemotaxonomy is used 
more extensively in the study of lichens than in any other type of organism - the chemistry 
of over 5000 species, approximately 33% of those described, has been investigated to 
some degree.20 
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Cortical pigments are commonly used as co-discriminators within the higher taxonomic 
ranks. For example, the anthraquinone parietin ( 1.10) and several closely related 
derivatives produce the distinctive yellow-orange coloured thallus characteristic of the 
lichen family Teloschistaceae. At the generic level, the presence of several cortical 
polyketides, including atranorin (1.11) and usnic acid (1.9), was used by Elix as a 
correlative character in his delimitation of the family Parmeliaceae.27 
The normally colourless compounds found in the lichen medulla are most often used as 
discriminators at the species level. 2° Chemical discrimination between species has been 
the subject of some controversy although the debate today is not over the validity of 
chemotaxonomy at the species level, but rather the precise application of chemical 
variation to taxonomic systems. 28-30 
1.3 Major Biosynthetic Classes of Lichen Secondary Metabolites 
The categorisation of lichen secondary metabolites according to their probable 
biosynthetic origin was first proposed by Asahina and Shibata in 1954. 31 Subsequent 
discoveries have resulted in several modifications; the most recent revision was reported 
by Culberson and Elix in 1986. 16 An overview of the principle classes of lichen 
secondary metabolites, listed according to their probable biosynthetic pathway, appear 
below. 
The Major Biosynthetic Classes of Lichen Secondary Metabolites 
1. Acetyl-polymalonyl Pathway 
Secondary aliphatic acids, esters and related derivatives 
Polyketide derived aromatic compounds 
Mononuclear phenolic compounds 
Di-, Tri- and Tetra-aryl derivatives of simple phenolic units 
Depsides and benzy 1 ethers 
Tri- and tetradepsides 
Depsidones 
Diphenyl ethers 
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Depsones 
Dibenzofurans and usnic acid derivatives 
Anthraquinones 
Chromones 
N aphthoquinones 
Xanthones 
2. Mevalonic acid Pathway 
Mono-, di-, tri,- sester- and sesquiterpenes 
Steroids 
Carotenoids 
3. Shikimic acid Pathway 
Aromatic amino acids 
Pulvinic acid derivatives 
Terphenyls 
Terphenylquinones 
9 
Lichen metabolites which arise via the acetyl-polymalonyl and shikimic acid pathways are 
discussed in greater detail in the following sections. 
1.4 The Acetyl-polymalonyl Pathway 
Metabolites which originate via the acetyl-polymalonyl pathway (polyketides or 
acetogenins) are derived from the head to tail combination of ~-ketomethylene units. 
These metabolites make up approximately 80% of the secondary products found in 
lichens. 20 Lichen polyketides are typically aromatic and often display characteristic 
hydroxylation patterns resulting from the alternating ketene residues. 
The theory of polyketide biosynthesis has its ong1ns in the work of Collie, who 
performed a series of experiments on the condensation and cyclisation of synthetic 
polyacetyl (ketomethylenic) compounds at the turn of the twentieth century.32-34 This 
work received scant attention for some fifty years until Birch independently postulated 
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that many aromatic natural products might arise via a biosynthetic route analogous to fatty 
acid biosynthesis, namely the head to tail linkage of acetate units. 35 
By using labelled acetate in feeding experiments with the mould Penicillium 
griseofulvum, Birch was able to provide experimental support for his acetate 
hypothesis. 36,37 Subsequent in vivo labelling experiments using Penicillium moulds38 ,39 
and lichens40 revealed that while the starter units of the metabolites studied were indeed 
derived from acetate, the chain extension moieties originated from malonate units. 
Polyketides are known to be assembled by multifunctional enzyme complexes called 
polyketide synthases. These enzyme complexes contain many common features with the 
fatty acid synthases of primary metabolism. Fungal polyketide synthases are made up of 
a large multi-functional polypeptide which contains all the necessary enzymic functions as 
discrete catalytic domains.41 The enzymes responsible for polyketide synthesis have been 
isolated from a number . of species of fungi, and recent studies have included the 
manipulation of these synthases to prepare unnatural polyketides for biological 
testing. 42.43 
In polyketide biosynthesis, both the chain starter and extension units are bound via 
thioester linkages to the polyketide synthase where condensation takes place (Figure 
1. 3). Subsequent condensations occur with the growing acyl chain which remains 
enzyme bound until a chain of the correct length is formed. The chain is then released to 
give an enzyme-free intermediate which can then undergo further enzyme catalysed 
modification to yield the final polyketide. Secondary functionalisation (e.g. oxidation, 
reduction, methylation and chlorination) can occur either during the chain assembly 
process or after the chain has been assembled. 
1.5 Lichen Polyketides 
The majority of acetyl-polymalonyl-derived lichen secondary metabolites result from the 
union of two or three polysubstituted phenolic units through oxidative coupling (either 
C-C or C-O bond formation) or intermolecular esterification processes. A second group 
of lichen polyketides are thought to originate via the cyclisation of a single polyketide 
chain. Metabolites arising from both of these groups are briefly discussed below. 
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Figure 1.3: Polyketide biosynthesis 
1. 5 .1 Depsides, Dibenzofurans and Related Polyphenols 
The phenolic subunits that give rise to this group of lichen polyketides are presumed to 
emanate via the condensation of one acetyl CoA starter unit and three malonyl propagating 
moieties to form the hypothetical 3,5,7-trioxooctanoic acid derivative (1.12) (Figure 
1.4). 
The thiol ester 1.12 can theoretically cyclise in three ways. An intramolecular aldol 
condensation between the C-2 methylene group and the C-7 keto moiety would be 
expected to lead to orsellinic acid (1.13). Regioselective C-methylation of the polyketide 
chain 1.12 prior to cyclisation and aromatisation could then give rise to /3-orsellinic acid 
( 1.14). These two phenolic units are precursors for the majority of the polyphenols 
discussed in this section, i.e. the depsides, diphenyl ethers, dibenzofurans, depsidones 
and depsones. 
Claisen condensation between the C-1 carbonyl and C-6 methylene group results in an 
alternative cyclisation product, phloracetophenone (1.15). This type of intermediate has 
been postulated in the biosynthesis of usnic acid (1.9) and related dibenzofurans. A third 
mode of cyclisation involves an aldol condensation between the C-3 carbonyl and C-8 
methyl group and would be expected to give 3,5-dihydroxyphenylacetic acid (1.16). It 
is of interest to note that this structural residue has not been observed in lichens. 
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Figure 1.4: Proposed derivation of depsides, dibenzofurans and related polyphenols 
Depsides, diphenyl ethers, dibenzofurans, depsidones and depsones are derived via the 
intermolecular esterification and/or oxidative coupling of orsellinic ( 1.13) and 
/3-orsellinic ( 1.14) acid precursors. Figure 1. 5 illustrates the proposed biosynthetic 
inter-relationships between these lichen-derived structural classes while Figure 1. 6 
provides a quantitative measure of the constituents of these classes. 
One of the most important developments in recent years has been the recognition of the 
key role played by p-depsides, the largest group of lichen substances, in the biogenesis of 
m-depsides, diphenyl ethers, dibenzofurans, depsidones and depsones. 
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As discussed earlier, the enzyme bound 3,5,7-trioxooctanoic acid thioester (1.12) can 
cyclise to form orsellinic acid (1.13), or undergo C-methylation and subsequent 
cylisation to form ,B-orsellinic acid (1.14) and phlorocetophenone (1.15) derivatives. 
The intermolecular esterification of orsellinic derivatives gives rise to the p-depsides while 
the oxidative coupling of phlorocetophenone residues yields the usnic acids. Additional 
condensation of the depside unit with a further orsellinic moiety 1.13 affords the 
tridepsides. The natural occurrence of a tetradepside has also been reported. 
27 
174 
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Derivatives 
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• Depsones 
Iii Simple Phenols 
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Figure 1. 6: Relative proportions of known depsides, dibenzofurans and related 
derivatives19 
One of the most intriguing biosynthetic relationships is that between p- and m-depsides. 
In 1986 Elix and Gaul observed the co-occurrence of the m-depside, m-scrobiculin 
(1.17) and the corresponding p-depside, p-scrobiculin (1.18) in a dynamic 
equilibrium. 44 
CO2Me OH 
H7C3 HOAC3H7 HOJ::XC02Me 0 I H7C3 () I 
O' T r(Y "O ~ C3H7 
MeO.., ~ ...._OH OH MeO 
(1.17) (1.18) 
These workers proposed that m-depsides might arise biosynthetically via C-hydroxylation 
of the B-ring of a p-depside followed by rapid intramolecular rearrangement to give the 
thermodynamically more stable meta-isomer. The co-occurrence of closely related p- and 
m-depsides such as divaricatic acid (1.19) and sekikaic acid (1.20) in a number of 
,, 
I 
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Ramalina species provides further circumstantial evidence support for such a proposal 
(Figure 1. 7).44 
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Figure 1. 7: Proposed biosynthesis of the m-depside sekikiac acid ( 1.20) 
Perhaps equally interesting are the proposed biosynthetic relationships between diphenyl 
ethers, depsidones and p-depsides. The majority of lichen diphenyl ethers are closely 
related to depsidones and many co-occurring diphenyl ether/ depsidone paus, e.g. 
norlobariol (1.21) and norlobaridone (1.22), are known.45 
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Furthermore, many isostructural p-depside - depsidone pairs, e.g. olivetoric acid 
(1.23) and physodic acid (1.24) have also been observed in the same organism. 16 
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The co-occurrence of such p-depside/ depsidone 
16 
CsH11 
0~ 0 
\\ 
0 
HO' 'v" 'o OH 
OH 
If 
0 
(1.24) 
paus led Elix, Jenie and Parker to 
suggest that p-depsides were biosynthetic precursors of the structurally related 
depsidones. 46 Elix and co-workers proposed that diphenyl ethers, derived 
biosynthetically from p-depsides, could undergo cyclisation to the corresponding 
depsidone. This transformation, known as the Smiles rearrangement, is shown in 
Figure 1.8. Further circumstantial evidence for the biogenesis of diphenyl ethers from 
p-depsides is provided by the co-occurrence of superlatolic acid (1.25) and micareic acid 
(1.26) in chemical races of the lichen Micarea prasina. 16 
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Figure 1. 8: Proposed biosynthesis of micareic acid ( 1. 2 6) via the Smiles 
rearrangement 
The remaining structural subclasses, dibenzofurans and depsones, are postulated to arise 
via the oxidative coupling of suitably substituted diphenyl ether and depside precursors, 
respectively (Figure 1.9).47-50 
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Figure 1.9: Proposed biosynthesis of dibenzofuran and depsone derivatives 
1.5.2 Single Chain Polyketide Derivatives 
The second major group of polyketide-derived lichen metabolites are far less numerous 
than the multinuclear polyphenols described above and comprise compounds which are 
presumed to be biosynthesised from a single polyketide chain. 16,51 ,52 Four major classes 
have been identified and examples of each group are shown in Figure 1.10. 
OH 0 Me 0 0 0 I OMeO 
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Figure 1.10: Major classes of single chain derived polyketides 
Unlike the polynuclear phenol derivatives described in § 1.5.1, members of these 
structural classes are found widely in free-living fungi. As shown in Figure 1.11, the 
majority of these single chain poly ketides are xanthones, e.g. thuringione ( 1. 2 7) isolated 
from Lecidella carpathica, or anthraquinones, e.g. haen1atommone (1.28) found in 
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Haematomma puniceum.19 Lichen-derived chromones, such as eugenitol (1.29) isolated 
from the mycobiont of Lecanora rupicola, and naphthoquinone derivatives, e.g . 4' -
hydroxy-8-methoxytrypethelone methyl ether (1.30) from the mycobiont of 
Trypethelium eluteriae, are far fewer in number with less than a score of each 
characterized and identified.19 
3 
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II Anthraquinones 
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Cl Napthoquinones 
II Xanthones 
• Miscellaneous 
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Figure 1.11: Relative numbers of single chain derived polyketides19 
Most of these single chain polyketide derivatives appear as pigments in the lichen cortex 
or medulla. While the chemistry of pigments found in a large number of Northern 
Hemisphere lichens have been examined, many pigmented Australasian lichens have yet 
to be investigated. 
1.5.3 Recent Developments in Lichen Polyketide Chemistry 
A number of orsellinic and /3-orsellinic acid derivatives have been isolated recently. The 
tridepside trivaric acid (1.31) was recently reported from the Ramalina americana 
chemotype complex by Culberson and co-workers.53 Elix and co-workers have isolated 
three new depsidones including 2-methoxypsoromic acid54 (1.32) identified in a number 
of Pertusaria and Sulcaria species; chalybaeizanic acid (1.33) , isolated from 
Xanthoparmelia amphixanthoides and quaestitic acid ( 1. 34) isolated from Hypotrachyna 
quaesita. 55 Interestingly, two brominated depsidones have also recently been reported. 
Acarogobien A (1.35) and B (1.36) were isolated fron Acarospora gobiensis.56 
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In contrast, little work has been reported on lichen substances derived from single 
polyketide chains in recent years. In early 2000, Hamada reported the isolation of two 
new isocoumarins, 8-methyldichlorodiaportin (1.37) and 6,8-dimethylcitreoisocoumarin 
(1.38), from the mycobiont cultures of several Graphis species. 57 Two new xanthones, 
1,5,8-trihydroxy-3-methylxanthone (1.39) and 1, 7-dihydroxy-5-methoxy-3-
methylxanthone (1.40) were also recently isolated from the cultured mycobionts of 
Pyrenula japonica and Pyrenula pseudobuf onia. 58 
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1.6 The Shikimic Acid Pathway 
Shikimic acid (1.41) plays a pivotal role in the biosynthesis of the three proteinogenic 
amino acids, phenylalanine (1.42), tyrosine (1.43) and tryptophan (1.44). These 
aromatic amino acids are, in turn, used in the construction of primary metabolic 
macromolecules such as peptides and proteins and are also precursors for numerous 
classes· of secondary metabolites.17,59-62 
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The importance of shikimic acid (1.41) in the biosynthesis of the aromatic amino acids 
was first revealed by Davis in the early 1950' s - some sixty years after its initial 
isolation from the fruit of the Japanese plant lllicium religiosum (Shikimi-no-ki). Davis 
elucidated several of the early metabolic sequences in the shikimic acid pathway through 
the concurrent use of isotopically labelled precursors, enzyme studies and auxotropic 
(growth factor deficient) mutant bacteria.63 
The biosynthesis of shikimic acid is outlined in Figure 1.12. The first step is known to 
involve a stereospecific aldol-type condensation between phosphoenolpyruvate (1.45) 
and D-erythrose-4-phosphate (1.46).64,65 
The resultant intermediate, 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP) 
( 1. 4 7), has been postulated to undergo an oxidation, dephosphory lation, cyclisation 
sequence ( all steps apparently catalysed by a single enzyme) to yield 3-dehydroquinic acid 
(1.48). 66-68 The proposed mechanism is shown in Figure 1.13. 
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Figure 1.12: Biosynthesis of shikimic acid (1.41) 
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Figure 1.13: Mechanism for the synthesis of 3-dehydroquinate (1.48) 
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NAD oxidation of the herniketal form of DAHP (1.49) to the ketone 1.50 allows the 
phosphate group to act as an intramolecular base, facilitating dephosphory lation. 
Reduction of the ketone 1.51 gives the corresponding alcohol 1.52. This is followed by 
abstraction of another proton to initiate ring opening and subsequent cyclisation to 
produce the dehydroquinate (1.48). 
The subsequent formation of 3-dehydroshikimate (1.53) (Figure 1.12) which involves 
the syn-elimination of water, is equally intriguing. The formation of an enzymic Schiff' s 
base 1.54 has been suggested as a possible mechanism.69-71 The sequential loss of a 
proton, from the protonated imine 1. 5 4, and a hydroxy ion ( or equivalent), from amine 
1.55, would then be followed by hydrolysis of the resultant Schiff' s base. Reduction of 
dehydroshikimate (1.53) then provides shikimic acid (1.41). 
The biosynthesis of the aromatic amino acids 1.42) and 1.43 from shikimic acid (1.41) 
also involves several mechanistically interesting steps (Figure 1.14). Selective 
phosphorylation of shikimic acid (1.41) is followed by condensation of the phosphate 
(1.56) with phosphoenolpyruvate (1.45) to give the enolpyruvyl ether 1.57. A 
reversible addition-elimination mechanism involving the formation of a tetrahedral 
intermediate 1.58 was first proposed by Sprinson based on several deuterium and tritium 
incorporation studies conducted on the enzymic system.72,73 This type of reaction is 
exceedingly rare in biological systems.4 Additional evidence for this mechanism was 
provided by subsequent isolation and characterisation of the proposed intermediate 
1.58.74 
1,4-Conjugate elimination from the enol ether 1.57 occurs stereospecifically, with loss of 
the phosphate group and the pro-6R hydrogen to give chrorismic acid (1.59).64,75 A 
concerted anti-1,4-elimination is chemically unfavourable, and it has been suggested that 
the elimination reaction proceeds via an enzyme bound intermediate 1.60. 64 
Transformation of the resultant diene 1.59 to prephenic acid (1.61) is proposed to occur 
via the only known naturally occurring example of a Claisen-type 3,3-sigmatropic 
rearrangement. The enzymic mechanism has been the subject of much speculation and 
several mechanisms have been proposed and reviewed.59,76,77 
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Figure 1.14: Biosynthesis of phenylalanine ( 1.42) and tyrosine ( 1.43) 
The formation of L-phenylalanine (1.42) and L-tyrosine (1.32) from prephenate (1.61) 
is known to proceed along several pathways. 17,59 The phenylpyruvate route begins with 
initial decarboxylation and dehydration to give phenylpyruvic acid (1.62) followed by 
transamination to yield the amino acid 1.42. Alternatively, the L-arogenate route involves 
transamination of the a-diketoacid 1. 61 to give L-arogenic acid ( 1.63) and subsequent 
elimination of carbon dioxide to yield L-tyrosine (1.43). 
1. 7 Lichen Shikimates 
Shikimic acid-derived lichen substances are far fewer in number ( <5%) than the 
secondary metabolites thought to originate via the acetyl-polymalonyl and mevalonate 
pathways.19,20 Shikimate-derived natural products can be divided into two broad groups; 
those which retain nitrogen atom(s) within their carbon frameworks and those which do 
not. Both groups are observed in lichens although non-nitrogen-containing shikimates 
[derivatives of phenylpyruvate (1.62)] predominate. All lichen shikimates are thought to 
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originate via the phenylalanine ( 1. 4 2) or tyrosine ( 1. 4 3) branches of the shikimic acid 
pathway. 
1. 7 .1 Phenylpyruvate Derivatives from Lie hens 
Three classes of lichen shikimates, p-terphenyls, p-terphenylquinones and pulvinic acid 
derivatives, are thought to derive from phenylpyruvate. Examples of the three classes are 
shown in Figure 1.15. 
Though members of all three classes have been isolated from both lichenized and non-
lichenized fungi, pulvinic acid derivatives are rarely found in non-lichenized fungi. Three 
carboskeletons have been observed in the pulvinic acid derivatives, as represented by 
pulvinic acid (1.64), pulvinic dilactone (1.65) and calycin (1.66). All three of these 
derivatives have been isolated from Pseudocyphellaria coronata.78 
OH !'0 ...... \\ --- OHO HO 0 
(1.64) (1.65) (1.66) 
OH nOMe OR1 
OH ~ R1 R2 R3 
(1.68) Me Ac Me 
HO~ I r( V II 'I I OR2 (1.69) Me Me Ac 
MeO,... ~ OR3 (1.70) Ac Ac Me HO i - --~ 
Figure 1.15: Lichen shikimates derived from phenylpyuvate 
The highly coloured p-terphenylquinones, e.g. thelephoric acid (1.67) from Lobaria 
retigera,51 and the pulvinic acids have long been known as pigments in a variety of lichen 
genera. In contrast, the colourless p-terphenyls have only been recently identified in 
lichens. The first lichen-derived p-terphenyls were reported from Relicina connivens in 
1994. Butlerins A (1.68) and B (1.69) were isolated as an equimolar mixture while 
butlerin C, identified as a diacetate, was tentatively assigned structure 1. 7 0. 7 9 
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p-Terphenyls and p-terphenylquinones are more commonly found in microfungi and 
wood rotting basidiomycetes respectively. 80,81 
Direct evidence regarding the biosynthetic origins of lichen shikimates is scant, though 
hypothetical pathways based on biosynthetic studies of analogous fungal products have 
been proposed. Feeding studies by Vining and his co-workers using 14C labelled 
precursors showed that shikimic acid (1.41) and L-phenylalanine (1.42) are readily 
incorporated into terphenyllin (1. 71), a fungal p-terphenyl isolated from Aspergillus 
candidus. 82 In addition, earlier work by Vining on the microfungal p-terphenylquinone 
volcrisporin ( 1. 7 2) suggested that the biosynthesis of this metabolite most probably 
proceeded via phenylpyruvic acid (1.62).83,84 
HO OMe 
(1.71) 
OH 
OH 
OH 
(1.72) 
The carboskeleton of lichen p-terphenyl derivatives is presumed to form via the Claisen-
like condensation of two moles of p-hydroxyphenylpyruvic acid (1.73). This reaction is 
facilitated by the highly activated methylene group which is both benzylic and a- to a 
carbonyl group. The condensation reaction yields the bisquinone intermediate 1. 7 4 
which equilibrates with its enol tautomer 1.75 (Figure 1.16). 
Labelling studies using the lichen Pseudocyphellaria crocata have shown that the 
diphenylbutenolide skeleton of several pulvinic acid derivatives can be derived from 
p-terphenylquinone precursors. 85 
OH 
0 
0 
(1.73) 
OH OH 
HO HO 
Figure 1.16: Proposed biosynthesis of lichen p-terphenyl derivatives 
OH 
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A possible reaction sequence, proposed by Maass, 85 is outlined in Figure 1.1 7 . 
Oxidative fission of the quinone 1. 7 6 may yield the diene 1. 7 7 which could then 
lactonise to give pul vinic acid ( 1.64). 
OHHO 
(1.77) 
Figure 1.17: Proposed biosynthesis of the pulvinic acids 
1. 7. 2 Lichen Shikimates Derived from Amino Acids 
OHHO 
(1.64) 
Less than a dozen aromatic amino acid derivatives have been isolated from lichenised 
fungi. 19 The first of these compounds, picroroccellin86,87 (1. 78), was isolated from 
Roccellafuciformis in 1877. Other derivatives include sticticin88 (1.79), from Lobaria 
laetevirens; hypothallin89 (1.80), isolated from Schismatomma hypothallinum, 
roccanin90,91 (1.81), isolated from Roccella canariensis and the scabrosin esters92 
isolated from Xanthoparmelia scabrosa. 
R1 =Hor Me 
R2 = Me or H 
( 1.78) 
HO 
HO 
C02Me 
(±)N(Meb 
0CI 
(1.79) 
~o 
0 0 NH 
~ 
(1.80) 
Several of these derivatives are worthy of further comment. Despite a large systematic 
search, picroroccellin (1. 78), isolated by Stenhouse and Groves in 1877, has defied all 
subsequent reisolation efforts.93 The lack of isolated material has severely hampered 
efforts to elucidate the structure of picroroccellin. However, the preparation of numerous 
dibenzyl-2,5-piperazinedione analogues by Elix. and Marcuccio has resulted in a revision 
of the structure proposed some six decades earlier. 94,95 Prior to our work, the structures 
of the scabrosin esters were also uncertain. A nonacyclic system 1. 8 2 was proposed for 
1; 
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the scabrosin core, though alternative structures were also possible based on the available 
evidence. 92,96 
HN ~o~~ 
NH 
OH 
HO ( 1.81) 
1.8 Biological Activities of Lichen Natural Products 
Lichens have been used as traditional medicines in many cultures throughout the ages and 
are still used by some indigenous societies today.97-99 
One of the first reported pharmaceutical use of lichen substances dates back to the ancient 
Egyptians who used preparations of Pseudevernia fuifuracea [ which contains the 
biologically active depsidone physodic acid ( 1.24)] in the 17th and 18th centuries BC. 
The father of modem medicine, Hippocrates, recommended U snea barbata [ containing 
usnic acid (1.9)] for uterine trouble while another member of the genus (Usnea 
longissima) [containing usnic acid (1.9) and the depside diffractaic acid (1.83)] was 
used by the ancient Chinese as an expectorant and for the treatment of ulcers. 97 
Me 
-~/ 
0 
0 HO~ A () Me 0, O Me 
0 ~ 11~0H Me OH 
HO' '---1/ "o--<( 1 OH HO Me MeO' I 'OMe "~ 
0 0 Me(1.83)Me ( 1-24) H11 Cs (1.9) Me 
In medieval Europe it was believed that plants that were useful in the treatment of disease 
bore a physical resemblance to the part of the human body which was afflicted. Thus the 
bright yellow lichen Xanthoria parietina was deemed suitable for treating jaundice, long 
hair-like Usnea species were used to treat disorders of the scalp while the tree lungwort 
Lobaria pulmonaria was thought to cure pulmonary tuberculosis due to the resemblance of 
the organism's surface to lung tissue. 100,lOl The 'Doctrine of Signatures' (similia 
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similibus), as this system of belief became known, formed the basis of European medical 
treatment for centuries. 
Indeed, the distinguished physician Dr Richard Mead, physician to King George II, is 
reported to have prescribed a 'certain cure for the bite of a mad dog'. The treatment 
involved the patient being bled of half a pint of blood, administered half an ounce of dried 
common dog lichen (Peltigera canina) in milk seasoned with black pepper and given a 
cold bath in lieu of breakfast every day for a month. 101 Perhaps unsurprisingly, an 
eighteenth century critic later commented: 
It is much to be lamented that the success of this medicine has not always 
answered expectations ... IOI 
While modem testing of many of the lichen extracts used in 'Signature' preparations 
show them to lack scientific foundation, many traditionally used lichen remedies have 
been found to have a legitimate basis. 
The discovery of penicillin during W odd War II stimulated considerable interest in the 
chemical constituents of lichens and the biological activity of lichen substances. Although 
a large number of lichen substances proved to be antibiotics, their activity was generally 
low compared to products obtained from other microorganisms. Low water solubility 
was a further drawback in the potential therapeutic use of lichen substances. 
Usnic acid (1.9) is the best known bioactive lichen substance. It has been shown to be a 
powerful plant growth regulator, 102 antibiotic, lOO tumour inhibitor103,104 and also 
exhibits antiviral, analgesic and antipyretic activity. 105 The dibenzofuran (1.9) was 
marketed in several European countries for the treatment of impetigo, ecthyma, dermatitis 
and infected eczema. However the commercial production of the usnic acid preparation 
ceased, in part due to the decreased abundance of the raw material. Approximately 40 kg 
of lichen was required to make 1 kg of U sno, a water soluble ammonium chloride salt of 
usnic acid. Interestingly U sno was found to be effective against tetracycline resistant 
bacteria. 100 A second lichen substance with notable activity is the p-terphenylquinone, 
polyporic acid (1.84). This metabolite was observed to possess potent in vivo 
antitumour activity.106,107 
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The tremendous advances in technology combined with an ever increasing understanding 
of the chemistry and biology of secondary metabolites has initiated a resurgence of 
interest in the potential biological activities of lichen secondary metabolites. 
Recently, the tridepside gyrophoric acid (1.85), the dibenzofuran usnic acid (1.9) and 
the depside diffractaic acid ( 1. 8 3) were shown to be potent antiproliferati ve agents 
inhibiting human kerainocyte growth with IC5o values of 1.7, 2.1 and 2.6 µM , 
respectively .1°8 Other studies have shown the depsides atranorin ( 1.11) and diffractaic 
acid (1.83) and the aliphatic lactone, protolichesterinic acid (1.86) were shown to inhibit 
leukotriene B4 biosynthesis in polymophonuclear leukocytes. 109 Protolichesterinic acid 
(1.86) has also been shown to inhibit HIV-1 reverse transcriptase. 110 
The depsidone lobaric acid (1.87) has been shown to inhibit the formation of cysteinyl-
leukotrienes (potent inflammatory agents) with an effective dose of 5.5 µM. 111 Usnic 
acid (1.9) and a number of depside derivatives have also been reported to inhibit tumour 
promoter-induced Epstein-Barr virus activation112 while polysaccharides isolated from 
Cetraria islandica have been found to have significant immunological activity. 113 
Me 0 
HO 
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OH 
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1.9 Aims of this Work 
The present work details the chemical investigation of a number of lichen shikimate and 
polyketide derived secondary metabolites. 
Chapters Two through Five report the isolation, characterisation and structural elucidation 
of five new polyketide-derived lichen pigments. These natural products were isolated 
from mycobiont cultures of the North American lichen Leconora hybocarpa (Tuck.) 
Brodo and three Australasian lichens: Flavoparmelia euplecta Stirt. (Hale), 
Pseudocryphellaria coronata (Miill. Arg.) Malme and Myelconis erumpens McCarthy & 
Elix respectively. Three of the isolated lichen compounds were observed to contain 
carbon frameworks not previously observed in lichenized fungi. Furthermore, one of the 
newly isolated metabolites was found to possess a carboskeleton unprecedented in the 
chemical literature. The cytotoxic activities of the majority of the new lichen metabolites 
were also evaluated. 
Chapter Six describes the total syntheses and unambiguous structural assignment of three 
shikimate-derived lichen p-terphenyls. In addition, the total synthesis of two further 
p-terphenyls not yet observed in Nature was accomplished. Finally, Chapter Seven 
details the reisolation and structure revision of a family of piperazinedione derivatives 
previously found in the lichen Xanthoparmelia scabrosa. The antiproliferative activities of 
several of the scabrosin esters were also evaluated. 
~., 
I 
~ 
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2.1 Lichen Mycobiont Cultures: A Source of New Metabolites 
The cultivation of spore-derived lichen mycobionts has attracted increasing attention over 
recent years, in both university and industrial laboratories around the world. 1,2 Much of 
this work has been fuelled by the drive for new bioactive metabolites and has resulted in 
the isolation of numerous previously unknown secondary products. 3-9 
Recent examples of such metabolites include the dibenzofuran hypostrepsilalic acid ( 2 .1) , 
isolated from mycobiont cultures of the lichen Stereocaulon japonicum;4 the quinone, 
graphisquinone (2.2), from cultures of Graphis scripta and Graphis desquamescens;5 the 
benzopyranone, graphislactone B (2.3 ), from the mycobiont of Graphis scripta var. 
pulverulenta;6 cristazarin (2.4), a naphthazarin obtained from spore-derived cultures of the 
lichen Cladonia cristatella;7, and 1,8-dihydroxy-5-methoxy-3-methylxanthone (2.5) from 
the cultured lichen mycobionts of Pyrenula japonica and Pyrenula pseudobuf onia. 8 
0 OMeO 
II CHO CH3 COOH Meo~ ~ i:C 'O 
MeO I -& J.__ .OH Me 
HO~ ~OH MeO' r( -u 
0 ,.,,,__,,.. ~ 'OMe 
,, __ .. (2.1) (2.2) 
OH 0 OH 
I II 
Et 
MeO' I '1( 'OH ylU 0 Me 
OH 0 OMe 
(2.4) (2.5) 
Very recently, the isolation of two isocoumarin derivatives, 8-methyldichlorodiaportin 
(2.6) and 6,8-dimethylcitreoisocoumarin (2. 7), has been reported from the mycobiont 
cultures of several Grap his species. 9 
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This chapter describes the isolation and structural elucidation of hybocarpone (2.8), a 
novel bisnaphthazarin derived pentacycle, from the cultured mycobiont of Lecanora 
hybocarpa (Tuck.) Brodo. The structure of hybocarpone (2.8) was established by 
spectroscopic methods and its relative configuration predicted by molecular modelling. 
The proposed structure and stereochemistry were confirmed by single crystal X-ray 
analysis. Hybocarpone (2.8) was found to exhibit potent cytotoxicity against the murine 
P815 mastocytoma cell line and this activity is also discussed. The dinaphtho[2,3-b:2,3-
d]tetrahydrofuran-tetraone carbon skeleton of this pigment 2.8 has not previously been 
recorded in the chemical literature. 
HO OH 
0 Mj OH ·o 
(2.8) 
2.2 Collection, Cultivation and Isolation 
The lichen Lecanora hybocarpa (Tuck.) B rodo t is endemic to North America. It has a 
wide distribution throughout the deciduous forest regions of the eastern United States and 
has also been observed in scattered localities on the west coast of the continent. Previous 
investigations of the chemistry of L. hybocarpa have identified the depside atranorin 
(2.9), roccellic acid (2.10) and traces of unidentified substances. 10 
Me 0 Me 
\\ 
0, ~ ... OH H02C C02H 
H,,H Me 1'' 
HO' Y 'OH I 'C02Me H (CH2)11CH3 
Me 
(2.9) (2.10) 
Specimens of the lichen were collected from woodland in Louisiana, United States of 
America by Dr Hamada. Colonies of the lichen mycobiont were cultivated for eight 
months during which time they changed in colour from yellow to red. They were then 
t A voucher specimen, identified by Dr H. T. Lumbsch (Essen, Germany), is deposited at the Institute of 
Public Health and Environmental Sciences, Osaka City, Japan (NH 95112689). 
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harvested, dried and extracted exhaustively with acetone. The resultant residue was sent to 
our laboratory in Canberra for further investigation. 
Standardized HPLC analysis11 ,12 revealed that the acetone extracts contained a mixture of 
the known xanthones, arthothelin13 (2.11) and 6-O-methylarthothelin14 (2.12) and an 
orange-red pigment of unknown structure. The mixture was separated using repeated 
fractional crystallisation, yielding the unknown metabolite, hybocarpone (2.8), as the 
major product (45 mg, 0.65%). The identities of the two minor xanthones 2.11 and 
2.12 were confirmed by comparison with authentic, synthetic material (TLC, HPLC, UV 
and MS). 
HO 
Me O OH 
Cl (2_11 ) Cl 
Cl 
OH Meo 
Me O OH 
Cl Cl (2.12) 
2.3 Structural Elucidation 
Cl 
OH 
Hybocarpone (2.8) precipitated from aqueous ethanol as a fine orange red powder. 
Examination of the UV absorption spectrum suggested the pigment was a 
polyhydroxylated naphthoquinonoid derivative15 while IR absorption bands at 3382, 
1652, 1632 and 1596 cm-1 indicated the presence of hydroxy groups and conjugated 
carbonyl moieties, respectively. 
A naphthazarin framework was indicated by the 1 H NMR spectrum which exhibited two 
strongly chelated phenolic protons at 8 10.94 and 8 13.13 (Table 2.1). Two additional 
hydroxy protons were evident as broader singlets at 8 4.90 and 8 6.57 and a singlet 
consistent with an aromatic methyl group was observed at 8 2.28. A triplet at 8 0.68 and 
two multiplets at 8 2.26 - 2.36 and 8 2.60 - 2.66 indicated the presence of an ethyl 
functionality, however the chemical shift of these signals were uncharacteristically upfield 
compared to the typical polyhydroxynaphthoquinone systems of 6-methylcristazarin 7 
(2.13) (8 1.03 t; 8 2.47 q) and triacetylsquamarone16 (2.14) (8 1.11 t; 8 2.58 q) 
(Figure 2.1). 
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High resolution mass spectrometric analysis of hybocarpone (2.8) showed a molecular 
ion at 544.1218, corresponding to a molecular formula of C26H24O13. The EIMS showed 
few fragment ions of significant intensity aside from the base peak at m/z 264 
(corresponding to C 13H 120 6). These observations, coupled with the low number of 
signals present in the 1 H NMR spectrum indicated that hybocarpone (2.8) was an oxo-
bridged dimer with a high degree of symmetry. 
8 2.47 (q) 
~ 0 OH 
8 1.03 (t) c:::::> 
0 OH 
(2.13) 
Me 
OMe 
8 2.58 (q) 
~ 
8 1.11 (t) 9 
OAc 0 
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(2.14) 
Me 
OAc 
Figure 2.1: 1H NMR chemical shifts of the ethyl moiety in 6-methylcristazarin7 (2.1 3) 
and triacetylsquamarone 16 (2.14) 
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Table 2.1: 1H and 13C NMR data of hybocarpone (2.8) 
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Figure 2.2: 13C NMR spectru,n of hybocarpone (2.8) 
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The dimeric nature of the molecule was also apparent in the 13C NMR spectrum of 2. 8 
(Figure 2.2). Thus, the thirteen signals observed were consistent with two pairs of 
carbonyl carbons, twelve aromatic carbons (including six with oxy-substituents), two 
pairs of quaternary carbons at 8 99 and 8 67, two methyl groups and a pair of ethyl 
substituents. APT and gHMQC pulse sequences were used to confirm the assignment of 
chemical shifts associated with protonated carbons. 
Figure 2. 3 shows the two and three bond heteronuclear connectivities supporting the 
proposed structure for hybocarpone (2.8) (also presented in Table 2.1 ). 3Ic8 
correlations between the methyl group protons at 8 2.28 and C-5, C-7 in addition to those 
observed between the peri-hydroxy protons and their neighbouring carbon atoms (e.g. 8 
13.13 and C-6, C-8) allowed the substituents and substitution pattern of the aromatic rings 
to be determined with certainty (Figure 2.3A and Figure 2.3B ). In a similar manner, 
the 3 Jc8 correlations involving the ethyl methylene protons, and those associated with the 
hydroxy proton at 8 4.90 provided strong support for the tetrahydrofuran fragment shown 
in Figure 2.3C. 
l 
l 
0 H"'O 
B 
\ 
C 
Figure 2.3: Long range correlations observed in the gHMBC spectrum of 2.8 (dashed 
correlations indicates correlation between one methylene proton only) 
Further evidence for the proposed tetrahydrofuran substructure was provided by the 13C 
chemical shift data. In particular, the signal attributed to C-1 at 8 99 is typical for a 
hemiacetal moiety while the signals corresponding to the carbonyl carbons (8 193, 198) 
are consistent with a partially saturated quinonoid derivative. Typical quinone carbonyls 
resonate further upfield in the range 8 170 - 185.7,16 
Consideration of the probable polyketide origins of hybocarpone resulted in the proposed 
structure 2.8 being deemed more likely than the corresponding regioisomer 2.15. Indeed 
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there have been two reports in the literature which have described the characterisation of 
lichen-derived ethylmethylnaphthoquinones: the cristazarins7 (2.4) and (2.13) and 
squamarone 16 (2.16). In both cases the location of the sidechains, at positions C-3 and 
C-6, were consistent with the probable polyketide origins of the lichen metabolites. 
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Additional evidence was provided by a comparative study of peri-hydroxy proton chemical 
shift values based on a series of empirical guidelines described by Moore and Scheuer. 17 
As shown in Figure 2.4, the 8-hydroxy proton of the fungal metabolite 3-ethyl-2,7-
dihydroxynaphthazarin (2.17) was reportedly observed at 8 11.72 ppm. 18 In contrast, 
the signal attributed to the corresponding hydroxy proton of hybocarpone was observed 
significantly further upfield at 8 10.94. 
While a number of structural differences between the two compounds are apparent, it was 
considered that such a large upfield shift was consistent with shielding induced by a 
hemiacetal moiety a to the hydrogen bonded carbonyl. Interestingly, further support of 
this hypothesis was provided recently by Anufriev et al. who reported significant shielding 
induced by the gem-dials of 2,2-dihydroxy-2,3-dihydro-naphthazarins (e.g. Figure 2.4) 
on the hydrogen bond of the C-1 carbony I, 19 
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Figure 2.4: 1 H NMR chemical shifts of the peri-hydroxy protons in several naphthazarin 
systems18,19 
2.4 Determination of Relative Configuration 
Having determined the gross structure of hybocarpone, we next sought to establish the 
relative stereochemistry of the four stereogenic centres contained within its framework. 
The isochronicity observed in the 1 H and 13C NMR spectra of hybocarpone indicated that 
the molecule possessed either a twofold axis of rotation (C2) [through the central furan 
oxygen atom and the dimeric C-C bond] or a mirror plane ( cr) of symmetry [perpendicular 
to the plane of the molecule]. This reduced the number of stereoisomeric possibilities for 
the naphthazarin-derived dimer from 24 (= 16) to eight. The four relative configurations 
corresponding to these eight possible stereo isomers are shown in Figure 2.5. 
OH HO OH HO 
HO HO 
I 
., I/· 
- 'O -
oHO : OHO 
I 
C2 symmetry cr symmetry 
OH HO OH HO 
HO HO 
Figure 2.5: The four possible relative configurations of hybocarpone (2.8) 
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At this stage of our investigations it was recognized that the number of possible 
stereoisomers could, potentially, be further reduced through the use of chiroptical 
spectroscopy. If hybocarpone possessed a twofold axis of rotation and, importantly, was 
also enantiomerically pure it would be expected to exhibit optical activity. Conversely, the 
absence of optical activity would, of course, not distinguish between a racemic mixture or 
an enantiomer which contained a mirror plane of symmetry. 20 
Indeed, chiroptical analysis of hybocarpone revealed the metabolite was optically active, 
exhibiting a small negative optical rotation of [a]o - 19.2. This confirmed the presence of 
a C2 symmetry axis and established the relative configuration of the carbon atoms linking 
the two monomeric subunits through a C-C bond (8 67) as R*, R*. The relative 
configuration of the remaining two stereogenic centres were therefore either R*, R* or S * , 
S*. 
2.4.1 Molecular Modelling Studies 
The remaining two stereogenic centres ( the two hemiacetal carbon atoms) of hybocarpone 
presumably arise via the stereoselective intramolecular cyclisation of the 'open chain' 
hydrates 2.18 and 2.19, as shown in Figure 2.6. 4-Hydroxy ketones are known to 
ring close readily under all pH conditions. Such cyclisations are 5-exo-trig processes 
according to Baldwin's rules of ring closure. 21 As a consequence, the cyclisation of the 
hydrates 2 .18 and 2 .19 would be expected to be extremely facile in the aqueous 
environment of the synthesising cell. In order to predict the more thermodynamically 
favoured hemiacetal isomer (i.e. R*, R* and S*, S* at the hemiacetal carbon centres), we 
used molecular modelling studies to calculate the relative energies of the two alternate 
dias tereomers. 
The molecular modelling program Spartan 5.0.3 was utilised on a Silicon Graphic Indigo 
work station. Optimal geometries were calculated using semi-empirical methods with 
AMI parameters while preliminary minimisations were performed with a SYBYL force 
field. In each case, the conformation of the modelled molecule was minimised until the 
heat of formation converged to < 2 J-1 (0.5 cal-1). The molecules investigated were 
modelled in the gas phase. 
HO 
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(2.19) 
48 
OH 
' Me 
-
0 \ . 
Me O 
(2.20) E'ret 49.2 kJ mor1 
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Figure 2.6: Proposed equilibrium between hybocarpone (2.8) and diastereomer 2.20 
These modelling studies revealed a significant energy difference of 49.2 kJ mol- 1 (11.8 
kcal mol-1) between the heat of formation of the R*R*R*R* dihemiacetal (adjacent 
hydroxy and ethyl substituents are syn) and the alternate diastereomer (adjacent hydroxy 
and ethyl substituents are anti) 2.20 (Figure 2.6). 
The difference between the free energy content of two species at equilibrium, the Gibbs 
free energy change of a reaction (~G0 ), can be expressed in terms of enthalpy (~H0 ) and 
entropy (~S 0 ) as shown in Equation 2.1. The relationship between the relative 
stabilities of equilibrating species (~G 0 ) and their relative concentrations at equilibrium 
(Keg) is similarly described by Equation 2.2. 
~G0 = ~ 0 - T~S 0 (Equation 2.1) 
~G 0 = RT ln Keg (Equation 2.2) 
Due to the structural similarity of the two alternate hemiacetal configurations the difference 
in their corresponding entropies would be expected to be negligible. Calculations based on 
such an assumption equate the predicted energy difference of 49.2 kJ mo1-1 to a ratio at 
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ambient temperature of approx. 4.0 x 108 to 1 between the two equilibrating hemiacetals in 
favour of the R*, R* configuration. 
2.4.2 X-ray Crystallographic Analysis 
At this stage of our investigation we were able to obtain a single crystal of hybocarpone 
(2.8) suitable for X-ray diffraction analysis by the slow evaporation of aqueous methanol. 
This study allowed the confirmation of the proposed gross structure of hybocarpone (2.8) 
and also the relative configurations assigned to the four stereogenic centres (Figure 2 . 7 
and Figure 2.8). 
Hybocarpone (2.8) crystallised from a solution of aqueous methanol as small orange red 
prisms. The unit cell was found to contain two molecules of hybocarpone (2.8) and two 
molecules of methanol. Despite the limited precison of the study, resulting primarily from 
the small size of the crystal used, many of the hydrogen atoms were located in difference 
electron density maps. The remainder, with the exception of the hydroxy hydrogen atoms 
of the methanol molecules, could be generated from those which were located. 
0105 
Figure 2. 7: Thennal ellipsoid diagram of hybocarpone (2.8) with selected atom 
labelling. Ellipsoids show 50% probability levels. Hydrogen atoms are drawn as circles 
with small radii. 
(X-ray analysis performed by Dr A. C. Willis) 
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0 
Figure 2.8: Unit cell diagram for 2.8 projected down the b axis. Ellipsoids show 50% 
probability levels. Hydrogen atoms are drawn as circles with small radii. 
(X-ray analysis performed by Dr A. C. Willis) 
Most observed bond lengths and angles were in agreement with typical values, although 
0 the C-C bond linking the two subunits were significantly longer than normal at 1.60A. 
2.5 Naturally Occurring Bisnaphthazarins Derivatives 
Few bisnaphthazarins have been isolated from natural sources. Though the number of 
such naturally occurring naphthazarins is small, they have been found in a wide variety of 
organisms including plants, fungi, bacteria and both terrestrial and marine animals. 15,22,23 
Dimers in which the two monomeric subunits are linked through a single C-C bond 
comprise the simplest and most numerous subclass of bisnaphthazarins. An example of 
such a system is eucleolatin (2.21), isolated from the root bark of Euclea lanceolata.t 24 
A second subclass of bisnaphthazarins is exemplified by ethylidene-3,3'-bis(2,6,7-
trihydroxynaphthazarin) (2.22), isolated from the deep sea urchin Strongylocentrotus 
intermedius.25 Dimers of this type contain an additional ethylidene moiety between the 
two naphthazarin subunits. 
t The position of the quinonoid methyl substituent of eucleolatin (2.21) is not known 
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Several more complex naphthazarin dimers have been identified which possess multiple 
linkages, fusing the two naphthazarin subunits to a central ring. For example, 
phenocyclinone (2.23), isolated from Streptomyces coelicolor,26 contains a central 
methylbenzene moiety fused to the two naphthazarin 'halves'. Further examples of 
structurally complex bisnaphthazarin derivatives include rhododactynaphin-jc-1 (2.24) 
and xanthodactynaphin-jc-1 (2.25), two members of a family of pigments isolated from a 
species of aphid, Dactynotus jacae. 27 
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2.6 Lichen Bisnaphthazarins 
Lichen-derived bisnaphthoquinones are exceedingly rare. 
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Indeed, prior to our 
investigation only two reports detailing the isolation and characterisation of pigments of 
this type have been recorded. 18,28 Interestingly, the lichens examined in these two reports 
are closely related species and are both found throughout the Russian Far East. 
The first of these papers, published in 1982, describes the chemical investigation of 
Flavocetraria cucullata (Bell.) Karnef et Thell [ = Cetraria cucullata (Bell.) Ach.] by 
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Krivoshchekova, Stepanenko and co-workers.28 Spectroscopic analysis, coupled with the 
preparation of standard derivatives, enabled the principle component of the lichen extract to 
be identified as a diethyltetrahydroxybisnaphthazarin derivative. 
The Russian workers noted that dimeric 2-hydroxy-1,4-naphthoquinones normally form 
anhydro derivatives upon treatment with acid (Figure 2. 9). In contrast, the natural 
pigment, which they termed cuculuquinone, was recovered unchanged upon heating with 
concentrated sulfuric acid. As a consequent they rejected all 1,4- and 1,2-quinonoid 
structures and proposed a bisamphinaphthazarin tautomer 2.26. A second minor pigment 
was also isolated from the lichen and identified as the corresponding monomer 2. 2 7 with 
no further discussion. 
H+ 
H20 
0 0 ~ 
0 OHHO 0 0 0 
Figure 2.9: Formation of anhydronapthoquinone derivatives 
These structures are highly unusual and worthy of further comment. Failure to obtain the 
anhydro derivative, although unexpected, would not appear to be sufficient grounds to 
adopt the less stable bisamphiquinone structure which in acidic solution would certainly 
exist in tautomeric equilibrium [e.g. structure 2.28]. 
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Indeed, a reasonable explanation for the recovery of unreacted cuculuquinone is that the 
pigment did indeed form an anhydro derivative upon treatment with acid which 
subsequently underwent hydrolytic ring opening when the reaction mixture was quenched. 
The substitution pattern proposed by Krivoshchekova and Stepanenko is also highly 
unusual when consideration is given to the probable polyketide biogenesis of the 
naphthoquinonoid pigments. Thus, cyclisation of a hexaketide chain would be expected to 
give the naphthoquinone, 3-ethyl-2,7-dihydroxynaphthazarin (2.17) (Figure 2.10). 
The corresponding biogenesis of the isomeric 3-ethyl-2,6-dihydroxynaphthazarin (2.29) 
would require additional oxidation and, more importantly, reduction steps. 
OH 0 
Et 
0 0 0 I OH OH 
I~ I y 'OH 
OH 0 Me tom o: J ~ 0 0 (2.29) 8 ,...Enz OH 0 t t A A ~Et 
[O] [O] 
HO' I y 'OH 
OH 0 
(2.17) 
Figure 2.10: Likely biosynthesis of polyhydroxylated naphthazarins 
It is unfortunate that, due to a lack of isolated material, the Russian workers were not able 
to fully characterise the ethyldihydroxynaphthazarin monomer. Sixteen years earlier 
Moore, Scheuer and co-workers synthesised authentic 3-ethyl-2,7-dihydroxynaphthazarin 
(2.17) and the corresponding 2,6-isomer 2.29 in a program designed to identify 
pigments isolated from various Echinothrix (sea urchin) species.29 Interestingly, the 
melting point reported for the lichen metabolite, shown in Table 2.2, is much closer in 
value to 3-ethyl-2,7-dihydroxynaphthazarin (2.17). Furthermore, of the two synthesised 
naphthazarins 2.17 and 2.29 only the 2,7-dihydroxy derivative 2.17 was identified by 
Moore and Scheuer as a natural product 30 
In 1997, Krivoshchekova and Stepanenko reported the isolation of three 
naphthoquinonoid pigments from the red thallus tips of the lichen Cetraria islandica var. 
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polaris Rassad., a variety of Cetraria islandica (L.) Ach. 18 Curiously, the major pigment 
(m.p. 182-185 °C) was found to be identical to the known echinoid pigment, 3-ethyl-2,7-
dihydroxynaphthazarin (2.17), previously isolated by Moore et al. 30 The second 
naphthoquinone, 6,6'-bis(3-ethyl-2,7-dihydroxynaphthazarin) (2.30), was also identifed 
as a known marine natural product. 22 
N aEhthazarin Melting Point °C 
lichen-derived ethyldihydroxynaphthazarin (F. cucullata) 
synthetic 3-ethyl-2,7-dihydroxynaphthazarin (2.17) 
synthetic 3-ethyl-2,6-dihydroxynaphthazarin (2.29) 
183 - 18528 
190-19229 
248 - 24929 
Table 2.2. Melting points for selected ethyldihydroxynaphthazarin derivatives 
The third pigment was named islandoquinone and identified as a remarkable 
bisnaphthazarin which comprised 1,4-naphthoquinone and 2 3-dihydro-1 4-
, ' 
naphthoquinone moieties linked by an ether bridge. Such a carboskeleton had not 
previously been observed in Nature. Following analysis of the spectroscopic data 
(primarily IR and 1H NMR), a 3-ethyl-3-O-(3'-ethyl-1',4'-naphthoquinon-2'-yloxy)-
2-oxo-2,3-dihydro-1,4-naphthoquinone structure 2.31 was tentatively suggested. 
OH 0 
.. 
0 OH OH 
0 OH OH O O ~OH 
EL~ Jl ~ Et HO, ~ A ~o 
OH 0 yY Et HO' y I 'OH Et 0 OH 
0 OH (2.30) OH 0 (2.31) 
In mid-1999 a second Russian group proposed a revised structure 2. 3 2 for 
islandoquinone.19 Anufriev and his co-workers prepared a number of synthetic 2-oxo-
2,3-dihydronaphthazarins, including the 7,7'-didehydro analogue of islandoquinone 
(2.33 ), and noted the ease with which these derivatives could be hydrated to give gem 
diols such as 2.34. 
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HO O OH 
0 OH HO \ Jl ~ ~OH 
HO~O 
I I f 
Et Et 0 OH 
0 OH (2.32) 
The IR spectra of the 2-oxo substrates were observed to contain an intense absorption 
band at ~ 17 50 cm-1, attributed to the non intramolecular hydrogen bonded C=O group of 
these compounds, which was absent in the spectra of the corresponding hydrates (and of 
islandoquinone ). 
0 OH 
OH 0 0~ 
0 
"-J l' ,,.J 
Et Et () OH 
I II 
OH 0 (2.33) 
0 
H2O 
- H2O 
0 
HO 
OHHO 
0 
OH (2.34) 
0 OH 
OH 
In addition, the 1 H NMR spectrum of these gem-diol derivatives exhibited broad signals at 
8 4.2 - 5.5 ppm which were attributed to the two protons of the geminal hydroxy groups. 
Upon re-examination, comparable signals were observed in the corresponding spectra of 
islandoquinone. Anufriev also noted that hydration of dimer 2. 3 3 resulted in the 
predominance of a different naphthazarin ring tau to mer in the product 2. 3 4 . The revised 
structure for islandoquinone followed directly from a comparison of 1 H NMR data. 
2. 7 Naturally Occurring Dimeric Cyclic Dihemiacetals 
The cyclic dihemiacetal moiety observed in hybocarpone (2.8) is highly unusual, indeed 
only two other cyclic dihemiacetal dimers have been characterised from natural sources. 
In 1997 Luis and co-workers reported the isolation of two dimeric phytoanticipins (natural 
antibiotics) 2.35 and 2.36 from the resistant banana cultivar hybrid SH-3481. 31 The 
dimers were found to be derived from phenylphenalenone subunits and differed only in the 
para-substituent of the lateral phenyl rings. 
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Of particular interest to us was the relative configuration assigned to the stereogenic centres 
of the central dihemiacetal ring. As we noted with hybocarpone (2.8), Luis and his co-
workers recognized that the symmetry observed in the 1 H and 13C NMR spectra of the 
phenylphenalenone dimers indicated the presence of a symmetry element. 
R 
(2.35) R = H 
(2.36) R = OH 
R 
However based on this spectroscopic evidence Luis proposes S 1 symmetry for the SH-
3481-derived dihemiacetals and other symmetrical configurations, including C2 symmetry 
appear to have been overlooked. 
It is also interesting to note that, as was the case with hybocarpone 2. 8, small positive 
optical rotations [2.35 a= 3.6; 2.36 a= 10] were observed for both phenylphenalenone 
dimers 2.35 and 2.36. Luis and his co-workers attributed these optical activities to the 
'semihelicoidal conformation' which they assumed their proposed isomers adopted in 
solution. 
The data obtained in our stereochemical investigation of hybocarpone (2.8) suggests that 
further work is needed to clarify the relative configurations of the two phytoanticipins 
2.35 and 2.36. 
2.8 Biosynthetic Considerations 
Hybocarpone (2.8) is presumed to arise via a hexaketide chain 2.37 for which two 
modes of folding are possible, as shown in Figure 2.11. Methylation, multiple 
oxidation steps and reduction of the ketoalkyl side chain, either prior or subsequent to 
cyclisation of the hexaketide, would then be expected to afford the intermediate, 6-ethyl-
2,7-dihydroxy-3-methylnaphthazarin (2.38). 
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0 OH 
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OH 
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HO 
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Figure 2.11: Proposed biosynthesis of hybocarpone (2.8) 
---
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While the sequence of these steps cannot be determined without experimental data, 
previous biosynthetic studies with structurally related fungal-derived polyketides have 
indicated that structural modifications such as alkylations take place prior to the cyclisation 
of the polyketide chain.32 In contrast, feeding studies with 6-ethyl-5-hydroxy-2,7-
dimethoxy-1,4-naphthoquinone a metabolite of Hendersonula toluroideae, have indicated 
that reduction of the ethyl side chain of this naphthoquinone takes places after 
cyclisation. 33 
The key dimerisation step is presumed to occur via the stereoselective intermolecular 
oxidative phenolic coupling of two identical radical species 2. 3 9. Significantly, a chiral 
product of this process has not previously been observed in naturally occuring quinonoid 
systems. Such systems typically rearomatise after the dimerisation step. Stereoselective 
oxidative couplings are known in other biological processes such as the biosynthesis of 
lignins, lignans (Figure 2.12) and algal cell wall polymers.34 
As discussed earlier (refer § 2. 6), the resultant hexanone 2. 4 0 would be expected to 
readily hydrate to yield the corresponding gem-diol 2 .18 and 2 .19 which would then 
undergo stereoselective ring closure to give hybocarpone (2.8). 
HO 
Meo 
OH 
HO 
0 
0 , c::_ 
Meo-Q H 
----------- OH oXo Me < 
Meo>=----- '-- ·_.,,,----.._OH 
O~_ H 
H Q-oMe 
OH 
Figure 2.12: Proposed stereoselective biosynthesis of lignan derivatives 
2.9 Evaluation of Antiprolif erative Activity 
Mass screening programs of natural products and synthetic compounds by the American 
National Cancer Institute have identified the quinone moiety as a pharmacophore that 
commonly affords cytotoxic activity.35 As the quinonoid carbon fran1ework of 
hybocarpone (2.8) was previously unreported in the chemical literature, we became 
interested in testing the lichen-derived compound for biological activity. We were able to 
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initiate preliminary testing through a collaboration with Dr P. Waring at the John Curtin 
School of Medical Research, Australian National University. 
The particular assay used in our study was a thymidine incorporation assay. 36 Normal 
healthy cells synthesise DNA as they grow and proliferate, incorporating nucleotide bases 
such as thymidine from the surrounding media. Pulsing the cells with a radiolabelled 
nucleotide and monitoring the incorporation of labelled material into the cells allows a 
measure of the inhibitory effects of a toxin on DNA synthesis to be made. This procedure 
is routinely used to assess the antiproliferative capacity of potential new pharmacological 
agents. Furthermore, a number of compounds found to exhibit significant activity in this 
assay have been demonstrated by Waring and co-workers to possess potent 
immunosuppressant properties. 37,38 
Cells from the mouse P815 mastocytoma cell line were treated with the serially diluted 
lichen metabolite 2.8 and incubated for 18 h at 37 °C. The cells were then pulsed with 
tritiated thymidine for a further 6 h after which time they were harvested and the 
incorporation of radiolabelled thymidine measured using a P-scintillation counter. A 
comparative measure of activity was provided by treating cells with the mycotoxin 
gliotoxin (2.41). Gliotoxin (2.41) was chosen as a control as previous studies by 
Waring and co-workers have shown this metabolite to exhibit significant 
immunosuppressant activity. 38-43 
OH HO 
HO 
o- :. 
o HO OHo (2.8) 
OH N 82 N-Me 
OHH O~OH 
(2.41) 
Hybocarpone (2.8) was found to possess potent cytotoxicity against P815 cells yielding 
an ICso value of 0.27 µM (Figure 2.13). In comparison, the mycotoxin control, 
gliotoxin (2.41), gave an IC50 value of 1.30 µM. The potent activity observed would 
indicate that further biological trials are worth pursuing. 
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Figure 2.13: Antiproliferative activity of hybocarpone (2.8) relative to gliotoxin (2.41) 
At present the mechanism of action of hybocarpone (2.8) is unclear. In this regard, it 
would be of interest to examine the relationship between the structure of the pigment 2.8 
and its activity, particularly the effect of modifying the stereochemistry of the central ring. 
A comparison of the activity of the unnatural enantiomer with respect to that produced in 
vivo is also eagerly awaited. 
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Flavoparmelia euplecta (Stirt.) Hale 
Chapter 3 66 
3.1 The Lichen Flavoparmelia euplecta 
Flavoparmelia euplecta (Stirt.) Hale is a green to yellow-green foliose lichen endemic to 
the coastal regions of eastern Australia. Commonly found on both rock and tree substrata, 
it is characterized by an orange-red lower medulla which turns an intense purple colour on 
treatment with 10% aqueous potassium hydroxide. 1 
Previous chemical investigations of this lichen species have resulted in the identification of 
a number of known lichen products. 1 These metabolites include the cortical pigment usnic 
acid2 (3.1) and the medullary depsidone protocetraric acid3 (3.2). In addition to these 
known compounds, several yellow-orange pigments of unknown structure have also been 
observed. 
Me 
Me 0 
I \\ OH 
' 
Me / OH HO 0 OH 
0 
(3, 1) IYI~ (3.2) 
The isolation and structural elucidation of two of these pigments, euplectin ( 5, 11-
dihydroxy-2-methy lindeno[ 5 ,6-h ]4H-chromene-4,10-dione) (3.3) and coneuplectin 
(5,1 l-dihydroxy-2-methylindano[5,6-h]4H-chromene-4,10-dione) (3.4), is described in 
this chapter. The indenone and indanone moieties identified in these metabolites are rarely 
observed in Nature. Indeed, the chemical investigation of F. euplecta described herein 
comprises the first report of these substructures in lichenized fungi. 
0 OH 
1 
0 OH 0 
1 
(3.3) Me (3.4) Me 
The molecular structures of the y-naphthopyrone derived metabolites (3.3) and (3.4) were 
established using multidimensional NMR spectroscopic methods. Highfield (600 MHz) 
gHMBC and gNOE experiments were particularly beneficial in the characterisation of these 
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metabolites. In addition, the cytotoxicity of the more abundant y-naphthopyrone (3.3) 
against the murine P815 mastocytoma cell line was also examined. The activity of this 
metabolite is discussed in § 3. 6. 
3.2 Collection and Isolation 
Specimens of the lichen Flavoparmelia euplecta (Stirt.) Halet were collected from rock 
outcrops in pastoral land, 18 km south of Bermagui, on the south coast of New South 
Wales, Australia. 
Thin layer and high performance liquid chromatographic analysis of the total acetone 
extract of the lichen confirmed the presence of the cortical pigment usnic acid2 ( 3 .1) and 
the medullary depsidone, protocetraric acid3 (3.2) as major metabolic constituents. The 
extract was also found to contain the known anthraquinone pigment skyrin4 (3.5) and two 
structurally unknown yellow-orange pigments. 
OH O OH 
Me 
HO Me 
(3.5) 
OH O OH 
The dried lichen thallus (21.8 g) was extracted in a Soxhlet extractor with anhydrous 
diethyl ether for 26 h. The ethereal solution was then concentrated and permitted to cool, 
whereupon most of the unwanted protocetraric acid (3.2) precipitated. The mixture was 
filtered and the filtrate subjected to radial chromatography over silica gel using ethyl acetate 
as eluant. 
Two major yellw orange bands were observed. The faster moving yellow band afforded 
a mixture of usnic acid (3.1) and skyrin (3.5) (68 mg), the composition of which was 
confirmed by HPLC and UV spectroscopy. The more polar orange band was found to 
contain a mixture of the two pigments (3.3) and (3.4) which were separated by 
1 A voucher specimen, identified by J. A. Elix, has been lodged in the herbarium of the Australian 
National Botanic Garden, Canberra, Australia (CANB). 
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preparative layer chromatography over silica gel using 15 % glacial acetic acid/ toluene as 
eluant. 
As before, two major yellow-orange bands developed. The faster moving band yielded a 
mixture of euplectin (3.3) and coneuplectin (3.4) (94 mg, 0.4 %) as a yellow-orange 
solid. Repeated crystallisation of this mixture from chloroform afforded the major 
pigment, euplectin (3.3) (10.5 mg). The mother liquors thus enriched in the minor co-
metabolite (3.4) were then concentrated and the resultant residue repeatedly crystallised 
from chloroform to afford coneuplectin (3.4) (3 .1 mg). 
3.3 Structural Elucidation 
3.3.1 Euplectin 
Euplectin (3.3) crystallised from chloroform as fine orange-red needles which 
decomposed at 320 °C. The UV-vis spectrum of the pigment (3.3) was suggestive of a 
polycyclic aromatic structure, exhibiting maxima at A 219, 246, 280, 328 and 433 nm. 
A strong molecular ion was evident in the mass spectrum at m/z 294. High resolution 
mass measurement of this ion yielded a molecular formula of C 17 H 1 oO 5, corresponding 
to thirteen degrees of unsaturation. 
The 1 H NMR spectrum of euplectin ( 3. 3) contained signals characteristic of a strongly 
chelated phenolic hydroxy substituent at 8 13.05, a broad exchangeable singlet at (8 
11.07) and two aromatic hydrogens at 8 6.87 and 6.84 (Figure 3.1, Table 3.1). In 
addition, an olefinic proton (8 6.27) and a downfield methyl group at 8 2.51 were 
evident. The spectrum also indicated the presence of two coupled "alkene" protons (J = 
5.7 Hz) resonating as doublets centred at 8 7.49 and 6.19. 
The 13C NMR data further supported the proposed molecular formula, exhibiting 
seventeen discrete resonances (Table 3.1). Two a,~-unsaturated carbonyl groups (8 
198 and 183) were readily apparent, as were five aromatic or olefinic methine moieties at 
8 147, 132, 116, 110.3 and 110.1. 
-..J 
en 
-..J 
. 
u, 
-..J 
. 
.Ci, 
-..J 
. 
w 
-..J 
. 
I'\) 
-..J 
. 
1-l 
-..J 
. 
0 
en 
lD 
en 
. 
CXl 
en 
. 
-..J 
en 
. 
en 
en 
. 
u, 
en 
. 
.Ci, 
en 
w 
""CS 
""CS 
3 
Chapter 3 69 
E 
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Figure 3.1: A portion of the IH NMR spectrum of the crude mixture of euplectin (3.3) 
and coneuplectin (3.4) (signals labelled as 'E' and 'C' respectively) 
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One bond C-H correlations were assigned with the aid of a gHMQC pulse sequence. 
Nine signals in the 13C NMR spectrum of euplectin (3.3) were attributed to quaternary 
carbons including six in the range 8 168 - 142, and another three observed at 8 110.2, 
108.3 and 107.7. 
The highfield (500 MHz) gHMBC spectrum of euplectin (3.3) was surprising complex, 
exhibiting 35 long range H-C connectivities (Table 3.2). 
2 
3 
4 
Carbon 
No. 
4a 
5 
6 
6a 
7 
7a 
8 
9 
10 
10a 
11 
lla 
llb 
12 
0 
13C (3.3) 
8 (mult) 
167.96 (s) 
110.32 (d) 
182.68 (s) 
110.18 (s) 
160.31 (s) 
110.05 (s) 
144.12 (s) 
115.64 (d) 
142.45 (s) 
147.21 (d) 
132.27 (d) 
198.44 (s) 
107.69 (s) 
155.63 (s) 
108.29 (s) 
156.80 (s) 
20.63 (q) 
""""' 
7 8 
9 
0 
0 
Me12 
1H (3.3) 
8 (mult, J Hz) 
6.27 (s) 
13.05 (s, OH) 
6.87 (s) 
6.84 (s) 
7.49 (d, 5.7) 
6.19 (d, 5.7) 
11.07 (bs, OH) 
2.51 (s) 
7 
(3.4) 
Me12 
13C (3.4) 
8 (mult) 
167.53 
110.91 (d) 
182.40 (s) 
109.80 (s) 
159.04 (s) 
106.45 (s) 
144.59 (s) 
113.87 (d) 
152.02 (s) 
25.37 (d) 
36.10 (d) 
209.57 (s) 
116.38 (s) 
157.52 (s) 
106.16 (s) 
158.72 (s) 
2Q.?7(q) 
Table 3.1: 1 Hand 13C NMR chemical shift data for 3.3 and 3.4 
0 
1H (3.4) 
8 (mult, J Hz) 
6.31 (s) 
12.89 (s,OH) 
6.82 (s) 
7.04 (s) 
3.16-3.20 (m) 
2.78-2.82 (m) 
9.60 (bs, OH) 
2.51 (s) 
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The close proximity of a number of these correlations (e.g. those involving carbon signals 
at 8 110.3, 110.2, 110.1 and 8 107. 7, 108.3) hampered initial assignment efforts. 
However after detailed analysis three major structural fragments could be discerned 
(Figures 3.2 - 3.4). 
The in den one moiety (rings C and D) was identified using correlations arising from three 
protons: H-7 (8 6.84), H-8 (8 7.49) and H-9 (8 6.19) (detailed in Figure 3.2). The 
13C chemical shift of the indenone carbonyl (8 198) is typical for a planar a-~-
unsaturated carbonyl carbon atom.5 In addition, the 1H NMR chemical shifts of the two 
conjugated alkene protons, H-8 (8 7 .49) and H-9 (8 6.19) are consistent with the 
comparable values of the alkene protons in 2-cyclopenten-1-one [H-3 (8 7.71) and H-2 (8 
6.10)]. 6 
OH OH OH 
Figure 3.2: Selected H-C long range correlations observed in the gHMBC spectrum of 
euplectin (3.3) 
Of particular importance in establishing the substitution pattern of the indenone aromatic 
ring were the 3Jc8 correlations observed between H-8 and the aromatic methine carbon 
atom C-7 (8 116) and between H-7 and the ring junction quaternary C-l0a (8 107). 
~~---&--.----~\!,@,-!,\l'l 
Proton No. 1H 8 gHMBC (3.3) 
(3.3) C No. (JcH) 
------ < 1.6 - -<~--~--- ... _,..,----.. ~-~·~--~-o.:~~~-.=----
H-3 6.27 
H-5 (OH) 13.05 
H-6 6.87 
H-7 6.84 
H-8 7.49 
2(2), 4(2)a, 4a(3), 5( 4)a, 12(3) 
4a(3), 5(2), 6(3), 6a( 4)a 
4(4), 4a(3), 5(2), 6a(2)a, 7(3), lla(3) 
6(2), 6a(2), 8(3), 9(5) a, 10(4), 10a(3), 1 la(3) 
7(3), 7a(2), 9(2), 10(3), 10a(3), 11(4) a 
H-9 6.19 7a(3), 8(2), 10(2), 10a(3), 1 la(4) a 
H-12 2.51 2(2), 3(3) 
~ . .~ 
~~-~~~l!l.~~~""1.':8'~~~~~ 
Table 3.2: H-C long range correlations in the gHMBC spectrum of 3.3 
(a depicts weak correlation) 
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Further evidence for the proposed structure was provided by two 4lcH 'w' couplings 
observed between H-7 and the carbonyl carbon atom C-10 (8 198) and between H-8 (8 
7 .49) and a signal at 8 155 which was attributed to the phenolic carbon atom, C-11. Such 
an assignment was consistent with the 1 H NMR chemical shift observed at 8 11. 07 
(typical for a weakly hydrogen bonded phenolic proton). Also apparent in the gHMBC 
spectrum was a 5JcH 'epi-z' correlation between H-7 and C-9 (8 132). 
The second structural fragment to be identified was the chromone nucleus (rings A and B, 
Figure 3. 3 ). The assignment of this partial fragment was based on connectivities 
arising from four proton signals: H-12 (8 2.51), H-3 (8 6.27), H-6 (8 6.81) and OH-5 (8 
13.05). 
~ 
~ O, S) 
Me 
~ 
~ 
Figure 3.3: Selected H-C long range correlations observed in the gHMBC spectrum of 
euplectin (3.3) 
The methyl protons at 8 2.51 (H-12) were observed to give rise to two correlations, a 
2lcH coupling to C-2 (8 183) and a 3lcH coupling to C-3 (8 110.3). Five correlations 
involving the olefinic proton at 8 6.27 were evident including a weak 2lcH coupling to the 
carbonyl carbon atom at 8 183 (C-4) and a weak 4lcH 'w' coupling to the phenolic carbon 
atom C-5 (8 160). A strong 3JcH coupling, attributed to the quaternary carbon atom at 8 
110.2, was also apparent. 
The phenolic proton (8 13.05) gave rise to four readily assigned connectivities: a 2lcH 
coupling to C-5 (8 160), 3JcH correlations to both the ring junction carbon atom C-4a (8 
110.2) and the aromatic methine carbon atom C-6 (8 110.1) and, importantly, a weak 
4lcH 'w' coupling to the quaternary carbon atom C-6a (8 144). These couplings indicated 
that euplectin possessed an angular y-naphthopyrone framework. The six correlations 
observed between the aromatic proton H-6 (8 6.87) and surrounding carbon atoms (the 
3lcH correlation between H-6 and C-4a (8 110.2) and the 4lcH coupling between H-6, C-
4 (8 183) were particularly instructive and confirmed the assignments outlined above. 
r., 
I 
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The 1 H and 13C NMR assignments of this partial fragment were found to be in good 
agreement with those made for other compounds containing a 6-hydroxy-2-
methylchromone moiety.7 
The remaining ambiguity, namely the substitution pattern of the central naphthalene core 
(Figure 3. 4 ), was resolved by means of a number of highfield (500 MHz) gNOE 
experiments. Despite the proximity of the two aromatic protons H-6 and H-7, which at 8 
6.87 and 8 6.84 were only 0.03 ppm apart, clear NOEs were apparent in the appropriate 
spectra (Figure 3.5). NOEs were also observed between H-7 (8 6.84) and the olefinic 
proton H-8 (8 7 .49). 
OH 
C 
Figure 3.4: Selected H-C long range correlations observed in the gHMBC spectrum of 
euplectin (3.3) ( dashed arrows correspond to gNOE correlations) 
Thus the major orange pigment, euplectin, was found to have the structure 5, 11-
dihydroxy-2-methylindeno[5,6-h ]4H-chromene-4, 10-dione (3.3). 
3.3.2 Coneuplectin 
The second pigment 3. 4, isolated as fine yellow needles, exhibited a molecular ion two 
mass units higher than its co-metabolite 3. 3. The 1 H NMR spectrum revealed two 
methylene groups resonating as multiplets at 8 2.78-2.82 and 8 3.16-3.20, suggesting 
that 3.4 was the 8,9-dihydro derivative of 3. 3. This conclusion was further supported 
by examination of the 13C NMR spectrum which revealed an a,~-unsaturated carbonyl 
group at 8 209 in addition to two methylene carbon atoms at 8 25 and 36. The complete 
assignment of the 1 H and 13C NMR chemical shifts of 3.4 , reported in Table 3 .1 , was 
confirmed by both gHMBC and gNOE spectral data (Tables 3.3 and Figure 3.6). 
Chapter 3 74 
Figure 3.5: gNOE spectra of euplectin (3.3) 
7 . l Sl l . D 5 6 • 9 5 6 . 8 5 ppm 
Figure 3.6: gNOE spectra of coneuplectin (3.4) 
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Thus the minor yellow pigment, coneuplectin, was found to have the structure 5, 11-
dihydroxy-2-methylindano[ 5 ,6-h ]4H-chromene-4, 10-dione (3.4). 
Compounds containing indenone or indanone moieties have not previously been observed 
in lichenized fungi. Indeed such derivatives have rarely been identified in any of the 
organisms subjected to the scrutiny of natural product chemists. 
Proton No. 
H-3 
H-5 (OH) 
H-6 
H-7 
H-8 
H-9 
H-12 
8 1H 
(3.4) 
6.31 
12.89 
6.82 
7.04 
3.18 
2.80 
2.51 
gHMBC (3.4) 
Carbon No. (JcH) 
2(2), 4(2)a, 4a(3), 5(4)a, 12(3) 
4a(3), 5(2), 6(3) 
4a(3), 5(2), 7(3), 1 la(3) 
6(2), 6a(2), 8(3), 10a(3), 1 la(3) 
7(3), 7a(2), 9(2), 10(3), 10a(3) 
7a(3), 8(2), 10(2), 10a(3)a 
2(2), 3(3) 
Table 3.3: H-C long range correlations in the gHMBC spectrum of 3.4 
(a depicts weak correlation) 
3.4 Naturally Occurring Naphthopyrones 
Naturally occurring naphthopyrone derivatives can be categorised into three main structural 
types. These structural types differ in the substitution pattern of the terminal pyrone ring. 
The first of these structural classes is exemplified by rubrofusarin8,9 (3.6). Such 
derivatives possess a y-pyrone ring linearly fused to the naphthalene moiety. A second 
class of naphthopyrones contains metabolites, such as toralactone10 (3. 7), which have an 
a-pyrone ring linearly fused to the naphthalene system. The third structural class also 
possesses a y-pyrone ring but in this case the pyrone ring and the naphthalene fragment 
have an angular configuration. An example of this class of naphthopyrones is 
flavasperone (= asperxanthone) (3.8), isolated from various strains of Aspergillius 
niger. l l,12 
MeO 
OH OH 0 
(3.6) 
Me 
MeO 
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OH OH 0 
(3.7) 
Meo 
0 
3.4.1 Naphthopyrone Derivatives from Lichen Sources 
76 
0 
OMeOf 
(3.8) Me 
Previous investigations of lichen chemistry have identified only two naphthopyrone-
derived metabolites. Canarione (3.9), a linear pyranonaphthoquinone, has been isolated 
from the lichen Usnea canariensis (Ach.) Du Rietz. 13 Haemoventosin (3.10), first 
isolated from the crustose Norwegian lichen Ophioparma ventosa (L.) Norman 
(= Haematomma ventosum (L.) Massal.) is a linear pyranonaphthazarin derivative. 14,15 
Further discussion of the chemistry of this metabolite 3.10 follows in Chapter Four. 
0 
HO_ Jl ~ ~o~ _Me 
0 OH 0 
(3.9) 
0 OH 
Meo_ Jl ~ /'-.. .,,Me 
0 OH 0 
( 3.10) 
3.4.2 Naturally Occurring Angular y-Naphthopyrones 
A small number of angular y-naphthopyrones have been identified in non-lichen natural 
sources since the discovery of flavasperone 11 ,12 (3.8) some fifty years ago. Angular 
y-naphthopyrones which illustrate the structural variation observed within this class appear 
in Figure 3. 7. 
Heptaketide-derived angular y-naphthopyrones have been isolated from the genus 
Aspergillus, e.g. fonsecinone C16 (3.11) isolated from the mould Aspergillus fonsecaus ; 
from leaves of the plant Guiera senegalensis, e.g. 5-methylflavasperone17 (3.12) and 
from several species of trees from the genus Cassia. 
Cassia-derived angular y-naphthopyrones include a number of derivatives isolated from the 
roots of the small South American tree Cassia pudibunda. These metabolites include the 
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sulfate casiapyrone-10-sulfate (3.13) and the glycoside 10-demethylflavasperone-10-O-~-
D-apiofuranosyl-(1 • 6)-O-~-D-glycopyranoside (3.14 ), and were shown to exhibit 
antimicrobial activity against various Actinetobacter species. 18 Very recently, the 
constituents of Cassia tora seeds, used as a traditional medicine in Asia, have also been 
investigated. 19 A number of phenolic glycosides, including the gentiobioside derivative of 
demethylflavasperone (3.15), were isolated and screened for antibacterial activity. 
Meo 
OMe OH 0 
Meo 
OH 0 
(3.11) 
Me 
MeO 
OMe 0 
(3.12) 
MeO, ~ ~ _un 
0 
6-/J 
I 
Me 
OH HO 
0 
Me 
OH 
-·. 
(3.14) 11 "--Y "--Y 
0 y T T OMe 0 
(3.16) 
Me 
Me 
I Meo 
II "I "I 
0 
T T Y 0 o 03S.., 
I 
Me 
(3.13) 
Meo 
oh ~o 
0 0 
-·. '" .. 
OH I Me 
OH 
(3.15) 
Figure 3. 7: Naturally occurring angular y-naphthopyrones found in non-lichen sources 
Several angular y-naphthopyrones, including the likely octaketide comaparvin20 (3 .16 ), 
have been isolated from various species of crinoid (sea lily). It has been proposed that 
these crinonoid pigments play an ecological role for the producing organism, possibly 
acting as feeding deterrents.21,22 
Intriguingly, prior to our investigation of Flavopannelia euplecta, only three nonaketide-
derived naphthopyrones have been reported in the literature.23,24 Toe structures of 
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ligustrones A (3.17) B (3.18) and C (3.19), from the pathogenic rust Cercospora 
ligustrina Boerema, were determined using spectroscopic methods and the preparation of 
over a dozen derivatives by Merlini and co-workers in 1975. 
The rarity and complexity of the indanochromenedione core of the euplectins (3.3) - ( 3. 4) 
and ligustrones (3.17) - (3.19) suggest that the two organisms, the mycobiont of 
F. euplecta and the rust C. ligustrina, bear a close evolutionary relationship. A proposed 
biosynthetic pathway leading to the euplectins (3.3) and (3.4) is discussed in the next 
section. 
0 OMeO 
(3.17) Me 
R 
0 OMeO 
(3.18) R=H Me 
(3.19) R = OH 
3.5 Biosynthetic Considerations 
A proposed biosynthesis of the naphtho-y-pyrones euplectin (3.3) and coneuplectin (3.4) 
is detailed in Figure 3. 8. The lichen-derived pigments are presumed to arise via the 
nonaketide 3.20. While two folding patterns are possible for the polyketide chain, the 
'twisted open chain' conformation depicted in Figure 3. 8 is favoured, based on data 
obtained by Leeper and Staunton during their biosynthetic investigation of the heptaketide 
napthopyrone, rubrofusarin (3.6).25 
Intramolecular condensation of the nonaketide 3. 2 0, followed by oxidation of the 
resultant polycycle 3.21, would be expected to afford the pentol 3.22. An additional 
oxidation step would then yield the corresponding hydroxyquinone 3.23. 
Subsequent base-catalysed 3-exo-trig ring closure of the tautomeric o-quinone 3.24 could 
then afford the bicyclo[3.1.0]hexa-2,6-dione derivative 3 .25. Hydration of the terminal 
cyclopropanone ring would then result in the gem-diol 3.26 which upon base-catalysed 
ring opening could yield the carboxy lie acid 3.27. 
1· 
I 
0 
0 
(3.20) Me 
HO 
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HO 
0 -3H20 
OH 
(3.21) 
/[OJ 
[O] H-A /OH OH Of () 
(3.22) Me ( O 
0 
_) 
Me 
HO' Jl ✓----- CXOH 
I h /,0 ~ ~ .h 
0 OH 0~ ~ d_,H OH O,o 
(3.23) Me I C (3.24) Me :s 
r :s O OH 
H20/ 
~\ 9H OH (3.25) 
0-
Me 
., 1/" < ' ----0 
A-H 
\) 0 
(3.26) 
OH 
(3.4) 
Me 
HO 
0 
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0 OH 
1 /co2 (3.27) Me 
0 
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0 OH 
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0 
Figure 3.8: Proposed biosynthesis of euplectin (3.3) and coneuplectin (3.4) 
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Decarboxylation of the acid 3.27 would lead to the corresponding trial 3.28. It is 
interesting to note that although none of the proposed precursors have been detected in a 
lichen source, the diol ligustrone C ( 3 .19) has been isolated from the fungus Cercospora 
ligustrina Boerema. 23 
Dehydration of the trial 3.28 would then be expected to afford euplectin (3.3) and 
enzymatic reduction of the 8,9-olefinic bond would give the cogenor, coneuplectin (3.4). 
3. 6 Evaluation of Antiprolif erative Activity 
In view of the unusual indeno[5,6-h]4H-chromenedione skeleton possessed by the 
eupletins and the paucity of literature data on the biological activity of such derivatives, we 
evaluated the cytotoxicity of euplectin ( 3. 3) against the murine P815 mastocytoma cell 
line. As discussed in Chapter Two, these studies were conducted by the author in the 
laboratory of Dr P. Waring at the John Curtin School of Medical Research, Australian 
National University using gliotoxin (3.29) as a control. 
OH 
(3.3) Me 
N 82 N-Me 
OHH 0}=-\_0H 
(3.29) 
Euplectin (3.3) was found to exhibit moderate cytotoxicity against the growth of murine 
P815 cells with an IC50 of 1.67 µg/mL (Figure 3.9). 
Unfortunately the paucity of the minor naphthopyrone (3.4) precluded the evaluation of 
its cytotoxic activity. 
The activity observed in this assay, (as was the case with the bisnaphthazarin derivative, 
hybocarpone, discussed in Chapter Two) would indicate that further investigations are 
worth pursuing. 
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Figure 3.9: Antiproliferative activity of euplectin (3.3) relative to gliotoxin (3.29) 
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4.1 The Lichen Pseudocyphellaria coronata 
The large, foliose, Australasian lichen Pseudocyphellaria coronata (Mtill. Arg.) Malme 
was first collected by Joseph Banks and Daniel Carlsson Solander during the great 
Endeavour circumnavigation of the world by Captain Cook ( 17 68 - 1771) .1' An 
epiphyte of trees and shrubs, Ps. coronata is among the most common and widespread of 
the corticolous species of its genus. The lichen is found in a wide variety of habitats and 
is often a significant component of the local fore st ecosystem. 2 
Ps. coronata has long been characterised by the presence of an acetone soluble, reddish 
purple medullary pigment. 2 This characteristic was first recognized by the botantist 
Babington some 150 years ago who noted that: 3 
'Here and there the su,face ( especially after being wetted) has a delicate purple-
violet tint by which character the species may usually be recognised ... ' 
Although the chemical constituents of this species have been investigated in considerable 
detail since Babington made this observation, the purification and structural elucidation of 
the medullary pigment has eluded a number of earlier investigators.4,5 
This chapter describes the structural elucidation and stereochemical assignment of this 
pigment, a new pyranonaphthazarin, which we have named coronatoquinone ( 4.1). The 
structure of coronatoquinone [lS,5,8, 1 0-tetrahydroxy-7-methoxy-3-methyl-6,9-dihydro-
1H-naphtho[2,3-c ]pyran-6,9-dione] (4.1) was established by spectroscopic methods and 
its absolute configuration determined from chiroptical measurements. In addition, the 
antiproliferative capacity of coronatoquinone (4.1) against the murine P815 mastocytoma 
cell line was evaluated and is also discussed. 
HO 
MeO 
0 HO 
0 HO 
(4.1) 
OH 
l 
0 
Me 
' This collection is preserved in the herbarium of the British Museum (Natural History). 
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4.2 Previous Chemical Investigations of Ps. coronata 
In the early 1900s, Zopf obtained from Sticta orygmaea [= Ps. coronata] a brown 
sparingly soluble pigment which he named 'orygmaeic acid'. Zopf noted the pigment 
yielded purple salts upon treatment with alkali but was unable to determine its molecular 
composition. 6 
Some 50 years later Murray4 re isolated the pigment and found it to be identical in 
structure to polyporic acid ( 4.2), a p-terphenylquinone originally discovered in the wood 
rotting fungus Polyporus nidulans.7,8 Murray also isolated three pulvinic acid 
derivatives, namely pulvinic acid ( 4.3 ), pulvinic dilactone ( 4.4) and calycin ( 4.5), as 
well as a number of compounds of unknown structure. The most abundant of these 
unknowns, identified as 'compound D', was a colourless, non-polar, optically active, 
highly crystalline solid. Although Murray was unable to characterise or obtain 
derivatives of 'compound D' he suggested the natural material might be of triterpenoid 
ong1n. 
Murray also attempted to characterise the distinctive reddish purple pigment responsible 
for the colour of the lichen's medulla. However difficulties experienced in obtaining an 
accurate molecular formula precluded the structural determination of this compound. 
( 4.2) 
0 
( 4.4) 
0 
0 OHO 
(4.5) 
Ps. coronata [= Sticta coronata] was also the subject of study by Burton and Cain in the 
course of screening indigenous New Zealand plant products for experimental anti-cancer 
activity.9,10 A crude preparation from Ps. coronata was found to significantly prolong 
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the lifespan of mice previously innoculated with an acute lymphocytic leukaemia. 
Polyporic acid ( 4.2) derived from the lichen was shown to possess comparable 
antileukaemic activity and was, consequently, attributed as the causative agent. 
Twenty five years after Murray's initial work on the constituents of Ps. coronata, Corbett 
and co-workers re-examined the unknown non-polar components described previously. 5 
Purification of the reisolated lichen extract afforded a series of novel triterpenoids based 
on the chair, boat, chair, chair conformational sequence of the parent triterpene, stictane 
( 4. 6). However, the authors were unable to shed further light on the structure of the 
unknown highly coloured medullary pigment. 
R2 11 •·· 
R3-,,. 
R4 
. Rs 
R5 
(4.6) R = H 
4.3 Isolation of Coronatoquinone 
Our investigation of Pseudocyphellaria coronata (Mull. Arg.) Malmet began with the 
collection of specimens from the trunks of Nothofagus trees south of Mt Cook National 
Park in the South Island of New Zealand in 1995. 
The lichen material was dried and extracted for consecutive 24 h periods with light 
petroleum, diethyl ether and acetone respectively. TLC analysis of the crude mixtures 
from each extraction revealed coronatoquinone ( 4 .1) to be concentrated in the ethereal 
extract together with significant amounts of the p-terphenylquinone, polyporic acid8 
( 4.2), and the butenolide derivatives, pulvinic acid11 ( 4.3) and pulvinic dilactone11 
(4.4). Chromatography of the acetone extract also yielded the known depsidones stictic 
acid11 ( 4. 7), constictic acid12 ( 4.8), cryptostictic acid13 ( 4.9) and physciosporin14 
( 4.10) which were readily identified by comparison with authentic material. 
+ A voucher specirn.en has been deposited in the herbarium of the Australian National Botanic Garden, 
Canberra, Australia (CANB). 
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The ethereal solution was evaporated and the resultant residue purified by fractional 
crystallization from toluene, 50% ethyl acetate/ toluene and 20% ethyl acetate/ toluene. 
Me q R1 R2 Me 0 
0 R2 ~/-0 Me (4.7) CHO Me 
MeO' y 'o)=f OH (4.8) CHO CH20H HO~,...._// \)-QH 
R1 
I 
CHO 
Me1 ~o 0 ( 4.9) CH20H Me 
(4.10) Meo 
This resulted in a mixture consisting predominantly of coronatoquinone ( 4.1) and 
polyporic acid (4.2) in a ratio of approximately 2:1 as determined by 1H NMR 
spectroscopy. Separation of this mixture proved somewhat difficult. Several attempts 
were made using a number of different chromatographic techniques, however, the most 
satisfactory results were obtained by repeated fractional crystallisation. 
In this manner, recrystallisation of the least soluble fractions obtained above eventually 
afforded polyporic acid ( 4.2) (90 mg, 0.90% ). The more soluble fractions were 
combined in a similar manner and repeatedly recrystallised from 10% ethyl acetate/ 
toluene to give the deep red pigment, coronatoquinone (4.1) (12 mg, 0.12%). 
4.4 Structural Elucidation 
Coronatoquinone ( 4.1) crystallised from ethyl acetate/ toluene as deep red microcrystals. 
The UV - vis spectrum was reminiscent of a naphthoquinone, 15,16 though a number of 
bathochromic shifts (indicative of extended conjugation) could be discerned. IR 
absorption bands at 3414, 1655 and 1601 cm-1 provided further evidence for the 
presence of both hydroxy and conjugated carbonyl moieties. 
The EI mass spectrum of coronatoquinone ( 4 .1) exhibited a very weak molecular ion 
(M+, 2%) at m/z 320. The major feature of the spectrum was the base peak at m/z 302 
(M+-H2O), suggestive of the facile loss of water from the molecule under ionization 
conditions. Accurate mass measurement on the molecular ion corresponded to a 
molecular formula of C1sH12Os - consistent with ten degrees of unsaturation. 
! 
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The 1 H NMR spectrum of the pigment 4 .1 in deuteriochloroform was remarkable, 
exhibiting only six singlets in a ratio of 3 :3: 1: 1: 1: 1. A signal at 8 2.16 ( corresponding to 
three protons) was characteristic of an unsaturated methyl group (adjacent to C=C or 
C=O) (Table 4.1). Another at 8 4.18 (corresponding to three protons) was indicative 
of a methoxy substituent though the chemical shift of this signal was notably downfield. 
0 HO OH 
Me 11 
11 - - I - 4 
12 0 HO 
(4.1) 
Carbon 13C data 1H data gHMBC 
No. 8 (mult) 8 (mult) Carbon No. (lcH) 
1 88.33 (d) 6.48 (d, 6.3) C-3(3), C-4a(3), C-10(3)3 , C-10a(2)3 
3 159.46 (s) 
4 94.67 (d) 6.20 (s) C-3(2), C-5(3), C-10(4)3 , C-10a(3), C-11(3) 
4a 133.60 (s) 
5 154.73 (s) 13.29 (bs, OH) C-4a(3), C-5(2), C-5a(3), C-9(5)3 , C-10( 4)3 
5a 109.95 (s) 
6 181.15 (s) 
7 141.92 (s) 
8 148.89 (s) 
9 184.24 (s) 
9a 108.06 (s) 
10 157.37 (s) 12.65 (bs, OH) C-4a(4)3 , C-6(5)3 , C-9a(3), C-10(2), C-10a(3) 
10a 120.75 (s) 
11 20.65 (q) 2.09 (s) C-3(2), C-4(3) 
12 60.87 (q) 3.87 (s) C-7(3) 
Table 4.1: 1H and 13C NMR data of coronatoquinone (4.1) 
(a denotes weak correlation) (CD3SOCD3) 
Further signals were suggestive of an alkene proton (8 6.30) and a methine proton at 8 
6.71. The spectrum also revealed the presence of two chelated phenolic hydroxy groups 
at 8 12.10 and 13.09 ppm. Two notable differences were observed when the 1 H NMR 
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spectrum of coronatoquinone ( 4.1) was recorded in d6-dimethyl sulfoxide. Most 
noticably, the signal attributed to the methine proton appeared as a doublet centred on 8 
6.48 (J = 6.3 Hz). A new broad doublet, consistent with an exchangable hydroxy 
proton, was also evident around 8 7. 70. 
The 13C NMR and APT spectra of coronatoquinone ( 4.1) exhibited fifteen discrete 
signals, including eleven corresponding to quaternary carbons (Table 4.1). Signals at 8 
181 and 184 were consistent with naphthoquinonoid carbonyl carbons17,18 while the five 
signals between 8 159 and 142 ppm were indicative of either olefinic or oxy-substituted 
aromatic carbons. 
One bond C-H correlations were established with the aid of a gHMQC pulse sequence. 
This experiment revealed a particularly significant connectivity, namely that between the 
carbon signal at 8 88 (indicative of a hemiacetal moiety) 19 and the methine proton 
resonating at 8 6.48. 
The substitution pattern of the heterocyclic ring was established primarily through 
correlations observed in the gHMBC spectra of coronatoquinone ( 4.1) (Figure 4.1 and 
Table 4.1). Of particular diagnostic value were the 3Jc8 couplings observed between 
the methine proton at 8 6.48 and the three carbon atoms C-3, C-4a and C-1 0; and those 
observed between the olefinic proton (8 6.20) and carbon atoms C-5, Cl0a and C-11. 
The proximity of the alkene proton (8 6.20) and C-methyl group at 8 2.09 was confirmed 
by a through-space correlation observed in the 'NOESY spectrum' of the pigment 4.1. 
l 
l 
0 HO 
e 
l 
l 
0 0 OH 
0 OH 
Figure 4.1: Long range correlations observed in the gHMBC spectrum of 4.1 
l 
l 
The presence of the a-hydroxy benzyl alcohol moiety of this portion of the molecule was 
further corroborated by the data obtained in the previously described EIMS analysis. The 
I 
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weak molecular ion (M +, 2 % ) and the fragment of largest abundance at m/z 302 (M+ -
H2O) were consistent with the ready elimination of water from across the fused phenol 
and lactol ring system (Figure 4.2). 
0 7 +• 0 0 7+• 
II II HO 
- H20 HO 
-
MeO Meo 
0 OH 0 OH 
Figure 4.2: Proposed fragmentation of coronatoquinone (4.1) under El conditions 
2JcH, 3JcH and 41 CH 'w' couplings arising from the peri-hydroxy protons (5-OH and 10-
OH) enabled the complete assignment of the benzenoid chemical shifts (Figure 4.1). In 
addition, 5JcH 'epi-z' connectivities observed between 5-OH and C-9 and also between 
10-0H and C-6 allowed the unambiguous assignment of the two quinone carbonyl 
carbon chemical shifts (8 184 and 181 respectively) within the naphthazarin system. 
The ~-hydroxy methoxy substitution of the quinone ring fragment followed from the 
HREIMS-derived molecular formula and the NMR spectroscopic data (1H and 13C) 
outlined above. Further evidence for these oxy-substituents was provided by the 
significant downfield shift observed for the methoxy protons at 8 4.18 in the CDCl3 1 H 
NMR spectrum. 20 In deuteriochlorof orm, the singlets arising from unhindered aromatic 
or quinonoid methoxy protons are typically found in the region 8 3.87 - 3.94. Upon the 
introduction of a substituent adjacent to the methoxy moiety a notable downfield shift can 
be observed. For example, the methoxy protons of 2,3-dimethoxynaphthazarin, 
2-methoxy-3-ethylnaphthazarin and 3-methoxynaphazarin-2-yl acetate are observed in the 
region 8 4.04 - 4.13 (CDC13).20 The paramagnetic shift resulting from a /3-hydroxy 
substituent is even more pronounced; the methoxy protons in such cases characteristically 
lie between 8 4.14 - 4.24 (CDC13).20 
The 2D NMR spectroscopic data described above did not appear to be sufficient to 
discriminate between two possible regioisomers: 1,5,8, 1 0-tetrahydroxy-7-methoxy-
3-methyl-6,9-dihydro-1H-naphtho[2,3-c ]pyran-6,9-dione ( 4.1) and structure 4.11 in 
I 
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which the quinonoid oxy-substituents are in the alternate (7-hydroxy-8-methoxy) 
orientation. 
O OH OH 0 OH OH 
II I I 
HO~ Jl ~ ~O 
MeOJ! '§-:( 'O I I /'. ,.,.1 Meo HO 
0 OH 
( 4.11) 
In particular, potentially diagnostic 2 J CH and 3 J CH couplings arising from the quinone 
hydroxy proton were not evident due to rapid intermolecular exchange in both CDC13 and 
d6-dimethyl sulfoxide. 
However, consideration of the probable biosynthetic ong1ns of coronatoquinone 
(discussed in § 4. 7) resulted in the 7-methoxy-8-hydroxy naphthazarin 4.1 being 
deemed more likely than the corresponding 7 ,8 regioisomer 4.11. 
In addition, although the absence of signals arising from the quinonoid hydroxy proton 
was unfortunate, the aforementioned 2lcH, 3icH and 4lcH correlations involving the peri-
hydroxy protons (Table 4.1) were invaluable in the eventual assignment of the structure 
of coronatoquinone. 
As discussed in Chapter 2, the 1 H chemical shifts of hydrogen bonded peri-hydroxy 
protons are influenced by the stereoelectronic character of neighbouring substituents. 
Indeed, the influences of both quinone and aromatic substituents on the 1 H chemical 
shifts of peri-hydroxy protons in naphthoquinone systems have been investigated in a 
definitive study by Moore and Scheuer.20 
Moore and Scheuer examined the effects exerted by methoxy and hydroxy substituents 
(amongst others) on the 1H NMR chemical shifts of peri-hydroxy protons in bothjuglone 
[5-hydroxy-1,4-naphthoquinone] and naphthazarin systems. A number of their results 
are summarised below (Table 4.2). 
The empirical correlations determined by Moore and Scheuer clearly contrast the differing 
influence imparted by hydroxy and methoxy substituents in simple naphthoquinone 
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systems. Moore and Scheuer also examined several disubstituted naphthazarin systems, 
e.g. 4.12 and 4.13, and observed good agreement between the experimentally derived 
chemical shifts of peri-hydroxy protons and values obtained by summing the effects of 
each substituent on the peri-hydroxy protons (Figure 4.3). 
0 OH 
0 (juglone) 
Compound 
juglone 
naphthazarin 
2-hydroxyjuglone 
3-hydroxyjuglone 
2-hydroxynaphthazarin 
2-methoxyjuglone 
3-methoxyjuglone 
2-methoxynaphthazarin 
0 OH 
0 OH (naphthazarin) 
1 H Chemical shift 8 ~ from chemical shift of 
(observed) 
C-5 OH C-8 OH 
11.93 
12.43 12.43 
12.31 
11.06 
12.76 11.49 
12.23 
11.70 
12.63 12.17 
parent naphthoquinone (ppm) 
C-5 OH C-8 OH 
0 
0 
+ 0.38 
- 0.87 
+ 0.33 
+ 0.33 
- 0.23 
+ 0.20 
0 
-0.94 
-0.26 
Table 4.2: The effect of various quinonoid ring substituents on the 1 H chemical shift of 
peri-hydroxy protons20 
The results of these studies suggested to us that the differing influences exerted by the 
methoxy and hydroxy substituents of 4.1 and 4.11 would be reflected in the expected 
chemical shifts of the peri-hydroxy protons of coronatoquinone and its alternate 
reg101somer. 
8 11.69 (Cale) 8 11.49 (Cale) 
811.55 (Obs) ti =+O ·14 8 11.48 (Obs) ti= +O .01 
0 OH ~ 0 OH t:;:=:J 
II I HO HO 
MeO Et 
0 OH 0 OH 
(4.12) ¢:::::, (4.13) ¢::::, 
8 12.40 (Obs) 8 12.87 (Obs) 
8 12.50 (Cale) ti= +O .10 8 12.93 (Cale) ti= +O .06 
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Figure 4.3: A comparison of calculated and observed 1 H chemical shifts of the peri-
hydroxy protons of disubstituted naphthazarins20 
A subsequent search of the literature revealed a number of fungal metabolites derived 
from the pathogenic fungi Fusarium solani (Mart.) Sacc., and its telemorph Nectria 
flaematococca which bore significant structural similarities to coronatoquinone. These 
metabolites are described in greater detail in § 4.5. Of particular interest were the 
pyranonaphthazarins, anhydrofusarubin lactol21,22 ( 4.14 ), anhydrofusarubin 
lactone21,23 ,24 (4.15) and anhydrofusarubin24 (4.16). The 1H NMR chemical shifts of 
these three pyranonaphthazarins are depicted in Figure 4.4. 
8 13.25 
~ 
0 OH OH 
MeO' y I '-..1/' 'Me Meo 
0 OH ¢:=::, 
(4-14) 812.85 
0 
ll 
0 
8 14.28 
~ 
OH 0 
1 ll 
0 
J 
Me MeO 
OH ¢:::::;, 
(4.15) 
8 12.75 
8 13.10 
~ 
0 OH 
Me 
0 OH ~ 
(4-1G) 812.74 
Figure 4.4: 1 H NMR chemical shifts of the peri-hydroxy protons of anhydrofusarubin 
derivatives (CDCl3)21-24 
The expected 1 H NMR chemical shifts of the peri-hydroxy protons of regioisomers 4. 1 
and 4.11, shown in Figure 4.5, were calculated by applying the corresponding 
displacement factors derived by Moore and Scheuer to the values reported for 
anhydrofusarubin lactol (4.14)_21,22 
0 
HO 
MeO 
0 
10-0H 8 12.31 (Cale) 
~ 
OH OH 
_,,.L 
0 
OH ~ 
Me 
(4-1) 5-OH813.18 (Cale) 
10-OH 8 12.10 (Obs) 10-OH 8 13.12 (Cale) 
MeO 
HO 
0 
~ 
OH OH 
l ,,.L 
0 OH 
(4.11 ~ 
0 
Me 
5-OH 8 13.09 (Obs) 5-OH 8 12.37 (Cale) 
Figure 4.5: A comparison of calculated 1H NMR chemical shifts of the peri-hydroxy 
protons of regioisomers 4.1 and 4.11 with the values observed for coronatoquinone 
(CDCl3) 
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Comparison of the calculated 1 H NMR chemical shifts with the values observed in the 1 H 
NMR spectrum of the lichen pigment revealed a clear correlation between the chemical 
shifts calculated for the 7-methoxy-8-hydroxy regioisomer 4 .1 and those observed 
experimentally for coronatoquinone. Specifically, the differences between calculated and 
observed values for the 5-OH and 10-OH protons of structure 4.1 were ~ +0.09 and~ 
+0.21 respectively, compared to~ -0.72 and~ +1.02 for the corresponding 7-hydroxy-
8-methoxy isomer 4 .11. This evidence is fully consistent with the lichen metabolite, 
coronatoquinone, having structure 4.1. 
4.5 Naturally Occurring Pyranonaphthazarins 
4.5.1 Pyranonaphthazarins from Lichen Sources 
Prior to our investigation, only one other lichen-derived pyranonaphthazarin has been 
identified in the chemical literature. In 1971 Bruun and Lamvik isolated the 'colouring 
matter' haemoventosin from the crustose Norwegian lichen, Ophioparma ventosa (L.) 
Norman[= Haematomma ventosum (L.) Massal.]. 25 
The Scandinavian workers suggested a dihydrofuronaphthazarinoid structure 4 .1 7 for 
this pigment, but their experimental data was inconclusive. Some twenty years later, 
Maksimov et al. 26 proposed an o-quinonoid structure 4 .18 for haemoventosin. This 
proposal was based on the purported formation of a quinoxaline derivative upon 
treatment of the pigment with 1,2-phenylenediamine. 
OH 0 OH 0 
Me Meo Meo 
0 OH 0 0 
( 4.17) Me 
In 1995 Huneck and co-workers further investigated the structure of haemoventosin. 27 
The revised structure 4 .19 resulted from extensive two-dimensional NMR experiments 
conducted on the acetyl derivative, 10-O-acetylhaemoventosin ( 4.20). Chiroptic 
measurements also revealed that the monoacetate 4.20 was optically active ([a] +354). 
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The stereochemistry of the stereogenic centre (C-3S) of the acetylated derivative 4. 2 0 
was assigned by comparison of the corresponding CD spectrum with that of the 
structurally similar fungal metabolite, 1 0-O-acetyl-semi-xanthomeglin28 ( 4.21). 
Meo 
0 OH 0 
0 OH 
( 4.19) 
Me MeO 
0 OAc 0 
0 OH 
(4.20) 
Me MeO 
4.5.2 Pyranonaphthazarins from Non-Lichen Sources 
0 OAc 0 
.,'Me 
0 
( 4.21) 
While naturally occurring pyranonaphthazarins have been isolated from a variety of 
higher plant, bacterial and non-lichenized fungal sources, the number of such derivatives 
is relatively small. 29-31 Of particular relevance to the present investigation are the 
chemistries of two main chemosyndromes. 
The first of these pyranonaphthazarine chemosyndromes contains derivatives of 
fusarubin ( 4.22). These metabolites have been isolated from a number of species of the 
fungal genus Fusarium, though particular attention has centred on the multitude of 
pyranonaphthazarins found in Fusarium solani (Mart.) Sacc. and its corresponding 
telemorph, Nectria haematococca. These metabolites include the previously described 
anhydrofusarubin lactol21,22 (4.14), anhydrofusarubin lactone21 ,23 ,24 (4.15), 
anhydrofusarubin24 ( 4.16) and fusarubinoic acid23 ( 4.23). The molecular structures of 
these pyranonaphthazarins were determined using 1 H NMR and mass spectroscopy 
coupled with the comparison of the physiochemical data of structurally related 
co-metabolites. 
0 OH 0 OH OH 0 OH 0 
Jl ~ ~ 
0 UH 
Meo 
Me Meo MeO 
0 OH 0 OH 0 OH 
( 4.22) (4.14) ( 4.15) 
Meo 
0 OH 
0 OH 
(4.16) 
0 
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0 OH 
0 OH 
(4.23) 
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F. solani is a cosmopolitan species and is a known pathogen and saprophyte. A number 
of isolates have been observed to cause root rot in a variety of important agricultural 
crops including legumes, Citrus, tomato and capsicum. Other strains of this species have 
also been found responsible for diseases in humans, crustaceans and other animals. 32 
Fusarium strains have been observed to produce different naphthazarin pigments in 
varying amounts and ratios and a correlation between naphthazarin formation and 
pathogenicity has been reported. 33 
In addition to their pathogenic properties, fusarubin derivatives have been observed to 
exhibit a diverse range of more useful biological activities. These include antimicrobial 
activity against gram-positive bacteria34,35 and the yeast Saccharomyces cerevisiae,34 as 
well as insecticidal, 36,37 phytotoxic, 33,38 antifungal, 32 and antitumour39 properties. 
The second major group of pyranonaphthoquinones, known collectively as 
ventiloquinones, have been isolated from the root bark of various species of the higher 
plant genus Ventilago (Rhamnaceae). Characterised by a cis-dihydro-1,3-dimethylpyran 
moiety, ventiloquinones vary in the type and position of the oxy-substituents on the 
naphthazarin ring system. 
The ventiloquinones are known to be optically active. The stereochemistry of the 
dihydropyran ring of ventiloquinone E40 ( 4.24) was deduced by chiroptic comparisons 
(CD and specific rotation data) with 6-hydroxy-7-methoxy-eleutherin41 ( 4.25), 
eleutherin42 ( 4.26) and isoeluetherin42 ( 4.27). 
The stereochemistries of the other ventiloquinone derivatives were subsequently assigned 
on biosynthetic grounds and by comparison of specific rotation values. 
OMe O Me 
MeO' In"-/ '"Me 
OMeO 
(4.24) 
[a]= +438 
OMe O Me 
0 
(4.26) 
[a]= +346 
Me 
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MeO' In'-.../ '"Me 
OH 0 
MeO 
(4.25) 
OMe O Me 
0 
(4.27) 
[a]= +46 
.,,Me 
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Interestingly, a number of ambiguities still exist in the structural assignment of several of 
the ventiloquinones. For example, ventiloquinone A ( 4.28) is known to possess a 
methylated peri-hydroxy group, though the position of this substituent on the aromatic 
ring is uncertain.40 
Ventiloquinone O ( 4.29) bears a strong structural resemblance to coronatoquinone 
( 4.1 ), although the orientation of the quinonoid oxy-substituents is not known. 43 
Catalytic hydrogenation of ventiloquinone O ( 4.29) followed by methylation with 
diazomethane was shown to yield ventiloquinone D ( 4.30).40 
OR1 0 Me 0 OH Me 
0 
< 0 0 Me 
OR2 0 0 OH 
(4.28) R1 = H (Me); R2 = Me (H) (4.29) R1 = H (Me); R2 = Me (H 
[a]= +350 [a]= +618 
Another pertinent compound belonging to this chemosyndrome is ventiloquinone C 
( 4.31). Ven tiloquinone C ( 4. 31) was isolated as a 2: 1 mixture of regioisomers which 
could not be separated by chromatography. Furthermore, the identities of the 
co-occurring isomers could not be distinguished.40 
0 OH Me 
Meo 
MeO..., 'r( f '-/' ,.Me 
0 OH 
(4.30) 
[a]= +308 
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OH 
(4.31) R1 = H (Me); ~ = Me (H; 
4. 6 Absolute Configuration of Coronatoquinone 
Coronatoquinone (4.1) possesses a stereogenic centre at C-1. Anhydrofusarubin lactol 
(4.14) possesses a comparable centre although the optical activity of this metabolite has 
not been investigated. 21 ,22 
In order to ascertain the chirality of the C-1 centre of coronatoquinone (4.1) we 
examined the chiroptic properties of the pigment. Initial difficulties, which arose from 
the intense colour of the pigment, were overcome through the use of extremely dilute 
solutions. 
The CD spectrum of coronatoquinone revealed a number of small Cotton effects at A 
300, 380 and 475 nm. The corresponding ORD spectrum exhibited strong positive 
Cotton effects at A 372, 493, 527 and 565 nm and is illustrated in Figure 4.6. 
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Figure 4.6: The ORD spectrum of coronatoquinone (4.1) 
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Coronatoquinone (4.1) was found to exhibit a large positive optical rotation ([a]0 +684, 
c 0.005). This value is comparable to those reported for the structurally similar 
ventiloquinones (e.g. ventiloquinone O ( 4.29) [a]o +618 and ventiloquinone D ( 4.30) 
[a]0 +308) discussed in the preceding section(§ 4.5). Consequently the C-1 centre was 
assigned as the S enantiomer. 
Treatment of coronatoquinone (4.1) with methanol afforded the methyl ketal (4.32) 
(Figure 4.7). This derivative was observed to be optically inactive. 
0 OH OH 0 OH OMe 
Jl ~ 
~o 
II I <, HO~ MeOH HO l 1:r ~f Meo Meo 
II 
0 OH 0 OH 
( 4.1) (4.32) 
Figure 4.7: Methanolysis of coronatoquinone (4.1) 
The observed enantiomeric purity of coronatoquinone ( 4.1) is surprising considering the 
anticipated susceptibility of the lactol moiety to ring opening. Although unexpected, the 
observed chirality of the pigment sheds light on the biosynthetic pathway to this 
metabolite as discussed in § 4. 7. 
4. 7 Biosynthetic Considerations 
From a biosynthetic viewpoint, coronatoquinone ( 4 .1) is presumed to arise vza a 
heptaketide chain 4.33 (Figure 4.8). 
The polyketide ong1ns of the structurally related fusarubin derivatives has been 
demonstrated by a number of research groups, in particular those of Gatenbeck44 and 
Kurobane45 , but little is known about the biosynthetic sequence after cyclisation and 
aromatisation of the cyclised polyketide. 
It is presumed that, like the structurally related anhydrofusarubins22 4 .14, 4 .15 and 
4 .16, cyclisation and aromatisation of the heptaketide is fallowed by a sequence of 
oxidation and methylation steps to give the carboxylic acid 4.34. Lactonisation, 
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followed by elimination of water, would then be expected to afford the lactone 4. 3 5. 
Enzymic reduction of the lactone 4.35 could then give coronatoquinone (4.1). Evidence 
for such a reduction is provided by the observed optical activity of the pigment 4.1. 
0 0 0 [O] ~ OH OH 
OH 
0 0 0 
0 -,,"'-./"~Me HO'~~..........,,, 'Me 
(4.33) [Me]/ t t ~ 0 OH [O] [O] HO 
MeO' n I~ 'Me 
0 OH 
(4.34) 
l 
0 OH OH 0 OH 0 0 OH 0 
[H] ~HO, A.~ A_ enzymic HO ':::::: 0 -H20 HO 
MeO' 'V' "'Y" ~ 'Me Meo/ ')(' "r JMe Meo II I Me 
0 OH 0 OH 0 OH 
(4.1) ( 4.35) 
Figure 4.8: Proposed biosynthesis of coronatoquinone (4.1) 
4.8 Evaluation of Antiprolif erative Activity 
As discussed in § 4. 5, pyranonaphthazarins have been observed to exhibit a diverse 
range of biological activities including antibiotic, insecticidal, phytotoxic, antifungal and 
cytotoxic properties. In light of such properties, the antiproliferative activity of 
coronatoquinone ( 4 .1) against the murine PS 15 cell line was evaluated. As the 
p-terphenylquinone co-metabolite of coronatoquinone ( 4.1 ), polyporic acid ( 4.2 ), was 
previously found to exhibit potent in vivo antileukaemic activity, this metabolite was also 
tested against the known immunosuppressant, gliotoxin46-5 l ( 4.36). 
However, both compounds proved less effective than gliotoxin ( 4.36) yielding ICso 
values of~ 100 µM (Figure 4.9). In comparison, gliotoxin ( 4.36) gave an ICso value 
of 1.30 µM. 
HO 
Meo 
0 HO 
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---~ 0 
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Figure 4.9: Antiproliferative activity of coronatoquinone (4.1) and polyporic acid (4.2) 
relative to gliotoxin (4.36) 
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5.1 The Lichen Genus Myeloconis 
Myeloconis, a genus of pyrenocarpous lichens, was first described by McCarthy and Elix 
in 1996. 1 Four new species were recognised from specimens found in lowland and 
montane tropical forests of the Neotropics and eastern Paleotropics. 
The most remarkable feature of the new genus was observed to be the occurrence of 
intense yellow and/or orange crystals in the lichen medulla. These crystals were 
immediately conspicuous when the thallus was tom or sectioned. t 
In order to ascertain the identity of the intensely coloured Myeloconis pigments, named 
myeloconones, the extraction of Myeloconis erumpens McCarthy & Elix was undertaken. 
This lichen, the most frequently collected of the four species, has a very distinctive 
thallus with exposed patches and eruptions of yellow medullary material clearly visible 
against the brownish thallus surf ace. 
This chapter describes the isolation, characterisation and structural elucidation of 
myeloconone A2 (5.1), a new polyhydroxylated phenalenone, from the lichen 
Myeloconis erumpens. The structure of myeloconone A2 (5.1) was established as 6,7,9-
trihydroxy-3,8-dimethoxy-4-methyl-lH-phenalen-1-one ( or an equivalent tautomer), 
primarily using NMR spectroscopic methods. Myeloconone A2 ( 5 .1) represents a class 
of polyketide-derived pigments not previously reported in lichenized fungi. 
Me 
12 
OMe 
11 10 
(5.1 a) 
HO 
HO 
OMe 
0 
OH 
Me OMe 
( 5.1 b) 
t The name Myeloconis is derived from the Greek myelos (marrow, pith) and konis (dust), in reference to 
the powdery yellow and/or orange pigments found in the lichen medulla.1 
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5.2 Collection and Isolation 
Specimens of the lichen Myeloconis erumpens McCarthy & Elix were collected from the 
trunks of Castanopsis trees, at an altitude of 1400 m, 9 km south of Bulolo, Morobe 
Province, Papua New Guinea in 1982 by Mr H. Streimann.+ 
The lichen material (0.63 g) was dried and extracted for 18 h with diethyl ether. 
Evaporation of the ethereal solution yielded an intense yellow crude extract (0.11 g). 
TLC and mass spectrometric analysis of the lichen extract revealed two major co-
metabolites: the pigment myeloconone A2 and the known anthraquinone fragilin ( 5. 2). 
The crude extract was purified by flash chromatography using ethyl acetate/ light 
petroleum as eluant to afford myeloconone A2 as a bright yellow solid (64 mg, 14.2%). 
Cl 
OH O OH 
0 
(5.2) 
Me 
5.3 Structural Elucidation 
5.3.1 Myeloconone A2 
The structure of myeloconone A2 ( 5 .1) was established primarily through mass 
spectrometric and NMR spectroscopic analysis. 
A strong molecular ion was evident in the mass spectrum of 5 .1 at m/z 302. High 
resolution mass measurement of this ion yielded a molecular formula of C16H 14O6, 
corresponding to ten degrees of unsaturation. 
The corresponding 1 H NMR spectrum of myeloconone A2 ( 5 .1) was uncomplicated, 
exhibiting a total of five singlets in a ratio of 1:1:3:3:3 (Figure 5.1 and Table 5.1). 
Two of these signals, at 8 6.80 and 6.48, were characteristic of aromatic or quinone 
hydrogens. The three remaining singlets corresponded to two O-Me substituents (8 3.99 
and 3.80 ppm) and a C-Me group at 8 2.74. Thus, eleven of the fourteen protons 
identified in the molecular formula could be accounted for in the 1 H NMR data. 
+ A voucher specimen, identified by J. A. Elix, has been deposited in the herbariurn of the Australian 
National Botanic Garden, Canberra, Australia (CANB). 
Chapter 5 111 
-'1 
-----6.88~ 
-----6.487 
m 
<.n 
.,i:. 
-----3.987 
-----3.884 
w 
-----2.7•8 
-----2.498 
DMSO 
ru 
..... 
-0 
-0 
3 
Figure 5.1: 1H NMR spectrum ofmyeloconone A2 (5.1) 
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The three remaining protons were therefore attributed to readily exchangeable hydroxy 
moieties. 
Carbon 
No. 
1 
2 
3 
3a 
3b 
4 
5 
6 
6a 
7 
8 
9 
9a 
10 
11 
12 
13C 
8 
172.60# 
97.15 
166.24 
110.70 
126.77 
145.51 
116.84 
163.52 
105.21 
162.37 
132.69 
169.86# 
103.07 
59.63 
25.45 
56.19 
lH 
8 (mult, J Hz) 
6.48 (s) 
6.80 (s) 
3.99 (s) 
2.74 (s) 
3.80 (s) 
H-2 (2) 
H-10 (4) 3 
gHMBC 
(C,H) 
H-2 (2), 3 H-10 (3), H-11 (4)3 
H-2 (3), H-5 (3), H-11 (3) 
H-2 (4),3 H-11 (2) 
H-11 (3) 
H-5 (2)3 
H-5 (3) 
H-12 (4) 3 
H-12 (3) 
H-2 (4) 3 
H-2 (3) 
H-5 (3) 
Table 5.1: 1H and 13C NMR data for myeloconone A 2 (5.1) (CD3SOCD3 ) 
(a depicts a weak correlation;# 13C signals may be interchanged) 
The 13C NMR spectrum of 5 .1 further supported the proposed molecular formula, 
exhibiting sixteen discrete resonances. One methyl (8 25.45), two methoxy (8 56.19 and 
59.63) and two methine (8 97.15 and 116.84) carbon atoms were readily apparent 
(Figure 5.2 and Table 5.1). The remaining eleven signals corresponded to 
quaternary carbon atoms. Interestingly, four signals, attributed to oxygenated sp2 
hybridized carbon atoms (8 172.60, 169.86, 163.52 and 162.37), were noticably 
broadened. One bond C-H correlations were readily assigned using gHMQC data. 
The mass spectrometric and NMR spectroscopic data described above suggested a carbon 
skeleton equivalent to a hydrocarbon formulated as 'C13H80'. This formulation contains 
a remarkable degree of unsaturation relative to the number of core carbon atoms 
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Figure 5.2: l3C NMR spectrum of myeloconone A 2 (5.1) 
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was consistent with a tricyclic phenalenone framework. Further evidence for this 
conclusion was provided by gHMBC long range C-H connectivities (Figure 5.3). 
OMe 
HO 
Me OMe 
Figure 5.3: Correlations observed in the gHMBC spectrum of myeloconone A2 (5.1) 
The aromatic proton singlet at 8 6.80 yielded three strong C-H long range correlations, 
assigned as 3lcH couplings, to quaternary carbon atoms at 8 110.70 and 105.21 and the 
methyl carbon atom at 8 25.45. In addition, a weak connectivity to an oxy-substituted 
carbon atom (8 163.52) was assigned as a 2lcH correlation. 
Three strong correlations involving the methyl protons at 8 2. 7 4 were also readily 
apparent. Two of these connectivities, i.e. to the methine carbon atom at 8 116. 84 and 
quaternary carbon atom at 8 110.70, were assigned as 3JcH couplings while the third, 
involving the quaternary carbon atom at 8 145.51, was attributed to a 2lcH coupling. A 
fourth, weaker correlation was observed between the methyl protons (8 2.74) and the 
oxy-substituted quaternary carbon atom at 8 166.24. This connectivity was consistent 
with an unusually large 4lcH coupling. Interestingly, an identical 4lcH connectivity was 
observed in the HMBC spectrum of a recently reported structurally related phenalenone 
derivative, erabulenol B (5.3).2 
Me 
' 
Me 
Me 
Me 
A further three strong long range correlations were observed to arise from the methine 
proton singlet at 8 6.48. Again, two of these connectivities were consistent with 3JcH 
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couplings, in this instance to quaternary carbon atoms at 8 110.70 and 103.07. The third 
strong connectivity was assigned as a 21 CH coupling to the oxy-substituted carbon atom at 
8 166.24. A 3JcH correlation between the O-Me protons at 8 3.80 and the carbon atom at 
8 166.24 established the location of this methoxy moiety within the structural fragment 
(ring C). 
Three weaker long range correlations arising from the methine proton singlet (8 6.48) 
were also evident in the gHMBC spectrum. The strongest of the three correlations, that 
between the methine proton and carbon atom 8 172.60, was assigned as a 2JcH coupling. 
The remaining two connectivities, to carbon atoms 8 169.86 and 145.51 were attributed 
to long range 4lcH coupling. 
The methoxy group which resonated at 8 3 .80 in the 1 H NMR spectrum was observed to 
exhibit a strong 3JcH correlation to the quaternary carbon atom at 8 132.69. A weaker 
correlation to 8 162.37 was attributed to a 41 cH coupling. Furthermore, the considerable 
upfield chemical shift displayed by the methoxy substituted carbon atom suggested this 
moiety was positioned ortho to two oxy-substituted residues. 
Thus, the 1 H and 13C NMR spectra of myeloconone A2 were consistent with a highly 
oxygenated phenalenone. This derivative can be represented by four tautomeric 
structures 5.la - 5.ld. 
HO 
HO 
Me OMe 
( 5.1 a) 
HO 
0 HO 
Me OMe 
(5.1 b) 
OH 0 
OMe 
I OH 
Me OMe 
( 5.1 C) 
OH HO 
OMe 
I 
~OH 
Me OMe 
( 5.1 d) 
OH 
The broad linewidths of the four 13C NMR signals at 8 172.60, 169.86, 163.52 and 
162.37 are indicative of a high degree of intramolecular mobility between the four 
tautomeric species (5.la) - (5.ld) at room temperature. Such a process is dependent 
.I. 
upon the temperature T (K) and the free enthalphy of activation ~G+ of the reaction . 
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In addition, the peri-hydroxy protons of 9-hydroxyphenalenones are typically strongly 
hydrogen bonded, displaying a strong downfield signal in the vicinity of 8 16 - 18. 3 ,4 
The absence of such signals form the 1 H NMR spectra of myeloconone A2 is thus further 
evidence for the rapid interconversion of tautomeric species in solution. 
The gHMBC correlations described above, in particular connectivities between proton H-
3 (8 6.48) and carbon atoms resonating at 8 169.86 and 172.60, are consistent with a 
rapidly interconverting mixture of tautomers 5.la and 5.lb. Presumably this tautomeric 
pair is favoured over tautomers 5 .1 c and 5 .1 d because of the proximity of the electron 
rich methoxy moiety on ring C. 
5.3.2 9-Hydroxyphenalenones and Intramolecular Proton Exchange 
Intramolecular proton exchange in 9-hydroxyphenalen-1-one derivatives has been the 
subject of a number of theoretical and/or spectroscopic investigations.5-9 
A single crystal X-ray analysis of 9-hydroxyphenalenone, carried out by Abraham and 
co-workers, determined the atomic distances between oxygen atoms 0-1 and 0-9 and the 
intramolecularly hydrogen bonded hydrogen atom to be effectively symmetrical [ 0-1 · · · H 
= 1.31 A, O-9···H = 1.26 AJ. 6 Two explanations were given to account for this data: 
either (i) the phenalenone contained a symmetric intramolecular hydrogen bond, as in 
structure 5.4b, or (ii) the hydrogen atom was undergoing rapid exchange between two 
closely spaced asymmetric equilibrium positions (structures 5.4a and 5.4c).6 
Subsequent low temperature studies, especially with laser-excited fluorescence and 
fluorescence excitation, and ab initio calculations conclusively demonstrated the 
asymmetric nature of the hydrogen bond and the occurrence of rapid intramolecular 
proton exchange between equivalent tautomers 5.4a and 5.4c, even in the solid state.5,9 
OH 
I 
0 
( 5.4a) (5.4b) (5.4c) 
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Ab initio calculations yielded an energy barrier of 21.77 kJ mol- 1 for this tautomeric 
interconversion. Interestingly, the average barrier between the related 9-hydroxy-2-
methylphenalenone (5.Sa) and 9-hydroxy-8-methylphenalenone (5.Sb) was observed to 
have the same value as the 9-hydroxyphenalenone system 5. 4, while the two tautomers 
were predicted to have an energy difference of 1.93 kJ mol-1. The 2-methyl phenalenone 
was identified as the more stable tautomer.5,9 
The rapidity of the interconversion was attributed to the low energy barrier, the small 
interminimum distance ( the distance between the position of the hydrogen atom m 
structures 5.Sa and 5.Sb) and the small energy difference of the two tautomers. 5,9 
Me Me 
(5.5a) (5.5b) 
A further crystallographic study has recently been carried out on a 9-hydroxyphenalenone 
derivative, namely xanthoherquein tetraacetate (5.6). This study again revealed 
symmetrical intramolecular 0···H···0 hydrogen bond lengths between oxygen atoms 0-1 
and 0-9 [0-l···H = 1.29 A, 0-9···H = 1.23 AJ.1° In addition, the corresponding 
oxygen - carbon bond distances were also found to be equivalent [C-1···0-1 = 1.289(4) 
0 0 
A, C-9···0-9 = 1.292( 4) A], further suggesting the presence, in the solid state, of 
tautomers (5.6a) and (5.6b) in approximately equal proportions. 
AcO 
Me OAc 
(5.6a) 
0 
OAc 
OMe 
AcO~ ~ .,,0 
AcO 
Me OAc 
( 5.6b) 
5.4 Naturally Occurring Phenalenone Derivatives 
Myeloconone A2 ( 5 .1) belongs to a small family of phenalenones previously found in 
several non-lichenized fungal species. 11 -16 The first member of this family to be 
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characterised was atroventin ( 5. 7) ( or an equivalent tautomer) isolated from the fungi 
Penicillium atrovenetum in 1955. 17 The structure of atrovenetin (5.7) was eventually 
solved a decade later by the X-ray study of a trimethylated derivative. 18 
Other derivatives, for example deoxyherqueinone (5.8) (or an equivalent tautomer), 
norherqueinone (5.9), herqueinone (5.10), iso-herqueinone (5.11), 
iso-norherqueinone (5.12) and herqueichrysin (5.13) (or an equivalent tautomer), were 
subsequently isolated from Penicillium herquei or P. atrovenetum. 11 ,19-22 
HO 
OR 
0 
Me 
(5.7) R = H 
(5.8) R = Me 
0 
OR 
Me 
(5.9) R = H 
(5.10)R=Me 
0 
OR 
(5.11)R=Me 
(5.12)R=H 
, 
~ 
HO 
OMe 
0 ... ~ ,OH 
Me OH 
( 5.13) 
Over the last three years several phenalenone derivatives have been isolated from a 
number of Penicillium and Aspergillius species. Erabulenol A (5.14) and B (5.3), 
produced by Penicillium species FO-5637, were identified as inhibitors of the cholesteryl 
ester transfer protein by Omura and co-workers in 1998. 2 The structure of erabulenol B 
(5.3) was determined primarily from NMR spectroscopic data. Comparison of the 13C 
NMR shifts of erabulenol A (5.14) with those of deoxyherqueinone (5.8) showed that 
erabulenol A ( 5 .14) possessed the same phenalenone skeleton and 1, 2, 2-
trimethy ltetrahydrofuran ring. 
OMe OMe 
I I OH 
0 
i 
Me 
Me Me 
-::. 
Me' 4 I y Id (5.3) (5.14) 
Me 
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Interestingly, erabulenol A ( 5 .14) was found to have a negative specific rotation, [ a 0 ] 
-220, compared to the positive value, [a0 ] +55.9, reported for the isomeric 
deoxyherqueinone (5.8). 20 Omura thus assigned the opposite stereochemistry at the C-
2' centre for the erabulenol derivative 5.14. Curiously, the phenalenone 5 .14 was also 
assigned a different tautomeric structure than deoxyherqueinone (5.8) by comparison of 
the 13C NMR data. 
Funalenone (5.15) ( or an equivalent tautomer), isolated from Aspergillus niger in 1999, 
was found to possess novel collagenase inhibitory activity.23 This metabolite 5.15 is the 
demethyl derivative of myeloconone A2 (5.1) and, interestingly, the oxy-substituted 
carbon atoms C-1, C-3, C-4 and C-9 are also reported to display broad signals in the 
corresponding 13C NMR spectrum. 
Even more recently, two metabolites possessing a phenalenone skeleton, sculezonanes A 
(5.16) and B (5.17), have been isolated from a marine-derived Penicillium species. 24 
HO 
HO 
OMe 
Me OH 
(5.15) 
OH Me 
R 
OMe 
OH 0 
0 
(5.16) R = H 
(5.17) R = OH 
As discussed earlier, myeloconone A2 (5.1) is the first phenalenone derivative identified 
in lichenized fungi. However a structurally related naphtho[l ,8-cd]pyran, simonyellin 
(5.18), has recently been isolated by Elix and co-workers from the lichen Simonyella 
variegata.25 Simonyellin (5.18) has been postulated to arise from a polyhydroxylated 
phenalenone namely, 3,5,6,9-tetrahydroxy-7-methyl-4-methoxy-phenalenone ( 5 .19) 
(Figure 5.4). 
This intermediate 5.19 is similar in structure to myelaconone A2 ( 5 .1) and the isolation 
and characterisation of other related phenalenone derivatives is thus expected in the 
future. 
J~ l ~ 
Me('~"SCoA 
HO 
MeO 
HO 
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OH 
0 Me 
(5.19) 
Figure 5.4: Proposed biosynthesis of simonyellin (5.18) 25 
5.5 Biosynthetic Considerations 
MeO 
HO 
0 
0 Me 
( 5.18) 
120 
OH 
The first evidence to indicate the polyketide origins of fungal-derived phenalenones was 
provided through the use of isotopically labelled precursors in 1961. 26 In subsequent 
work, Simpson used doubly labelled acetate and mevalonate to investigate the 
biosynthetic origins of herqueichrysin (5.13).22 The proton-noise-decoupled 13C NMR 
spectra of the [1,2-13C2] acetate enriched samples were consistent with only one of three 
possible folding modes of the acyclic polyketide chain. 
A proposed biosynthesis of myeloconone A2 (5.1) is illustrated in Figure 5.5. 
0, ,,,J __ "-. .,,_O 
Me o (5.20a) 
~ 
0 0 
Me o (5.20b) 
)( 
0 
Me O (5.20c) 
X = COSCoA 
/ [O, Me] 
OH 
0 
Me OH 
(5.21) "-[Me] 
HO 
OMe 
HO, ~ A. ,,,,_0 
Me OMe 
(5.1a) 
OMe 
O'" ~ ~OH 
Me OH 
herqueichrysin (5.13) 
Figure 5.5: Proposed biosynthesis of myeloconone A2 (5.1) 
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The pigment 5 .1 is presumed to arise via a single heptaketide chain 5. 20. Three 
possible modes (5.20a-c) of folding lead to the hydroxylated methylphenalenone 5. 21 
though conformation 5. 2 0 b is deemed more likely based on the labelling studies 
conducted by Simpson. 22 An oxidation and methylation sequence would then be 
expected to yield the observed phenalenone-derived pigment (5.1). 
Chapter 5 122 
5.6 References 
1. McCarthy, P. M. and Elix, J. A., Lichenologist, 1996, 28, 401. 
2. Tomoda, H., Tabata, N., Masuma, R., Si, S.-Y. and Omura, S., J. Antibiot., 
1998,51,618. 
3. Highet, R. J. and Edwards, J. M., J. Magn. Reson., 1975, 17, 336. 
4. Zakharov, V. F., Gorelik, A. M., Karakhotin, S. N. and Reznichenko, A. V., 
Zh. Org. Khim., 1996, 32,420. 
5. Kunze, K. L. and de la Vega, J. R., J. Am. Chem. Soc., 1984, 106, 6528. 
6. Svensson, C., Abrahams, S. C., Bernstein, J. L. and Haddon, R. C., J. Am. 
Chem. Soc., 1979, 101, 5759. 
7. Rossetti, R., Haddon, R. C. and Brus, L. E., J. Am. Chem. Soc., 1980, 102, 
6913. 
8. Rossetti, R., Rayford, R., Haddon, R. C. and Brus, L. E., J. Am. Chem. Soc., 
1981, 103,4303. 
9. Engdahl, C., Gogoli, A. and Edlund, U., Magn. Reson. Chem., 1991, 29, 54. 
10. Trotter, J., Acta Cryst. C, 1992, 48, 942. 
11. Cooke, R. G. and Edwards, J. M., Prag. Chem. Org. Nat. Prod., 1980, 40, 
153. 
12. Ayer, W. A., Hoyano, Y., Pedras, M. S. and Van Altena, I., Can. J. Chem., 
1986,64, 1585. 
13. Ayer, W. A. and Pedras, M. S., Can. J. Chem., 1987, 65, 754. 
14. Ayer, W. A., Pedras, M. S. and Ward, D. E., Can. J. Chem., 1987, 65, 760. 
15. Ayer, W. A. and Ma, Y.-T., Can. J. Chem., 1989, 67, 2089. 
16. Ayer, W. A. and Ma, Y.-T., Can. J. Chem., 1992, 70, 1905. 
17. Neil, K. G. and Raistrick, H., Biochem. J., 1957, 65,166. 
18. Paul, I. C. and Sim, G. A., J. Chem. Soc., 1965, 1097. 
19. Suga, T., Yoshioka, T., Hirata, T. and Aoki, T., Chem. Lett., 1981, 1063. 
20. Suga, T., Yoshioka, T., Hirata, T. and Aoki, T., Bull. Chem. Soc. Jpn., 1983, 
56, 3661. 
21. Narasimhachari, N. and Vining, L. C., J. Antibiot., 1972, 25, 155. 
Chapter 5 123 
22. Simpson, T. J., J. Chem. Soc. Perkin Trans. 1, 1975, 1979. 
23. Inokoshi, J., Shiomi, K., Masuma, R., Tanaka, H., Yamada, H. and Omura, S., 
J. Antibiot., 1999, 52, 109 5. 
24. Komatsu, R., Shigemori, H., Mikami, Y. and Kobayashi, J., J. Nat. Prod., 
2000, 63, 408. 
25. Elix, J. A., Feige, G. B., Lumbsch, H. T., Mies, B., Wardlaw, J. H. and Willis, 
A. C., Aust. J. Chem., 1995, 48, 2035. 
26. Thomas, R., Biochem. J., 1961, 78,807. 
Chapter 6 
Total Synthesis of Butlerins A, B and C: Three 
p-Terphenylsfrom the Lichen Relicina connivens 
6.1 Naturally Occurring p-Terphenyls ................................................................. 12 6 
6.1.1 p-Terphenyls from N on-lichenized Basidiomycetes ................................. 12 6 
6.1.2 p-Terphenyls from Microfungi and Bacteria ............................................ 12 7 
6.1.3 p-Terphenyls from the Lichen Relicina connivens .................................... 129 
6.2 Synthesis of Naturally Occurring p-Terphenyls ........................................... 13 0 
6.3 Retrosynthesis of Pentasubstituted Butlerins A, B and C ......................... 132 
6.4 Synthesis of Butlerin A ..................................................................................... 13 3 
6.5 Synthesis of Butlerin B ..................................................................................... 13 6 
6. 6 Alternative Synthesis of Butlerin B ............................................................... 13 9 
6.7 Synthesis of Butlerin C ..................................................................................... 142 
6.8 Synthesis of 3 ',4,4''-Trimethoxy-p-terphenyl-2 ',5 '-diyl diacetate ........... 146 
6.9 Relative Thermodynamic Stabilities of the Acyl Migration Products ... 147 
6.10 Comparison of Synthetic and Natural Material ....................................... 148 
6.11 References ......................................................................................................... 14 9 

Chapter6 126 
6.1 Naturally Occurring p-Terphenyls 
6.1.1 p-Terphenyls from Non-lichenized Basidiomycetes 
Over the past sixty years close to fifty p-terphenyls have been isolated from natural 
sources. Interest in these compounds initially stemmed from their isolation as the leuco 
derivatives of various p-terphenylquinone pigments detected in the fruiting bodies of 
wood rotting fungi (genera of the class Basidiomycetes). The first such p-terphenyl to be 
identified was cycloleucomelone leucohexaacetate1,2 (6.1), isolated from the mushroom 
Boletopsis leucomelaena by Akagi in 1942t. Since this discovery, a number of partially 
acetylated basidiomycetes-derived p-terphenyls have been isolated and found to exhibit 
antibacterial properties3 and inhibitory activity against the enzymes 5-lipoxygenase4 and 
prolyl endopeptidase.5 
Leuco methyl ether derivatives, such as corticin A (6.2) isolated from Corticium 
caeruleum, comprise another subclass of p-terphenyls detected in pigmented 
(p-terphenylquinone co-metabolites) and non pigmented basidiomycetes. 6-9 
AcO OAc 
(6.1) 
OAc 
OAc 
MeO 
OMe 
( OH 
HO (6.2) 
Although the aforementioned methyl ether and acetate derivatives comprise the majority 
of known basidiomycetes-derived p-terphenyls, a number of more unusual metabolites 
have been observed. These compounds include the tetrabenzoate 
dibenzoylleucoaurantiacin10 (6.3), isolated from Hydnum aurantiacum; a number of 
(2Z,4S,5S)-4,5-epoxy-2-hexenoate derivatives, exemplified by leucomentin-211 ( 6.4) 
and the biogenetically related spiromentins, e.g. spiromentin J12 (6.5). 
t The structure of this natural product was revised by Steglich and co-workers in 1987.2 
Chapter6 127 
OH 
OBz 
I 
HO OBz (6.3) 
The leucomentin and spiromentin derivatives have been isolated from European and 
Japanese species of the mushroom Paxillus atromentosus respectively. 
M~kJ 
H, 0 
Me~,,=yO i 
0 H 0 
HO OH 
(6.4) 
OH 
HO 
Me 
HO/;,r--( ~ ... lo OH 
0 
0 
o-J .. o I H 
(6.S)~H 
H 
In 2000, an unusual nitrogenous p-terphenyl, sarcodonin ( 6.6) , was isolated from the 
fruiting bodies of the basidiomycete Sarcodon leucopus. 13 Sarcodonin ( 6.6) exhibited 
moderate cytotoxicity against KB and P-388 tumour cell cultures. 
AcO OAc 
AcO 
HO OH 
(6.6) 
6.1.2 p-Terphenyls from Microfungi and Bacteria 
p-Terphenyls have also been isolated from species of microfungi. A particularly rich 
source of these metabolites is the mould Aspergillus candidus. 
Microfungi-derived p-terphenyls were first identified by Marchelli and Vining who 
isolated terphenyllin (6.7) from cultures of A. candidus in the early 1970s.14,15 
Terphenyllin (6.7) and the closely related 4-deoxyterphenyllin ( 6.8) were independently 
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characterised by Takahashi and co-workers who found that these p-terphenyls displayed 
potent cytotoxicity to cultured HeLa cells. 16 3-Hydroxyterphenyllinl7,18 (6.9) and 3,3"-
dihydroxyterphenyllin19 (6.10), have also been isolated from A. candidus. 
3-Hydroxyterphenyllin (6.9) was identified as a potent inhibitor of plant growth 
[exhibiting significantly more activity than the less oxygenated terphenyllin (6.7)] while 
3,3"-dihydroxyterphenyllin (6.10) was found to exhibit potent cytotoxic activity against 
sea urchin embryos.+ 
R1 R2 R3 - .. ~ ,..OH 
(6.7) H OH H 
(6.8) H 
/'/ .......... /' .......... , /' ' 
H H 
R1 
R3 
(6.9) OH OH H 
(6.10) H OH OH R2A~ OMe 
Two further p-terphenyl derivatives, the oxido-bridged candidusins A ( 6.11) and B 
(6.12), isolated from A. candidus by Kobayashi and co-workers have also been shown 
to inhibit the development of sea urchin embryos.21 Although the mechanism of action of 
p-terphenyl metabolites has not yet been investigated in detail, Kobayashi noted common 
structural features (i.e. benzene rings and methyl phenyl ethers) possessed by the 
p-terphenyl candidusins 6 .11 and 6 .12 and the known mitotic poison and spindle 
inhibitor, podophyllotoxin (6.13). 
R 
HO OMe 
(6.11)R=H 
(6.12) R = OH 
OH 
.,,OH 
MeO)Q,,,·· 
I~ r-o 
Meo O 
OMe 
(6.13) 
The continuing search for new bioactive compounds led, in the late 1990s, to the 
discovery of new p-terphenyl derivatives from strains of Penicillium raistrickii,22 
Aspergillus arenarius23 and A. candidus.24,25 Of particular interest has been the 
prenylated derivative, arenarin A (6.14) isolated from A. arenarius and the terprenin 
+ This assay is a useful primary screening system for determining potential antineoplastic activity.20 
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series, e.g. terprenin (6.15), isolated from A. candidus. Arenarin A (6.14) was shown 
to display mild antifeedant activity against the fungivorous beetle Carpophilus hemipterus 
and cytotoxicity against a number of human tumour cell lines while the terprenin 
derivatives exhibited potent in vitro and in vivo suppressive effects on immunoglobin E 
antibody production. 
HO OMe 
(6.14) 
~: 
o_j e 
OH 
HO OMe 
( 6.15) 
O~Me 
OH Me 
In addition to the fungal p-terpheny ls outlined above, there is a report in the literature of a 
bacterium-derived p-terphenyl. 26,27 Terferol [ 4-methoxy-3,6-diphenylbenzene-1,2-diol] 
isolated from Steptomyces showdoensis was shown to be a potent inhibitor of cyclic 
adenosine 3',5'-monophosphate phosphodiesterase. 
6.1.3 p-Terphenyls from the Lichen Relicina connivens 
A recent investigation within our group of the lichen Relicina connivens (Kurok.) Hale 
led to the identification of the first p-terphenyls derived from a lichen source. Three new 
pentasubstituted p-terphenyls, butlerin A (3,4,4",6'-tetramethoxy[l,1':4',1 "-terphenyl]-
2'-yl acetate) (6.16), butlerin B (3,4,4",5'-tetramethoxy[l,1':4',1"-terphenyl]-2'-yl 
acetate) ( 6.17) and butlerin C (3,4,4 "-trimethoxy[l, 1 ':4', 1 "-terphenyl]-2',6'-diyl 
diacetate) ( 6 .18) were found co-occuring with the common cortical pigment usnic acid 
(6.19). 28 
Me 
R1 R2 R3 
2 (6.16) Me Ac Me Me,.,. Y 7' 1r-OH OR2 (6.17) Me Me Ac 
OR3 0 )=O (6.18) Ac Ac Me 
(6.19) 
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Butlerin A (6.16) and butlerin B (6.17), identified as two isomeric monoacetates, were 
isolated as an equimolar mixture. Their structures were established by X-ray crystal 
analysis but the two isomers could not be separated using fractional crystallization. The 
third p-terphenyl, butlerin C (6.18), was identified as a diacetate and, following analysis 
of the spectroscopic data (in particular 1 H NMR and mass spectra), tentatively assigned a 
structure with the two acetate substituents in a meta orientation. 
Traces of several related hexasubstituted p-terphenyls were also observed during this 
investigation but the identities of these derivatives remained to be resolved. Subsequent 
work by Elix and Ernst-Russell enabled the structures of these hexasubstituted 
p-terphenyls to be established as butlerin D (6.20), butlerin E (6.21) and butlerin F 
(6.22) by synthesis and both spectroscopic and chromatographic comparisons.29 
OMe 
R1 R2 R3 
(6.20) Ac Me Me 
(6.21) Ac Me Ac 
MeO' ,'i' OR3 
(6.22) Me Ac Ac 
An unusual feature of the six butlerin derivatives is the previously unreported co-
occurrence of both O-alkyl and O-acyl substitutions on the p-terphenyl carbon skeleton. 
The potent biological activities (i.e. cytotoxicity, plant growth and enzyme inhibition) 
exhibited by p-terphenyl derivatives (described in § 6.1.1 and 6.1.2) made butlerin A 
(6.16), B (6.17) and C (6.18) attractive synthetic targets. This chapter describes the 
total syntheses of the pentasubstituted p-terphenyls, butlerin A (6.16), butlerin B ( 6.17) 
and butlerin C (6.18) and confirms the tentative structure formerly assigned to butlerin C 
(6.18). 
6.2 Synthesis of Naturally Occurring p-Terphenyls 
A number of procedures have traditionally been used for the formation of the aryl-aryl or 
aryl-quinone linkages found in p-terphenyls and their quinone derivatives.30,3l The 
formation of the p-terphenyl skeleton has typically been accomplished by the electrophilic 
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arylation of a 1,4-benzoquinone derivative. Two such methods have been utilised in the 
past - a Friedel-Crafts type arylation as developed by Pummerer and Prell32 and a 
Meerwein reaction in which aryldiazonium precursors are exploited. 33 The oxidative 
coupling of quinone and aryl precursors using palladium(II) acetate has also been 
investigated.34 Unfortunately, all three methods suffer from poor to moderate yields of 
the desired p-terphenyl derivatives. 
In recent years catalytic cross-coupling reactions such as the Negishi,35 Stille,36 
Hiyama37 and Suzuki38 reactions have been employed to good effect in the formation of 
biaryl C-C bonds. 0 Though these coupling reactions generally proceed in moderate to 
very high yields, numerous steps are often required to prepare the necessary coupling 
precursors. 
The first (and prior to our work only) synthesis of a naturally occurring pentasubstituted 
p-terphenyl derivative was reported by Takahashi in 1975. 16 Takahashi constructed the 
carbon framework of his target p-terphenyl 6.23 from the readily available 1,4-
benzoquinone ( 6. 24 ), using a Friedel-Craft type electrophilic arylation (Figure 6 .1). 
Thiele-Winter acetoxy lation of the resultant diary lquinone 6. 2 5 then afforded the 
triacetate 6.26 which was subsequently converted to terphenyllin trimethyl ether (6.23). 
0 
a 
0 
(6.24) Meo 
OMe 
b 
Meo OAc (6.26) 
Meo 
OMe 
~ ~ 
OMe 
(6.23) 
OMe 
Reagents and conditions: (a) (i) PhOMe, AIC/3; (ii) FeC/3 (12 %); (b) Ac20, HC/04 (14 %); 
(c) 4 steps (4 %) 
Figure 6.1: Takahashi' s synthesis of terphenyllin trimethyl ether ( 6.23 )1 6 
0 The total synthesis of terprenin (6.15) , using the Suzuki reaction to construct the p-terphenyl skeleton, 
has since been reportect.39,40 
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A significant deficiency of Takahashi' s synthesis was the poor yield of the triacetate 6 . 2 6 
(approx. 14%) obtained in the Thiele-Winter reaction. The inefficiency of this step 
considerably limits the synthetic utility of Takahashi's route. The identity of possible side 
products was not revealed although the low yield probably results from competing 
Friedel-Crafts acylation type reactions on the methoxy-substituted aromatic rings.41 
6.3 Retrosynthesis of Pentasubstituted Butlerins A, B and C 
A synthetically important structural feature of the lichen p-terphenyls 6 .16 - 6 .18 is the 
oxygen substitution pattern of their respective central benzene rings. Butlerin A ( 6.16) 
can be distinguished from its pentasubstituted co-metabolites by the para orientation of the 
0-methyl moieties on the central ring of the molecule. In contrast, the methoxy 
substituents of the isomeric butlerin B (6.17) and the two acetoxy substituents of the 
remaining target 6 .18 are in the more synthetically challenging meta orientation. Our 
proposed retrosynthesis of butlerins A, B and C (6.16) - (6.18) relied on a derivatised 
hydroxyquinone precursor 6. 2 7 as the key intermediate for all three targets (Figure 
6.2). It was anticipated that this hydroxyquinone intermediate 6.27 could be prepared 
from the diarylquinone 6.25 which could in tum be synthesized from the inexpensive 
and readily available 1,4-benzoquinone (6.24). 
OMe R1 R2 R3 
(6.16) Me Ac Me 
(6.17) Me Me Ac 
OR2 
MeO,... "''/" OR3 
(6.18) Ac Ac Me 
(6.16) (6.17) (6.18) 
\ll 
OMe 
-
~ .,..OMe 
> II II 
MeO,... ~ - MeO 
X = halide, 
hydrogen, alkoxy substituent 
Figure 6.2: Retrosynthesis of butlerins A - C (6.16) - (6.18) 
> 
0 
/ 
0 
(6.24) 
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It was envisaged that the synthesis of butlerins B (6.17) and C (6.18) could be achieved 
via a 1,2 acyl migration. This type of intramolecular rearrangement has previously been 
utilised by the author in the synthesis of several hexasubstituted p-terphenyl derivatives.29 
The intramolecular migration of an acyl group from one phenolic hydroxy group to 
another was first observed by Fischer and his co-workers in their attempted synthesis of 
p-digallic acid (6.28). 42 Fischer found that careful hydrolysis of pentaacetyl-p-digallic 
acid ( 6.29) was unexpectedly followed by an intramolecular transesterification to give the 
thermodynamically more stable m-digallic acid (6.30) instead of the desired isomer 6. 2 8 
(Figure 6.3). 
HO 
HO 
OH 
AcO 
AcO 
NH40H(~ 
HOYC02H 
~I 
0 
OH (6.28) 
AcO 0 YYC02H 
I "Y"o~ 
~ 0 (6.29) Ac 
OAc 
1,2 acyl 
migration 
HO 
HO 
OH 
CO2H 
o--- I -oH 
OH 
(6.30) 
Figure 6.3: Fischer's attempted synthesis of p-digallic acid ( 6.28 )42 
6.4 Synthesis of Butlerin A 
Our synthetic approach to butlerin A (6.16), outlined in Figure 6.4, centred on the 
selective hydrolysis of a dihalide precursor [2,5-dichloro-3,6-di(p-methoxyphenyl)-1,4-
benzoquinone] ( 6. 31 ). It was envisaged that the resultant halo-hydroxyquinone 6. 3 2 
could then be derivatised and the remaining halide substituent removed at a later stage of 
the synthesis. 
Meerwein arylation43,44 of 2,5-dichloro-1,4-benzoquinone (6.33) using diazotised 
p-methoxyaniline afforded the desired diary lquinone 6. 31 in 21 % yield. Three signals 
were observed in the lH NMR spectrum of 6.31: a singlet at 8 3.87, typical for an aryl 
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methyl ether, and two doublets (J = 8.8 Hz) centred on 8 6.99 and 7 .22. The upfield 
doublet (8 6.99) was assigned to the four aromatic protons ortho to the electron donating 
O-methyl substituents. 
A significant amount of the monoarylated product, 2,5-dichloro-3-p-methoxyphenyl-1,4-
benzoquinone (31 % ), was also isolated from the reaction mixture. However, the 
diarylated chloroquinone 6.31 were readily separated from the unwanted 
monosubstituted product by fractional crystallisation. 
Although the Meerwein diarylation proceeded in moderate to low yield (21 % ), the 
construction of the p-terphenyl framework was economically achieved in one step from 
readily available starting material. 
0 0 0 0 
Ck Jl a Cl~An b Cl An Ck A. ~An C 
Cl An_, 'f( 'Cl OH An' If ~OBn 
0 0 0 0 
(6.33) (6.31) (6.32) /4 (6.34) 
OMe OMe 
d, e 
I 
c;cAn Cl ~ ~An g f I 
An_, OAc An An ~ 'OBn 
OMe OMe OMe 
(6.16) (6.37) (6.35) 
An= !-0-oMe 
Reagents and conditions: (a) p-anisidine, HCl(aq), NaN02 21 %; (b) K2C03(aq), 86%; 
(c) PhCHN2, 96%; (d) Na2S20 4; (e) CH2N2/ Mel, K2C03, 91 % (over 2 steps); (f) HCOONH4, 
Pd/C, 90%; (g) Ac20, py, 97% 
Figure 6.4: Synthesis of butlerin A (6.16) 
Selective hydrolysis43 of 6.31 was effected by refluxing the dichloride with an excess of 
potassium carbonate in aqueous dioxane to give 2-chloro-5-hydroxy-3,6-di-
(p-methoxyphenyl)-1,4-benzoquinone (6.32), a chocolate brown solid, in 86% yield. 
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As expected, six signals were observed in the 1 H NMR spectrum of the product 6. 3 2, 
including four doublets arising from the eight aromatic protons. 
The enol 6.32 thus obtained was benzylated under mild conditions by treatment with an 
excess of ethereal pheny ldiazomethane. Chromatographic purification of the reaction 
mixture gave the benzyl ether 6.34 as a bright orange solid in near quantitative yield. 
Sodium dithionite reduction of the benzylquinone 6.34 afforded the corresponding 
colourless benzene-1,4-diol which was immediately methylated by treatment with 
diazomethane followed by methyl iodide in the presence of anhydrous potassium 
carbonate to give the desired 5'-benzyloxy-2'-chloro-3',4,4",6'-methoxy-p-terphenyl 
(6.35) in excellent yields. 
Unfortunately, the reductive dechlorination of p-terphenyl 6.35 proved significantly 
more difficult than anticipated. Initial efforts included a two step procedure involving 
catalytic hydrogenolysis, using hydrogen and palladised carbon, to effect debenzylation 
followed by treatment with alkaline Raney nickel to dechlorinate the resultant phenol. 
This method was successfully used by Santesson45 in the dechlorination of the lichen 
xanthone thiophaninic acid ( 6. 3 6). However our repeated efforts resulted only in the 
recovery of 5-chloro-2,4-dimethoxy-3,6-di-(p-methoxyphenyl)phenol (Table 6.1). 
CH3 0 OH 
Cl 
H3CO OH 
Catalytic transfer hydrogenolysis46 using formic acid in N,N-dimethylformamide as the 
hydrogen donor and a palladised carbon catalyst was more successful with 33% 
conversion to the desired p-terphenyl 6.37 (as determined from the 1 H NMR spectrum). 
The remaining material was identified as unreacted 5-chloro-2,4-dimethoxy-3,6-di-
(p-methoxypheny 1 )phenol. 
The yield of phenol 6. 3 7 was significantly improved using the hydrogenolytic 
methodology developed by Spatola and co-workers.47 .48 Spatola systematically 
I 
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investigated the efficacy of a number of formate salts in addition to the effects of catalyst, 
donor quantity, temperature and solvent on the transfer hydrogenolysis of a number of 
aryl chlorides. 
. 
Catalyst Hydrogen donor Conditions Product 6.37 
Pd/C, Raney Ni H2 3 h, RT 0%¥ 
Pd/C, Raney Ni H2 3 h, ~ 0%¥ 
Pd/C formic acid, DMF 24 h, ~ 33%¥ 
Pd/C ammonium formate 48 h, ~ 90% 
Table 6.1: Conditions used in the debenzylation, dechlorination of p-terphenyl 6.35 
Hence, catalytic transfer hydrogenolysis of the chloroterphenyl 6.35 in an ethanolic 
solution of ammonium formate over palladised charcoal gave the pentasubstituted product 
6. 3 7 in 90% yield. Subsequent acetylation of the phenol 6. 3 7 using acetic anhydride 
and pyridine completed the synthesis of the desired natural product, butlerin A ( 6 .16) in 
excellent yield (97 % ) . 
6.5 Synthesis of Butlerin B 
Two synthetic sequences to butlerin B ( 6 .1 7) were devised, the first of these routes is 
illustrated in Figure 6.5. 
As discussed in §6. 3, it was envisaged that an intramolecular acetyl migration could be 
exploited in the key step of the proposed synthetic sequence. Although the precise ratio of 
the two acetates 6.38 and 6.39 at equilibrium could not be predicted, previous work by 
the author29 had suggested that the thermodynamic equilibrium would lie in favour of the 
desired 3,5-regioisomer [3',5'-didemethylbutlerin B] (6.39). Further support for this 
scenario was provided by molecular modelling studies which were used to calculate the 
relative thermodynamic stabilities of the two isomers. These calculations predicted a 
relative energy difference of 14 kJ mol-1 between the two acetates 6. 3 8 and 6. 3 9, in 
favour of the desired species 6.39 (Figure 6.6). 
¥ The debenzylated p-terphenyl, 5-chloro-2,4-dimethoxy-3,6-di-(p-methoxyphenyl)phenol, accounted for 
the remainder of the reaction mass 
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Reagents and conditions: (a) PhOMe, AIC/3, FeC/3 24%; (b) SnC/2, HG/, 90%; 
(c) Br2, FeC/3, 58%; (d) K2CO3(aq) 89%; (e) Ac2O, py, 92%; (f) H2, Pd/C; (g) CH2N:! 
Mel, K2CO3, 93% (over 2 steps). 
Figure 6.5: Synthesis of butlerin B (6.17) 
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Like the preceding synthesis of butlerin A (6.16), our synthesis of butlerin B (6.17) 
centred on a halo-hydroxyquinone intermediate. In the present case, however, the 
corresponding dibromo derivative 6. 40 was utilised since it was anticipated that 
debromination, of the appropriately substituted intermediate, would require milder 
conditions than analogous dechlorination. 
An 
OH 
OH 
(6.38) 
An 
OAc 
~Ere/ 0 kJ mo1-1 
OH 
An 
An 
An 
OH 
OAc 
(6.39) 
An 
OH 
~Ere/ -14 kJ moi-1 
Figure 6.6: Calculated relative energy differences of dials 6.38 and 6.39 
The synthesis of butlerin B (6.17) began with construction of the p-terphenyl framework 
using the Friedel-Crafts-type arylation developed by Pummerer and Prell.32 As expected, 
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treatment of 1,4-benzoquinone (6.24) with anisole in the presence of the Lewis acid, 
aluminium trichloride, resulted in a mixture of quinone, hydroquinone and quinhydrone 
derivatives. Oxidation of this mixture using ferric chloride afforded 2,5-di-
(p-methoxyphenyl)benzoquinone (6.25) in modest yield (24% ). The para orientation of 
the major product results from a combination of the o,p-directing effect of the methoxy 
substituent and steric hindrance to ortho attack. 
A consequence of the Friedel-Crafts-type arylation is the aromatisation of the 
monosubstituted product and the resultant deactivation of the biaryl derivative to further 
electrophilic substitution. Further substitution thus requires oxidation of the aromatised 
product by a second molecule of benzoquinone ( 6.24) in order to regenerate the 
quinonoid system. If it is assumed that two-thirds of the benzoquinone is consumed in 
the oxidation of the primary product en route to the bisanisylquinone 6.25, then only 
one-third of the starting quinone is available for arylation. In this case, the maximum 
theoretical yield would be 33% and the reaction proceeds at 73% (24/33) efficiency. 
Further functionalisation of the central quinonoid ring then commenced with the reduction 
of the diary lquinone 6. 2 5 using a mixture of stannous chloride and concentrated 
hydrochloric acid to give the corresponding benzene-1,4-diol 6. 41 in excellent yields. 49 
The diol 6.41 was sensitive to atmospheric oxidation and slowly reverted back to the 
quinone 6.25. 
Bromination of 2,5-di-(p-methoxyphenyl)benzene-1,4-diol (6.41) and subsequent 
oxidation with ferric chloride afforded the dibromoquinone 6. 4 0 in a moderate yields 
(58% ). The observed selectivity of this reaction results from the stronger o,p-activating 
influence of the hydroxy substituents relative to the alkoxy groups on the outer aromatic 
nngs. 
As observed previously with the analogous chloride 6. 31, refluxing the dibromo 
compound 6. 4 0 with an excess of potassium carbonate in aqueous dioxane resulted in 
selective hydrolysis to give the desired bromo-hydroxyquinone 6.42 in excellent yields 
(89% ).43 Acetylation of the enol 6.42 under acidic conditions then gave the 
corresponding ester 6.43. 
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Catalytic hydrogenolysis of the acetate 6.43 resulted in reduction of the quinone moiety, 
hydrogenolysis of the bromo-substituent and 1,2 migration of the acetyl group to give a 
mixture of diols, 6.39 and 6.38 in the ratio of approximately 9: 1 (as indicated by the 1 H 
NMR spectrum). The 1 H NMR chemical shifts of the respective C-methyl protons, 
shown in Figure 6. 7, were instrumental in the assignment of the two isomers. 
OMe OMe OH OH 
I I ~ An An _An 
An.., y ' OAc ~ An OMe An OAc An.., 'Y' 'OH 
OMe \\ OAc OH \ OAc ( 6.16) (6.17) \ (6.38) (6.39) \ 
82.08 8 2.05 
8 2.16 8 2.13 
Figure 6.7: Diagnostic 1H NMR chemical shifts of 6.16, 6.17, 6.38 and 6.39 
The C-methyl protons of the predominant isomer, assigned as 3',5'-dihydroxy-4,4"-
dimethoxy[l,1':4',1 "-terphenyl]-2'-yl acetate (6.39), exhibited a signal at 8 2.13. The 
analogous acetyl protons of the minor isomer, assigned as the 3,6-diol 6.38 were 
observed further upfield at 8 2.05. In comparison, the C-methyl protons of butlerin A 
(6.16) resonate at 8 2.08 while the corresponding C-methyl protons of butlerin B ( 6.17) 
exhibit at 8 2.16. 
Methylation of the isomeric diols 6. 3 8 and 6. 3 9 with diazomethane was then followed 
by treatment with methyl iodide and anhydrous potassium carbonate. Importantly, 
methylation of the 3,5-diol 6. 39 was found to occur preferentially and resulted in the 
exclusive formation of the desired butlerin B ( 6.17) in excellent yields (93% from the 
bromoquinone 6.43). 
6.6 Alternative Synthesis of Butlerin B 
A second independent synthesis of butlerin B ( 6 .17) was also developed utilising an 
acetal, 3-hydroxy-4,4,6-trimethoxy-2,5-di(p-methoxypheny l)cyclohexa-2,5-dien-1-one 
(6.44), as the key synthetic intermediate (Figure 6.8). The acetal 6.44 was prepared 
from the dibromoquinone 6.40 in a three step sequence. 
I 
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Reagents and conditions: (a) NaOH(aq) 78%; (b) Ac2O, W, 91 %; (c) NaOH, 
MeOH, 78%; (d) LiAIH4, 57% (e) Ac2O, py, 99%. 
Figure 6.8: Alternative synthesis of butlerin B (6.17) 
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Hydrolysis (nucleophilic conjugate addition and elimination) of the di bromide 6. 4 0 with 
aqueous methanolic sodium hydroxide afforded 2,5-dihydroxy-3,6-di-(p-
methoxyphenyl)-1,4-benzoquinone 6.45 in 78% yield. The formation of the purple 
disodium salt was very slow, requiring two days for completion. However, once formed 
the disodium salt precipitated from solution and could be isolated by filtration. Separation 
of the hydrolysed product from unreacted (undissolved) dibromide 6.40 was achieved by 
washing the precipitate with water. Acidification of the resultant permanganate coloured 
filtrate yielded the dihydroxyquinone 6.45 as a bronze coloured solid. 
Acid catalysed acetylation of the dihydroxy derivative 6.45 was readily achieved by 
treatment with acetic anhydride and concentrated sulfuric acid to give the dienol ester 
6.46 in excellent yields. Base catalysed methanolysis of the diacetate 6.46 resulted in 
the unexpected isolation of a pentamethoxy acetal 6.44. 
The EIMS of the acetal 6. 4 4 exhibited a molecular ion at mlz 412, consistent with a 
molecular formula of C23H240 7. This formula was subsequently confirmed by 
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microanalysis. The 1 H NMR spectrum revealed a singlet at 8 3.27 corresponding to two 
magnetically equivalent O-methyl substituents. Three additional singlets arising from 
O-methyl protons were also evident at 8 3.69, 3.84 and 3.86. Further observed signals 
included a broad exchangable singlet (8 6.38) and four sets of doublets (8 6.82, 6.97, 
7.38 and 7.71) arising from the outer aromatic ring protons. 
Efforts to identity the structure of the acetal culminated in the growing of crystals suitable 
for X-ray analysis. The acetal, which crystallised from a solution of ethyl acetate and 
cyclohexane as yellow orange prisms, was thus established as 3-hydroxy-4,4,6-
trimethoxy-2,5-di(p-methoxyphenyl)cyclohexa-2,5-dien-1-one (6.44) (Figure 6.9). 
06A 
Figure 6.9: Thermal ellipsoid diagram of 3-hydro:xy-4,4,6-trimetho:xy-2,5-
di(p-metho:xyphenyl)cyclohexa-2,5-dien-1-one ( 6.44) with selected atom labelling. 
Ellipsoids show 25% probability levels. Hydrogen atoms are drawn as circles with small 
radii. (X-ray analysis performed by Dr D. C. R. Hockless) 
Treatment of the acetal 6.44 with lithium aluminium hydride followed by acid hydrolysis 
of the resultant aluminate complex afforded the penta-substituted p-terphenyl, 2,5-
dimethoxy-3,6-di-(p-methoxyphenyl)phenol 6.47 in 57% yield. A proposed mechanism 
for this reaction is illustrated in Figure 6.10. 
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1,2-Addition to the carbonyl group would be expected to give the intermediate aluminate 
6. 4 8. · The corresponding keto tautomer 6. 4 9 could then undergo further hydride 
reduction to yield the dialuminate 6.50. Acid hydrolysis of the cyclohexene 6.50 would 
be expected to give the corresponding dial 6.51 which could then eliminate a mole of 
water and a mole of methanol to yield the observed tetramethoxyphenol 6.47. 
H3AI~ 
~\O 
MeO~ _An 
I I 
An,., ~OH 
Meo OMe 
(6.44) 
MeO~An 
An~OH 
OMe 
(6.47) 
GAIH4 
-H2O 
-MeOH 
GAIH3 
I 
H 0 
Meo An 
An" X "'OH 
Meo OMe 
Meo 
( 6.48) 
H [6H 
/'H 
,, An 
OH 
An' X~'H 
Meo l,OMe 
(6.51) 
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I 
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An,., X ,·o "AIH3 Meo OMe 0 
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( 6.49) 
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H OH 
An 
H 
An" X 'O-AIH3 
Meo OMe 0 
(6.50) 
Figure 6.10: Proposed mechanism for the LiAlH4 reduction of acetal 6.44 
Acetylation of the terphenyl 6. 4 7 using acetic anhydride and pyridine afforded the 
desired butlerin B (6.17) in excellent yield. 
6. 7 Synthesis of Butlerin C 
Our synthetic route to butlerin C (6.18) again employed an intramolecular 
transesterification in the key synthetic step (Figure 6.11). 
The synthesis began with the selective bromination of 2,5-di-(p-methoxyphenyl)benzene-
1,4-diol (6.41) using one equivalent of bromine in glacial acetic acid. Surprisingly, 
subsequent ferric chloride oxidation afforded a mixture of two compounds in a ratio of 
approximately 2: 1 (determined by 1H NMR spectroscopic and HPLC analysis). 
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The EI mass spectrum of the mixture exhibited a molecular ion at mlz 398 
(= C20H 150 4 79Br), corresponding to the expected 2-bromo-3,6-di-(p-methoxyphenyl)-
1,4-benzoquinone (6.52), and a second molecular ion at m/z 354 (= C20H 150 435Cl), 
identified as the analogous monochloride 6. 5 3. The bromoquinone 6. 5 2 was assigned 
as the major product by HPLC. Formation of the chloroquinone 6. 5 3 is presumed to 
result from a nucleophilic addition-elimination sequence between the bromoquinone 6. 5 2 
and solvated oxidant-derived chloride ions. 
OH 0 0 OAc 
An (YAn b (YAn A ,,An a I _c 
d An/ 1 An" If 'X An" If 'OBn An,,... [ "OBn 
OH 0 0 OAc 
(6.41) (6.52) X = Br (6.55) (6.56) 
(6.53) X = Cl 
le gl-
0 OAc OAc 
An An An 
An" !( 'OH An OAc An OH 
0 OH OAc 
(6.54) ( 6.58) (6.57) 
l' 
OAc OAc OAc 
I A ,,An ~ ,,An /4. ,,An 
~ + y + An,,... OAc An OMe An,,... [ "OMe 
OMe OAc OMe 
An= !-Q-oMe I (6.18) (6.59) (6.60) 
l i 
Reagents and conditions: (a) Br 2, FeC/3; (b) Na, BnOH, 27% (over 2 steps); (c) Na2S2O4; 
(d) Ac2O, py, 87% (over 2 steps); (e) H2, Pd/C; (f) CH2N2, Mel/K2CO3, [(6.18) 30%], 
[(6.59) 60%], [(6.60) 8%] (g) NaOH, MeOH. 
Figure 6.11: Synthesis of butlerin C (6.18) 
Attempts to hydrolyse the mixture of halides (6.52 and 6.53) using a slight excess of 
sodium hydroxide in methanol failed to produce the desired hydroxy quinone 6. 5 4 . The 
major product formed was identified as 2,5-dihydroxy-3,6-di-(p-methoxyphenyl)-1,4-
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benzoquinone ( 6.45) from the observed 1 H NMR data and by comparison with a sample 
of authentic material. The 1 H NMR spectrum was consistent with a symmetrically 
substituted p-terphenylquinone exhibiting a singlet at 8 3.86, corresponding to six 0-
methyl protons; two doublets centred on 8 7.00 and 8 7.53, corresponding to eight 
aromatic protons and a broad singlet at 8 8.13 due to two weakly intramolecularly bonded 
hydroxy protons. It is presumed that the formation of the dihydroxyquinone 6.45 results 
from the conjugate addition of a second mole of base to the quinone 6. 5 4 followed by in 
situ aerial oxidation of the resultant quinol. 
In light of the unsuccessful attempt to prepare the desired hydroxyquinone 6. 5 4, 
attention was focussed on the preparation of the corresponding benzyl ether 6. 5 5. 
Treatment of the haloquinones ( 6. 5 2 and 6. 5 3) with sodium benzy loxide in anhydrous 
benzyl alcohol under an inert atmosphere gave the benzyl ether 6.55 in modest yield 
[27% from the benzene-1,4-diol 6.41]. 
The benzyloxyquinone 6.55 was subsequently reduced in the presence of sodium 
dithionite and the intermediate benzene-1,4-diol acetylated under standard conditions to 
give the diacetate 6.56. 
As expected, catalytic hydrogenolysis of the diacetate 6. 5 6 over palladised charcoal 
resulted in concomitant debenzylation and intramolecular transesterification to yield a 
mixture of phenols 6.57 and 6.58 in an equilibrium ratio of approximately 15:7 (as 
determined by 1H NMR analysis). 
The major isomer exhibited two C-methyl signals in the 1H NMR spectrum at 8 1.98 and 
8 2.16 while the minor isomer displayed analogous signals at 8 1. 98 and 8 2.05. In 
comparison, examination of the corresponding 1 H NMR spectrum of butlerin A ( 6 .16) 
revealed the acetyl protons of this metabolite resonated at 8 2.08. Similarly, the C-methyl 
protons of the isomeric butlerin B ( 6.17) were observed at 8 2.16 (Figure 6.12). 
Thus, the chemical shifts of the acetyl protons of the four highly oxygenated p-terphenyls 
could be correlated to the position of the acetyl moiety within the central ring. The major 
isomer was therefore assigned as the 2' ,5'-diyl diacetate 6.57: the 8 2.16 signal was 
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attributed to the acetate moiety meta to the central ring hydrogen atom [ cf. butlerin B 
(6.17)] while the signal at 8 1.98 was assigned to the acetate group ortho to the central 
ring hydrogen atom. The corresponding signals of the minor isomer 6.58 were similarly 
assigned: the 8 2.05 was attributed to the acetate group para to the central ring hydrogen 
atom [cf butlerin A (6.16)] while the signal at 8 1.98 signal was, as previously, 
assigned to the acetate substituent ortho to the central ring hydrogen atom. 
OMe OAc ~ OAc 
~ 8 1.98 
~ _An ~ An ~ _An 
I 
An"' j ' OAc An"' y 'OMe An' J "OH An"' j ' OAc 
OMe \\ ·oAc OAc OH \\ (6.16) (6.17) \ (6.57) \ (6.58) 
82.08 8 2.05 
8 2.16 8 2.16 
Figure 6.12: Diagnostic 1 H NMR chemical shifts of 6.16, 6.17, 6.57 and 6.58 
The isomeric mixture (6.57 and 6.58) was subsequently methylated by treatment with 
ethereal diazomethane followed by methyl iodide/ anhydrous potassium carbonate to yield 
a mixture of two trimethyl ethers (6.57 and 6.58) in a ratio of approximately 3:7. As 
before, the relative proportions of the two components was determined by analysis of the 
1H NMR data. 
The major isomer exhibited signals at 8 2.01 and 2.17 in the 1 H NMR spectrum. As a 
consequence it was assigned as 3',4,4"-trimethoxy-p-terphenyl-2',5'-diyl diacetate 
(6.59) by comparison of the chemical shifts previously assigned to the C-methyl protons 
of the two diacetates 6.57 and 6.58 (Figure 6.13). 
An 
OAc p 61.98 
I ~ -An 
r 'OH 
0 
An 
Ac 
(6.57) \ 
8 2.16 
OAc ~ 8 1 .98 
OH 
(6.58) 
An 
OAc An 
\\ 
82.05 
OAc p 62.01 
I 
~ _An 
I 
r" OMe An 
OAc 
(6.59) \ 
8 2.17 
OAc ~ 81.99 
I 
I ----::, ,An 
r ' OAc 
OMe i 
(6.18) \\ 
8 2.07 
Figure 6.13: Diagnostic 1 H NMR chemical shifts of 6.57, 6.58, 6.59 and 6.18 
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The minor component of the isomeric mixture exhibited signals at 8 1.99 and 2.07 and 
was assigned as the 2',5'-diyl diacetate 6.18 in a similar manner. 
The different ratio observed for the methylated products 6 .18 and 6. 5 9 (3 :7) relative to 
that of the phenolic precursors 6.57 and 6.58 (15:7) is consistent with preferential 
methylation of the major isomeric precursor, phenol 6.57. 
Repeated preparative layer chromatography using high performance thin layer plates led to 
the separation of the two trimethyl ethers, 6.18 and 6.59. In addition to the expected 
bands containing the diacetates (6.18 and 6.59), a faint, less polar, UV active band was 
also observed. Subsequent isolation and analysis of this fraction identified it as 
4,4",5',6'-tetramethoxy-p-terphenyl-2'-yl acetate (6.60) (8% yield), a compound 
isomeric with butlerins A (6.16) and B (6.17). This derivative would appear to arise via 
the selective hydrolysis of the more labile acetate substituent. 
Comparison of the 1 H NMR spectroscopic data of the naturally occurring diacetate, 
butlerin C, revealed its identity with the minor diacetate of the methylation reaction, 
assigned as 3',4,4"-trimethoxy-p-terphenyl-2',6'-diyl diacetate (6.18). In order to 
confirm the assignment of the two isomers 6 .18 and 6. 5 9, the unambiguous synthesis 
of the 2,5-diyl diacetate 6.59 was undertaken. 
6.8 Synthesis of 3 ',4,4 "-Trimethoxy-p-terphenyl-2 ',5 '-diyl diacetate 
Nucleophilic substitution of the mixture of halides 6.52 and 6.53 prepared during the 
synthesis of butlerin C ( 6 .18) using sodium methoxide in anhydrous methanol gave the 
corresponding enol ether 6.61 in 44% yield [from the benzene-1 ,4-diol 6.41], illustrated 
in Figure 6.14. 
Catalytic hydrogenolysis of the methoxyquinone 6. 61 over palladised charcoal gave the 
corresponding quinol which was immediately acetylated by treatment with acetic 
anhydride and pyridine to afford the acetate 6. 5 9 in excellent yield and identical in all 
respects (TLC, EIMS, 1H NMR and m.p.) with the major isomer obtained above. 
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Figure 6.14: Synthesis of 3 ',4,4 "-trimethoxy-p-terphenyl-2 ',5'-diyl diacetate ( 6.59) 
6.9 Relative Thermodynamic Stabilities of the Acyl Migration Products 
The approximate equilibrium ratios of the diol (6.38 and 6.39) and diacetate (6.57 and 
6.58) systems, prepared in the syntheses of butlerins B (6.17) and C (6.18) 
respectively, are shown in Figure 6.15. Also depicted are the thermodynamic ratios of 
two hexasubstituted p-terphenyl systems (6.62, 6.63 and 6.64, 6.65) prepared by the 
author in a previous study. 29 
OH OH OAc 
An An An 
An.., I ' OAc An OH An An OAc 
OH OAc OAc OH 
(6.38) 1 : 9 (6.39) (6.57) 7:3 (6.58) 
OH OH OH OH 
An AcO An An MeO An 
An' I ' OAc An OH An OAc An OH 
OH OAc OH OAc 
(6.61) 1 : 3 (6.62) (6.63) 9: 11 (6.64) 
Figure 6.15: Approximate equilibrium ratio of isomeric acetate systems 
Comparison of the four isomeric acetate systems reveals that, in each pair, the substituent 
para to the migratory acyl moiety in the more thermodynamically stable isomer is a 
stronger electron donator than that in the less stable isomer. In the case of diols 6.38 and 
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6.39, for example, the acetate group in the more thermodynamically stable isomer 6. 3 9 
is para to the strongly electron donating hydroxy substituent (relative to the hydrogen 
atom). 
Furthermore, the magnitude of the observed equilibrium ratios of the four acetate systems 
can be correlated to the relative electron donating strengths of the 5' and 6' substituents in 
each isomer. Thus, in the case of diols 6. 3 8 and 6. 3 9, a large difference in electron 
donating capacity between the 5' and 6' substituents (hydroxy group and hydrogen atom) 
is reflected in a large equilibrium ratio ( 1 :9). 
By comparison, the 5' and 6' substituents (methoxy and hydroxy moieties) in the hexa-
substituted p-terphenyl diol system 6.64 and 6.65 are both strong mesomeric electron 
donors. The small differences in the electron donating abilities of these two substituents 
is consistent with the small equilibrium ratio observed. 
The difference in electron donating capacities of the 5' and 6' substituents (the moderately 
electron donating acetoxy and strongly electron donating hydroxy groups) in the 
remaining hexa-substituted system 6.62 and 6.63 lies somewhere between the preceding 
examples. As expected, the observed equilibrium ratio (1 :3) also lies between the ratios 
described above. 
A ratio of similar magnitude (15:7) is observed in the diacetate system 6.57 and 6.58 
which also contains 5' and 6' substituents (the moderately electron donating acetoxy and 
electronically neutral hydrogen atom) with a moderate difference in electron donating 
abilities. 
6.10 Comparison of Synthetic and Natural Material 
The synthetic samples of butlerins A (6.16), B (6.17) and C (6.18) proved identical in 
all respects to the material isolated from the lichen Relicina connivens28 (by TLC, HPLC, 
lH NMR and EIMS). 
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7.1 The Lichen Xanthoparmelia scabrosa 
In 1978 Begg, Elix and Jones reported the isolation of four unique piperazinedione 
derivatives from the foliose lichen Xanthoparmelia scabrosa (Taylor) Hale.I These 
compounds, the scabrosin esters, were subsequently found to possess significant 
cytotoxic activity.2 The scabrosin esters were formulated as derivatives of a multicyclic 
diol moiety 7.1 - 7 .4 on the basis of high resolution mass spectrometric and 1 H and l 3C 
NMR spectroscopic data, but their structures could not be rigorously established. 
0 
R)--o 
1 
0 
0 
O)--R2 
R1 R2 R1 R2 
(7.1) CH3 CH3 (7.3)C3H7 C3H7 
(7.2) CH3 C3H7 (7.4) CH3 CsH11 
A later investigation of the scabrosins by Elix and Hill revealed a number of 
inconsistencies in the structures previously proposed. In particular, several lID-I coupling 
constants, such as those arising from the hydrogen atoms assigned as the methine protons 
of the piperazinedione ring, could not be reconciled with the carbon skeleton reported in 
the original study.3 
This chapter describes the reisolation of the four scabrosin esters from the lichen 
Xanthoparmelia scabrosa and the reanalysis of these derivatives using modem 
multidimensional NMR spectroscopic methods (including 15N NMR spectroscopy) , CD 
spectroscopy and X-ray crystallography. This reinvestigation has resulted in the 
unambiguous structural revision (including absolute configuration) and complete spectral 
assignment of these metabolites, establishing them as a family of epidithiopiperazinedione 
derivatives 7.5 - 7.8. In addition. a new scabrosin ester, scabrosin butanoate hexanoate 
(7 .9), has been isolated and characterised. 
Furthermore, several scabrosin esters were found to exhibit potent cytotoxic activity 
against the murine P815 mastocytma cell line (IC50 ca. 0.5 µM) and the human breast 
MCF7 carcinoma cell line (IC50 ca. 1 nM). The epidithiopiperazinedione moiety identified 
in these compounds had not previously been observed in lichenized fungi. 
R1yO 
0 
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R1 R2 
( 7. 7) C3H7 C3H7 
(7.8) CH3 CsH11 
(7.9) C3H7 CsH11 
Xanthoparmelia scabrosa (Taylor) Hale is one of the most common species of the genus 
in Australia, occurring in all states and territories. The lichen has also been found on both 
islands of New Zealand, in Papua New Guinea, Fiji, Argentina, South Africa and Japan.4 
Specimens of the f oliose lichen were collected from a rocky outcrop just below the 
summit of a coastal cliff face, south east of Batemans Bay in New South Wales, 
Australia, by J. A. Elix and the author in 1996.1 X. scabrosa obtained from this site has 
previously been found to contain a relatively high proportion of the compounds of 
interest.5 
Figure 7 .1 details the procedure used to extract and purify the scabrosin esters. The air 
dried lichen thallus ( 105 g) was separated from adhering soil and rock and extracted with 
anhydrous ether for 68 h. Subsequent evaporation of the ethereal solution to one quarter 
of the initial volume afforded a pale green solid. Flash chromatography of the crude pale 
green mixture using toluene, acetic acid (85: 15) as co-eluents yielded the known cortical 
pigment usnic acid6 (7 .10), the known depsidone norlobaridone7 (7 .11) and a mixture 
of the scabrosin esters. 
Me 
HO 
Me 
HO 
Me 
(7.10) 
OH 
0 
HO 
00 
0 
0 
H11Cs 
(7.11) 
OH 
t A voucher specimen identified by J. A. Elix is deposited in the herbarium of the Australian Botanic 
Garden Herbarium, Canberra. 
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Further flash chromatography of the semi-purified mixture, eluting with ethyl acetate/ 
light petroleum (1: 1), afforded scabrosin dibutanoate (7. 7) (37 mg), scabrosin acetate 
hexanoate (7 .8) (81 mg), scabrosin acetate butanoate (7 .6) (120 mg) and scabrosin 
diacetate (7.5) (12 mg). 
Xanthoparmelia scabrosa (105 g) 
I i 
crude extract (0.98 g, 508 mg purified) 
II 
(7.10) (222 mg) scabrosin mixture (7.11) (9 mg) 
I iv 
I iii 
(7.7) (7.9) (7.8) (7.6) (7.5) 
(37 mg) (1 mg) (81 mg) (120 mg) (12 mg) 
Solvents and Conditions: (i) ether extraction, 68 h; (ii) flash chromatography, Ph Mel AcOH 
(85:15); (iii) flash chromatography, EtOAc/light petroleum (50:50); (iv) preparative TLC, 
EtOAc/light petroleum (50:50). 
Figure 7.1: Extraction procedure used to isolate the scabrosin esters 7.5 - 7.9 
TLC analysis of the crude scabrosin mixture revealed the presence of a fifth, previously 
unknown scabrosin ester. Preparative TLC enabled the isolation and subsequent 
characterisation of this metabolite which was identified as the butanoate hexanoate diester 
7.9 (1 mg). 
7.3 Structure Elucidation of the Scabrosins 
With the purified scabrosins esters in hand, we commenced our reinvestigation using a 
combination of multidimensional NMR spectroscopy, CD spectroscopy and single crystal 
X-ray analysis. Multidimensional NMR and CD spectroscopic studies were performed 
on the most abundant scabrosin ester, scabrosin acetate butanoate (7 .6) while X-ray 
diffraction analysis was carried out using the co-occurring scabrosin dibutanoate (7. 7). 
The X-ray analysis of the dibutanoate 7.7 was critical in establishing the presence of the 
disulfide moiety which was not detected by conventional electron impact mass 
spectrometric methods. 
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7.3.1 NMR Spectroscopic Studies 
Our NMR studies of the acetate butanoate diester 7. 6 comprised both 1 H, 13C and a 
series of two dimensional NMR experiments. Most spectra were recorded in deuterated 
dichloromethane which was deacidified by filtering through a short column of basic 
alumina prior to use. 
The 1 H NMR spectrum of scab rosin acetate butanoate ( 7. 6) is shown in Figure 7 . 2 
while the corresponding 1H NMR chemical shift assignments are detailed in Table 7.1. 
Signals arising from the protons of the acetate and butanoate side chains were clearly 
evident at 8 2.10 (s, 3H, C-Me) and 8 0.96 (t, 3H), 8 1.66 (sext, 2H) and 8 2.35 ( dt, 
2H) respectively. The remaining portion of the spectrum was found to exhibit a number 
of complex JHH coupling spin systems and was further complicated by the asymmetry 
arising from the differing ester side chains. 
The 1H-1H COSY data revealed seven strong correlations, assigned as shown in Figure 
7 .3. The 1H-1H COSY spectrum is illustrated in Figure 7 .4. As expected, a 2JHH 
coupling was observed between methylene protons H3a and H3~ (coupling vii in Figure 
7 .3) while three 3JHH correlations, evident between epoxide protons H7 and Hs (vi); 
epoxide proton H7 and methine proton H6 (iv) and between methine proton H6 and olefin 
proton Hs (i), were also consistent with the cyclohexene moiety proposed by Begg et al. 1 
The remaining three connectivities were assigned as long range 4JHH correlations. Two of 
these connectivities were consistent with allylic coupling between Hs and the methine 
protons observed at 8 4.26 (ii); and between H5 and the methylene protons at 8 3.72 (iii). 
The absence of a corresponding correlation between H5 and the methylene protons at 8 
2.85 is attributed to the difference in the angle ~ between the corresponding C-H bond 
and the axis of the n-orbital in the double bond. Allylic coupling is at a maxima as <I> 
approaches 0° and a minima as cp approaches 90°. 8 The third long range correlation was 
assigned as a 'w' 4JHH coupling between the methylene protons at 8 3.72 and methine 
protons at 8 4.26 (v) establishing these atoms to be in a sterically fixed 'w' configuration. 
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Figure 7.2: 1H NMR spectrum of scabrosin acetate butanoate (7.6) (CD2Cl2) 
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Carbon Carbon 
No. 8 (mult) 
1 1' 
' 
162.49 (s) 
2 2' 
' 
75.61 (s) 
3 3' 
' 
36.43 (t) 
4 4' 
' 
137.27, 
137.32 (s) 
5 5' 
' 
119.65, 
119.79 (d) 
6 6' 
' 
64.39, 
64.63 (d) 
7 7' 
' 
50.61, 
50.66 (d) 
8 8' 
' 
54.57 (d) 
9, 9' 55.80, 
55.84 (d) 
10 170.08 (s) 
11 20.16 (q) 
12 172.71 (s) 
13 35.36 (t) 
14 18.06 (t) 
15 13.00 (q) 
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11~0 
rn r 
0 
Proton 
8 (mult, J Hz) 
2.85 ( d, 16.65), 
3 
3.72 (dd, 0.8, 2.6, 16.5) 
5.91 (m, 2.6, 2.8, 5.7) 
5.65 (m, 4.6, 5.7) 
3.59 (dd, 3.4, 4.6) 
4.26 (d, 3.4) 
4.41 (bs, 0.8, 2.8) 
2.10 (s) 
2.35 ( dt, 1.5, 7 .5) 
1.66 (sext, 7.5) 
0.96 (t, 7 .5) 
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7 0 
0 ~15 12 14 
COSY gHMBC 
(H,H) (H,C) 
3.72 C-2 C-4 C-5 C-9 
' ' ' 
2.85, 4.41, 5.91 C-1 C-2 C-4 C-5 
' ' ' 
3.72, 4.41, 5.65 C-3 C-7 C-9 
' ' 
3.59, 5.91 C-4 C-5 C-10 
' ' 
4.26, 5.65 C-5 C-6 
' 
3.59 C-4, C-9 
3.72, 5.91 C-4, C-5, C-7, C-8 
C-10 
1.66 C-14, C-15 
0.96, 2.35 C-13, C-15 
1.66 C-13 C-14 
' 
Table 7.1: 1H and 13C NMR data for scabrosin acetate butanoate (7.6) (CD2Cl2) 
Proton coupling constants not apparent in the 1 H NMR spectra were determined using a 
SERF pulse sequence on a Varian /nova 500 spectrometer 
The complex coupling systems observed in the 1 H NMR spectra of 7. 6 were assigned 
using a number of 1 H-1 H SERF experiments, detailed in Figure 7. 5. Of particular 
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interest was the weak coupling (3JHH 0.8 Hz) observed between epoxide protons H8 and 
the methine protons H9. 
II I 
H ~ 
:H 
.__) 
<l> 
<)> = 0° : max 
<)> = 90° : min 
Figure 7.3: 1H - 1H correlations observed in the COSY spectrum of 7.6 
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Figure 7.4: 1 H -1 H COSY spectrum of scabrosin ester 7. 6 
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Figure 7.5: 1 H - 1 H coupling constants of 7.6 ( couplings in purple obtained using 
SERF pulse sequence) 
The 13C NMR spectrum of scabrosin acetate butanoate (7 .6) is shown in Figure 7. 6 
As was the case with the corresponding 1H NMR spectrum (Figure 7 .2), a notable 
feature of the 13C spectra is the slight asymmetry observed between several of the paired 
carbon resonances. This asymmetry is observed in the chemical shifts of five pairs of 
resonances and arises from the differing influences of the two ester side chains. The 
methine resonances at 8 64.39 and 64.63, previously assigned to the cyclohexene methine 
attached to the ester side chains, exhibit the largest difference in chemical shift. The 13C 
NMR signals of scabrosin acetate butanoate (7.6) were assigned on the basis of DEPT, 
1H- 13C gHMQC, 1H- 13C gHMBC and 1H-15N gHMBC experiments. 
Confirmation of the carbon multiplicities previously assigned by Begg et al. 1 was 
obtained using a DEPT pulse sequence. Thus the twenty four carbons atoms present in 
the molecule were assigned as eight quaternary (including four carbonyl carbon atoms), 
ten methine, four methylene and two methyl groups. 
As previously described by Begg et al., three 13C signals were observed in the range 
8 175 - 160. Two of these signals, at 8 170.08 (C-10) and 172.71 (C-12), were 
characteristic of ester carbonyls carbons atoms while the third, further upfield at 8 162.49 
(C-1), was in the typical region for amide carbonyl carbon atoms. 
Several other characteristic features were observed in the 13C NMR spectra. The methine 
carbon resonances at 8 119.65 and 119.79 (C-5) are typical of olefinic carbons, as are the 
quaternary resonances at 8 137.27 and 137.32 (C-4). 
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Figure 7.6: 13C NMR spectrum of scabrosin acetate butanoate (7.6) (CD2Cl2) 
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In addition, the epoxide carbons at 8 50.61, 50.66 (C-7) and 54.57 (C-6) are within the 
expected range for epoxides while the relatively large 1Jc-H values (181 - 185 Hz) detected 
by Begg et al. are also typical for this functional group. 1 
The carbon and proton connectivities of scabrosin 7. 6 were established using gHMQC 
and gHMBC pulse sequences (Table 7.1). Much of the data were in accordance with 
that reported by Begg, however, a number of long range 1H- 13C HMBC correlations 
revealed connectivities that could not be accommodated by the structure previously 
proposed. Diagnostic 1H- 13C HMBC correlations are illustrated in Figure 7.7 while the 
gHMBC spectrum of 7 .6 is shown in Figure 7.8. 
Figure 7. 7 A details the seven correlations arising from protons H-6, H-7 and H-8. A 
particularly important connectivity is the 2 lcH correlation apparent between epoxide 
protons H-8 and methine carbon atoms C-9. 
(8) 
0 
O~R 
R = alkyl side chains ( CHs and C3H7 ) 
(C) 
Figure 7.7: 1H - 13C correlations observed in the gHMBC spectrum of 7.6 
Heteronuclear correlations arising from protons H-9 and H-3a are shown in Figure 
7. 7B. Four connectivities are evident between the methine protons H-9 and adjacent 
carbon atoms, including 2 lcH couplings to C-4 and C-8 and 3 lcH couplings to C-5 and 
C-7. 
Two further sets of correlations, those involving protons H-5 and H-3~, are shown in 
Figure 7.7C. Three 3 JcH correlations are evident between H-5 and carbon atoms C-3, 
C-7 and importantly, C-9. Furthermore, as shown in Figure 7. 7B and Figure 7. 7 C, 
themethyleneprotonsH-3~and H-3a exhibited 3lcH correlations with carbon atoms C-1 
and C-9 respectively. 
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In addition to the ( 1 H- 13C) gHMBC experiment described above, a ( 1 H- 15N) gHMBC 
pulse sequence was also utilized in our investigation. The 1 H- 15N HMBC spectrum 
further confirmed the position of the hetero atom within the indole ring system, showing 
connectivities between protons H3a and the two nitrogen atoms (Figure 7 .9). Strong 
connectivities between the nitrogen atoms and protons H-8 were also observed. 
/\ /? 1---/;;'< ;; t 0 
\ N 0 
O)lR 
R = alkyl side chains ( CH3 and C3H7 ) 
Figure 7.9: lH- 15N correlations observed in the 1H- 15N gHMBC spectrum of7.6 · 
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7.3.2 · X-ray Crystallographic Analysis 
The structure of the scabrosin core was ultimately established by the single crystal X-ray 
analysis of scabrosin dibutanoate ( 7. 7), illustrated in Figure 7 .10 . Crystals suitable 
for the X-ray work were obtained by slow evaporation of a benzene/ ethanol solution. 
The dibutanoate 7. 7 exhibited C2 symmetry around a central axis and contained five 
distinct stereogenic centres. Importantly, the absolute stereochemistry of these centres 
could be unambiguously determined due to the pronounced anomalous dispersion effects 
induced by the two sulfur atoms bridging the central piperazinedione ring. 
Thus, the two bridgehead carbon atoms were found to have an R,R configuration. 
Interestingly, this stereochemistry is present in the majority of naturally occurring 
epithiopiperazinediones (discussed in §7.5). The crystal structure also established the cis , 
orientation of the epoxide moiety and its presence on the opposite face (to the disulfide 
bridge) of the hexahydroindole ring. 
Figure 7.10: Thennal ellipsoid diagram of scabrosin dibutanoate 7. 7 with selected 
atom labelling. Ellipsoids show 25% probability levels. Hydrogen atoms are drawn as 
circles with small radii. (X-ray analysis performed by Dr D. C.R. Hockless) 
Significant strain is apparent across the disulfide bridgehead of the scabrosin 
carboskeleton with a CSSC dihedral angle of 14.4( 4)°. As might be expected, the 
0 
disulfide bond itself is relatively weak with a bond length of 2.078( 4) A (bond lengths in 
0 
the order of 2.03-2.05 A are typical for acyclic disulfides). 
1•· 
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7.3.3 CD Spectroscopic Studies 
Circular dichroism measurements were also used to investigate the absolute 
configuration of the disulfide bridgehead carbon atoms of the scabrosin skeleton. 
The CD spectrum of scabrosin acetate butanoate (7.6) was found to exhibit a strong 
broad negative Cotton effect at 223 nm (~E -6.11) and a positive Cotton effect at 260 
nm (~E +2.28) (Figure 7.11). In comparison, the epidithiopiperazinedione gliotoxin 
(7.12) was observed to have negative and positive Cotton effects at A 231 and 268 nm 
(literature A 234 and 272 nm)9 respectively. 
The negative Cotton effect at 223 nm was attributed to n2, n3 • n* charge-transfer 
bands, where n2, n3 are disulfide orbitals and n* represents the antibonding n orbitals of 
the peptide groups, while the positive Cotton effect at 260 nm was assigned as a 
combination of peptide nn* transitions and disulfide n2, n3 • cr* transitions. These 
assignments were based on measurements and calculations performed by Nagarajan and 
Woody in their work on the circular dichroism of gliotoxin and related 
epidithiopiperazinediones. 9 
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Figure 7.11: CD spectrum of scabrosin acetate butanoate (7. 6) 
Nagarajan and Woody studied the CD spectra of a number of naturally occurring 
epidithiopiperazinediones (and their derivatives) including gliotoxin (7.12), 
acetylaranotin (7.13) and chaetocin (7.14). 
1•' 
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The absolute stereochemistry of these metabolites 7 .12 - 7 .14 had previously been 
established using X-ray crystallography. 10-12 Nagarajan and Woody found that the 
magnitude of the CD band arising from a combination of peptide nn* transitions and 
disulfide n2, n3 • cr* transitions, around 260-270 nm, could be reliably used as an 
indicator of epidithiopiperazinedione disulfide chirality. 
Thus, as the bridgehead carbon atoms of gliotoxin have an R, R configuration, the 
positive magnitude of the 260 nm Cotton effect observed in the CD spectrum of scabrosin 
acetate butanoate (7 .6) is consistent with an R,R configuration about the disulfide 
bridgehead carbons atoms. 
7.4 A New Scabrosin: Scabrosin Butanoate Hexanoate 
The fifth, previously unknown, scabrosin ester (7 .. 9) isolated from the lichen extract was 
identified on the basis of its mass spectrometric and NMR spectroscopic properties. 
C3H7"f<;) 
0 
H 
I 
0 
0 )l 
0 CsH11 
(7.9) 
High resolution mass spectrometric analysis of a fragment ion yielded a mass 
measurement of m/z 524.2150, consistent with the moiety C2gH32N20g (M -S2). The 
butanoate and hexanoate side chains were clearly identified from facile cleavage of these 
fragments (M -S2 -88) and (M -S2 -116) in the EI mass spectra and from signals in the 
I •. 
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range 8 0.90 to 8 2.41 in the 1H NMR spectra. The 1H NMR region downfield of 
8 2.80 was identical with those of the other scabrosin derivatives 7 .5 - 7 .8. 
7.5 Naturally Occurring Epidithiopiperazinediones 
Epidithiopiperazinediones comprise a relatively large class of secondary metabolites 
isolated from a variety of fungal species. Over seventy naturally occurring 
epidithiopiperazinediones have been identified and their numbers are steadily increasing 
- over the last six years almost a dozen reports have appeared in the literature. 13-22 
Epidithiopiperazinediones exhibit a diverse range of pharmacological properties which 
have been attributed to the presence of the central disulfide moiety. The chemistry and 
biological activity of these derivatives has been the subject of numerous reviews. 23-29 
The majority of naturally occurring epipolythiopiperazinediones are derivatives of one of 
two basic structural motifs. The first of these skeletal types, represented by 
gliotoxin 30,31 ( 7 .12), is characterised by a fused three ring indolopyrazine core 
structure. The second structural type is exemplified by sporidesmin31 ,32 (7 .15) which 
possesses a fused four ring indolopyrrolopyrazine nucleus. 
N § 2 N-Me 
OHH O~OH 
(7.12) 
Cl 
Meo 
: -N :. H ~N-Me 
(7.15) 0
1 
\ 
7.5.1 Epidithiopiperazinediones derived from Lichens 
The scabrosin esters 7.5 - 7.9 represent the first epidithiopiperazinediones isolated from 
lichenized fungi. In addition to the lichen species used in our study (Xanthoparmelia 
scabrosa ), the scabrosins have previously been observed (but not structurally identified) 
in a number of Parmelia33 and Xanthoparmelia5 species. The acetate butanoate 7 .6 and 
acetate hexanoate 7. 8 esters have also recently been identified in an U snea species 
collected in Sri Lanka.16 
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7.5.2 Cyclophenylalanine-derived Epidithiopiperazinediones 
The scabrosin esters (7 .5) - (7 .9) belong to a family of complex, highly modified 
cyclophenylalanine derivatives. Other members of this family of 
epidithiopiperazinediones are illustrated in Figure 7 .12. 
Aranotin (7.16), acetylaranotin (7.13) and apoaranotin (7.17), a series of 
dihydrooxepins, were first isolated from the fungi Arachniotus aureus in 1968 .11 ,34-36 
All three dihydrooxepin derivatives were found to possess potent antiviral activity. 
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Figure 7.12: Cyclophenylalanine-derived epidithiopiperazinediones 
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The emethallicins, e.g. emethallicin A37 (7.18) and E38 (7 .19) isolated from Emericella 
hetrothallica and SCH 6487417 (7 .20) extracted from an unidentified fungus, also 
contain dihydrooxepin and cyclohexadiene moieties. These derivatives (7 .18 and 7 .19) 
and 7 .20 were shown to posess potent antiallergy and epidermal growth factor receptor 
antagonist activities respectively. 
Two further dimeric epidithiopiperazinediones, epicorazine A (7 .21) and B (7 .22) 
isolated from the fungus Epicoccum nigrum, have been identified. 39,4o These derivatives 
contain 4-hydroxycyclohexenone fragments and have been shown to be inhibitors of 
gram-positive bacteria. 
A number of S-methyl cyclophenylalanine-derived dithiopiperazinediones have been 
isolated from natural sources. One such example, haematocin (7 .23) , has been isolated 
from cultures of the fungus Nectria haematococca in 2000. 41 Haematocin (7 .23) was 
found to inhibit the germ-tube elongation and spore germination of the rice blast fungus, 
Pyricularia oryzae. 
0 
Jl 
HO Me 
H . Q // : 
Me'l( OMeS 
O (7.23) 
7. 6 Biosynthetic Considerations 
A proposed biogenesis for the apoaranotin/gliotoxin, aranotin, epicorazine and scabrosin 
ring systems 7 .24 - 7 .27 is outlined in Figure 7.13. 
The key step in the biosynthetic array is thought to be the formation of an 2S ,3R arene 
oxide species 7 .28 from the corresponding phenylalanyl derivative 7 .29. The 
intermediacy of an arene oxide 7 .28 was first postulated by Neuss and coworkers, based 
on evidence obtained from labelling studies conducted using Arachniotus aure us. 34A2 
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The 5-exo-tet ring closure of arene oxide 7 .28 would then be expected to give the ring 
functionality 7 .24 observed in both apoaranotin and gliotoxin. 
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HO 
(7.27) 
scabrosin ring system 
HN\/ 
(7.29) 
[O] 
HN\/ 
(7.28) 
/ ~xo-tet 
HN 
(7.30) \/ 
~ 
0 HN 
(7.31) \/ l s-exo-tet 
0~ .- 0 
OH 
(7.25) 
aranotin ring system 
OH 
(7.24) 
apoaranotinl 
gliotoxin ring system 
l [O] 
0 l W(ca~ 
epicorazine ring system 
Figure 7.13: Proposed biogenetic relationships between the naturally occurring 
cyclophenylalanine-derived epidithiopiperazinedione ring systems 
The aranotin dihydrooxepin ring system 7.25 has been postulated to arise via the oxepin 
tautomer 7 .30 of arene oxide 7 .28. 34 .42,43 Thus, enzymatic oxidation of the oxepin 
7 .30 followed by 5-exo-tet ring closure of the resultant epoxide 7 .31 would be expected 
to produce the dihydrooxepin derivative 7. 25. The importance of 2S ,3R arene oxide 
7 .28 and oxepin 7 .30 tautomers in the biosynthesis of cyclo-(L-Phe-L-Phe)-derived 
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epidithiopiperazinediones is further highlighted by the structure of apoaranotin (7 .17) 
which possesses both dihydrooxepin and cyclohexadiene ring systems. 
No biosynthetic investigations have yet been carried out on the epicorazines 7.21 - 7.22, 
however the structural similarities between these derivatives and the cyclohexadienols 
apoaranotin (7 .17) and gliotoxin (7 .12) have long been recognised.43 .44 A plausible 
biosynthetic pathway involves the oxidation of diene 7 .24 to give the epoxide 7. 3 2 
which could then undergo acid catalysed rearrangement to afford the corresponding 
cyclohexedienone skeleton of the epicorazines 7.26. 
The biosynthesis of the scabrosin carboskeleton 7. 2 7 is presumed to proceed via the 
2S ,3R arene oxide tautomer 7. 3 3. The 5-endo-trig ring closure, followed by 
epoxidation of the resultant hexadiene 7 .34 could reasonably be expected to give the 
scabrosin ring system 7. 2 7. The biosynthesis of the scabrosins is discussed in more 
detail below. 
Although extensive research has been conducted into the biogenetic ong1ns of 
epidithiopiperazinediones, little is known about the incorporation of the sulfur 
moiety.43 .45.46 In 1971 Taylor and coworkers proposed a biosynthetic pathway for the 
introduction of sulfur which involved dehydropiperazinedione 7 .35 as a putative 
intermediate (Figure 7.14).29 However subsequent work by Brannon et al. established 
that phenylalanine was incorporated into the disulfide metabolite without loss of either of 
the benzylic hydrogens, making such an intermediate 7.35 unlikely.47 
0 
y - ../ ' OH ' (7.35) -..... y-- ,-N N-Me N S2 N-Me 
OH O}---COH ~ 0 / OH Or\_OH ~eye lo-(L-Phe-L-Ser) (7.12) 
Figure 7.14: Proposed biosynthesis of the disulfide bridge 
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A second mechanism has been postulated by Sammes45 and Herscheid.46 This 
mechanism has been suggested to involve an acylimine or acylimmidium ion derivative 
7. 3 6 as the sulfur acceptor and a cysteine or cystine containing residue as the sulfur 
donor. 
A possible biogenesis of the scabrosins esters 7. 5 - 7. 9 is depicted in Figure 7 .15. 
Little experimental work has been conducted on the biogenesis of cyclo-(L-Phe-L-Phe) 
derived epidithiopiperazinediones. Brannon and co-workers47 fed fully C-deuterated 
phenylalanine to Aspergillus terreus, a good source of acetylaranotin (7 .13 ), and 
observed that [2Hs] phenylalanine contributed to both halves of the symmetrical structure 
of the metabolite. Importantly, in the process only two deuterium atoms were lost, 
presumably from the a-positions of the cyclised amino acids. 
Thus, peptide coupling of two molecules of L-phenylalanine (7.37) would be expected to 
give the dipeptide cyclo-(L-phenylalanyl-L-phenylalanyl) (7 .38). Oxidation of the amide 
nitrogens could then give the corresponding hydroxamic acid 7.39.46 
Formation of the scabrosin carboskeleton is expected to arise via N euss oxidation of the 
aromatic ring to give the 2R,3S arene oxide 7 .40. As discussed earlier, the oxide is 
expected to lie in equilibrium with the corresponding oxepin tautomer 7 .41 and 2S,3R 
arene oxide 7. 4 2. Dehydration of the N-hydroxy-a-amino acid moiety could then give 
the acy limine 7 .43. 
Anti SN2' attack by the acylimine nitrogen on the 2S ,3R arene oxide ring would then be 
expected to afford the cyclohexadienol 7. 4 4. The geometric demands of this ring 
closure, effectively a 5-endo-trig process, would be expected to disfavour such a 
cyclisation.48 However, initial electrophilic opening of the epoxide would be expected to 
provide added impetus to overcome the unfavourable geometric demands.* 
The acylimmonium ion 7. 4 4, a very reactive electrophile, could then trap a sulfur 
nucleophile, such as a cysteine residue, to yield the thioether 7 .45. P-Elimination in the 
* Such a proposal is supported by the recent work of Jones et at.49,50 
,~, 
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cysteine fragment could then give the corresponding sulfide 7.46. A second epoxidation 
step would then result in the arene oxide 7 .47. 
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Figure 7.15: Proposed biosynthesis of the scabrosin esters 
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An identical biosynthetic sequence involving the second phenylalanine moiety would, in a 
similar manner, be expected to give the scabrosin dithiol 7 .48. Subsequent oxidative 
cyclisation to give the epidisulfide fragment, followed by sequential transesterification 
reactions could then be expected to give the appropriate lichen-derived scabrosin esters 
e.g. 7.5 - 7.9. 
7. 7 Cytotoxicity of the Scabrosins 
As discussed earlier, epidithiopiperazinediones have been the focus of considerable 
interest due, in part, to the vast and ever increasing array of biological properties 
exhibited by these metabolites.23,25,26,51-54 
One of the best studied members of the epidithiopiperazinedione class of fungal 
metabolites is the mycotoxin, gliotoxin (7 .12). Shortly after its discovery, gliotoxin 
(7 .12) attracted considerable attention as a result of the antibacterial and antiviral 
properties it was found to exhibit. 23 ,29 However interest in the chemotherapeutic 
properties of gliotoxin ( 7 .12), and related epidithiopiperazinediones waned after the 
general in vivo toxicities of these derivatives were realised.54 
More recently, interest in the epidithiopiperazinedione class has been rekindled following 
the discovery that gliotoxin (7 .12) exhibited selective toxicity to haematopoietic 
cells. 23 ,25,55,56 Gliotoxin (7 .12) has also been shown to induce apoptotic cell death in a 
number of different cell types and, in addition, has been found to inhibit an increasing 
number of thiol-requiring enzymes.23 Of particular interest in recent years has been the 
immunomodulating activities possessed by gliotoxin (7.12).23,25,55-58 
The ability of epidithiopiperazinediones to inhibit cell proliferation has previous! y been 
used as an in vitro measure of their immunomodulating effects. 23 Our efforts to assess 
the effects of the scab rosin esters 7 .5 - 7 .8 on cell proliferation have included two such 
assays. The first of these examined the ability of the scabrosin esters to inhibit thymidine 
incorporation against the mouse mastocytoma P815 cancer cell line. The second 
examined the inhibitory effect of scabrosin acetate butanoate (7 .6) on the formation of 
human breast tumour cell line MCF7 colonies. Both assays compared the activity of the 
scabrosin esters to the known immunomodulator, gliotoxin (7.12). 
R1yO 
0 
0 
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7. 7.1 Thymidine Incorporation Assay 
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The incorporation assay was performed as described in previous chapters. 
In addition to the epidithiopiperazinedione metabolites 7 .5 - 7 .8 and 7 .12, the activities 
of the tetrapeptide, oxidised-glutathione (7 .49) and the five membered heterocycle, 
lipoic acid (7 .50) were also examined. Both compounds have considerable importance 
in biological systems due to the chemistry of the disulfide moiety. Oxidised-glutathione 
(7.49) is used by a large number of enzyn1es either as a reductant or, alternatively, as a 
catalyst for a variety of reactions (including dehydrogenation, isomerization, 
dechlorination and hydration)59 while lipoic acid (7 .50) has been established as a 
cofactor in a number of enzyme catalyzed reactions.60 
NH2 
HOOC 
HOOC 
"'-NH 
O' Nys-sr-?° o 
O==( N 
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COOH 
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s S/ ✓, . COOH 
COOH 
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The antiproliferative behaviour of scabrosin ester 7. 6, gliotoxin (7 .12 ), oxidised-
glutathione (7 .49) and lipoic acid (7 .50) are illustrated in Figure 7 .16. As shown, 
the lichen epidithiopiperazinedione was found to be significantly more potent than the 
immunosuppressant, gliotoxin (7.12). By comparison, oxidised-glutathione (7.49) and 
lipoic acid (7.50) were found to be inactive in the µM range. 
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The ICso values of scabrosins 7.6 and 7.7 were found to be 0.56 and 0.50 µM 
respectively while the ICso of gliotoxin (7.12) was calculated to be 2.9 µM (Table 7.2). 
In order to assess the effect of varying side chain length on activity, the cytotoxicities of 
scabrosin diacetate (7.5) and scabrosin acetate hexanoate (7 .8) were also evaluated. 
The respective IC5o values were calculated as 0.63 and 0.42 µM, comparable to the 
values observed for scabrosin esters 7.6 and 7.7. This observation suggests that varying 
the side chain lipophilicity of the scabrosin esters does not significantly alter the 
cytotoxicities of the natural products. 
Disulfide 
scabrosin ester 7.5 
scabro sin ester 7. 6 
scabro sin ester 7. 7 
scabro sin ester 7. 8 
gliotoxin (7.12) 
oxidised-glutathione (7 .49) 
lipoic ~cid (7.50) 
Table 7.2: IC 50 values for various disulfides 
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Figure 7.16: Antiproliferative activities of various disulfides 
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7. 7.2 Clonogenic Assay 
The ability of scabrosin esters 7.6 and 7.7 to inhibit colony formation of the human 
breast carcinoma MCF7 cell line were also examined. MCF7 cells were seeded in a 
solution of culture medium supplemented with 10% Fetal Bovine Serum at 500 cells/well 
in 6-well plates and incubated at 37 °C for 24 h. Healthy cells would be expected to 
adhere to the surface of the well, forming a colony of daughter cells upon proliferation. 
The incubated cells were then treated with the scabrosin or gliotoxin toxin at 
concentrations ranging from 25 to 0.01 nM and incubated for a further 8-10 days at 37 
°C. The resultant cell colonies were washed, stained with 2% crystal violet, rinsed and 
counted. The assay was performed in duplicate. 
The results of the clonogenic assay are shown in Figure 7.17. The IC5o values for 
scabrosins esters 7.6 and 7.7 and gliotoxin (7.12) were calculated to be 1.0, 0.95 and 1.8 
nM respectively. As was the case with the preceding assay, the two scabrosin esters 7.6 
and 7.7 were found to be slightly more potent than gliotoxin (7.12). 
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Figure 7.17: Clonogenic assay comparing the effects of gliotoxin (7.12) and scabrosin 
esters (7. 6) and (7. 7) on the human breast tumour cell line MCF7. 
Figure 7.18 shows colonies of human breast carcinoma MCF7 cells following treatment 
with: (a) lnM scabrosin ester 7.6, (b) lnM gliotoxin (7.12), (c) 3nM scabrosin ester 7.6, 
and (d) 3nM gliotoxin (7.12). Figure 7.18e shows a well to which no toxin was added. 
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1 nM 7.6 (b) 1 nM 7.12 
3 nM 7.6 (d) 3 nM 7.12 
(e) control 
Figure 7.18: Human breast tumour cell line MCF7 colonies at various concentrations of 
epidithiopiperazinedione [ scabrosin ester 7.6 ( a and c) and gliotoxin (7.12) ( b and d) J 
j~· 
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Interestingly, the IC5o values for the epidithiopiperazinediones in the clonogenic assay are 
approximately ~ 103 times lower than those observed in the thymidine incorporation 
experiment. These results imply that the potency of the epidithiopiperazinediones is 
dependent upon the density of the cells. Thus, the lower the cell density, the lower the 
concentration of toxin required to disable or kill the cells. This evidence is consistent with 
literature reports in which the effect of ETP compounds has been shown to be biomass 
dependent. 61 
In comparison, the anticancer drug cisplatin [cis-diamminedichloroplatinum] has been 
found to exhibit only a two to three fold difference in activity between the two assays.62 
The observed dependence of the IC5o values of the scabrosin esters is indicative of the 
active uptake of these substrates by the proliferating cells. Such a phenomenon is 
consistent with a chemical defense function for the scabrosins in the lichen. Further 
experiments in this area are awaited with interest. 
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8.1 General Experimental 
Reagents 
Unless stated otherwise, reagents were purchased from Aldrich or Merck and used without 
further purification. All other sol vents were of AR grade, purified by literature 
procedures, and where appropriate, stored over freshly activated molecular sieves. 1 
CDCl3 was deacidified prior to use where necessary by passage through a column of 
chromatographic grade basic alumina. 
Experimental Procedures 
Unless specified otherwise, all reactions requiring anhydrous conditions were conducted 
in flame-dried glassware under an atmosphere of anhydrous nitrogen. 
Chromatography 
Thin layer chromatography (TLC) was conducted using MERCK TLC aluminium sheets 
or glass plates coated with silica gel 60 F 2S4 The developed plates were visualized under 
short-wavelength ultraviolet light using a Minerallight® Multiband UV-254/366 nm lamp. 
Several different staining reagents were used including [5% H2SO4 (w/v) in H2OJ, [5% 
H2SO4 (w/v), 5% (NH4)6Mo7O24, 0.2% CeSO4 (w/v) in H2OJ and [H2SO4 (4.5 ml), 
p-anisaldehyde (3 ml) in EtOH (200 ml)J .2,3 
Flash chromatography was carried out according to the procedure of Still et al.4 using 
Merck silica gel 60 (200-400 _mesh ASTM). Radial chromatography was performed on a 
Harrison Research 7924T ChromatotronTM with radial plates coated with silica gel 60 
PF254. Preparative TLC was performed using plates coated with MERCK silica gel 60 
PF254. 
High performance liquid chromatography (HPLC) was performed using a Spectra System, 
a Phenomenex Hypersil 5C18 column (250 by 4.6 mm) and a spectrometric detector 
operating at 254 nm with a flow rate of 1 ml/min. Two sol vent systems were used: 1 % 
aqueous orthophosphoric acid and spectroscopic grade methanol in the ratio 7:3 (A) and 
spectroscopic grade methanol (B). The run started with 100% A and was raised to 58% B 
within 15 min, then to 100% B within a further 15 min, followed by isocratic elution in 
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100% B for a further 10 min. The HPLC was coupled to a photodiode array detector for 
ultraviolet spectroscopic comparisons. 
Lichen compounds were identified by TLC using the methods standardized for lichen 
products5-8 and by HPLC with retention index values (RI) calculated from benzoic acid 
and solorinic acid controls. 9,1° For TLC, standard Rp values were determined in four 
independent TLC solvent systems: (A) toluene/dioxan/acetic acid (180:45:5); (B) hexane/t-
butyl methyl ether/formic acid (140:72: 18); (C) toluene/acetic acid (170:30) and (E) 
cyclohexane/ethyl acetate (75:25). 
Spectroscopy 
1 H and 13C spectra were recorded in CDC13, CD2Cl2, d4-methanol, d6-acetone or d6-
DMSO on one of the following spectrometers: Varian Gemini 300, Varian VXR 300S, 
Varian Inova 500 or Varian Inova 600. Chemical shifts (8) are expressed as values in 
ppm relative to the internal standard tetramethylsilane (0.00 ppm) or to residual solvent. 
The 1 H data are reported as: 8 chemical shift (multiplicity, homonuclear coupling 
constant(s), proton number, assignment); e.g., 8 0.68 (t, 31 = 7.4 Hz, CH3CH2, H-13). 
DEPT and APT spectroscopy were used to assign 13C signals which are cited as 8 
chemical shift (carbon number); e.g., 8 198, (C-9). 
Two dimensional NMR spectra were obtained on a Varian Inova 500 or Varian In ova 600 
spectrometer. Pulse sequences utilised include gH1'1QC, gHMBC, NOESY, COSY, 
SERF and 1H-15N gHMBC .. One-dimensional g-NOE data were obtained on samples 
degassed by the freeze-pump-thaw method. 1 
Infrared spectra (IR) were recorded on a Perkin-Elmer 683 or Perkin-Elmer 1800 Infrared 
Spectrophotometer as KBr plates. The spectra were recorded from 4000-200 cm-1 and 
the data reported as: Dmax wavenumber (in cm-1 ). 
Ultraviolet-visible spectra (UV /VIS) were recorded using a Cary 4G Spectrophotometer 
using spectroscopic grade solvents. The data are displayed as Amax wavenumber of the 
absorption peak in nm ( Emax, intensity of the absorption peak). 
Chapter8 188 
Optical rotation measurements were measured with a Perkin-Elmer 241 polarimeter using 
spectroscopic grade solvents. The data are displayed as [a] specific rotation of solution 
(c, concentration in g [solute] /100 ml [solution]) CD and ORD spectra were obtained 
using a Jobin Yvon CD6 machine and analysed using Dichro Software Version 1.2. CD 
measurements were made using a 0.05 cm cell, ORD measurements were obtained using 
a 2.0 cm cell. All measurements were made using spectroscopic grade solvents. CD data 
were displayed as Amax wavenumber of the absorption peak in nm (~£, molar circular 
dichroism in L mol-1 cm-1 ). ORD data was recorded as Amax wavenumber of the 
absorption peak in nm (<I>max, molar rotation in degrees cm2 dmol-1 ). 
Low resolution electron-impact mass spectra were measured on a VG AutoSpec 
Spectrometer a ZAB2-SEQ mass spectrometer or a VG micromass 7070F mass 
spectrometer recorded at 70 e V. The molecular ion peak (M+), structurally significant 
peaks and all peaks with relative intensity greater than 20% of the base peak and a m/z 
value greater than 70 mass units, are reported as: mlz value (assignment, relative 
intensity). High resolution electron-impact mass spectra (HREIMS) were determined on 
the same instruments by peak-matching. 
Other Characterisation Techniques 
Melting points are uncorrected and were recorded on a Leica Galen III microscope or a 
Reichert hot stage microscope. Microanalysis were performed by the Australian National 
University Microanalytical Service on a Carlo Erba EA 1106 CHN-O analyser. Boiling 
points are reported as b.p.[pressure (in mm Hg)] temperature, °C. 
I I~ 
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8.2 Antiprolif erative Activity Experimental 
8.2.1 Thymidine Incorporation Assay 
The procedure used was a modification of that described previously by Waring11 Jiang, 12 
Hume13 and co-workers. To determine the antiproliferative capacity of the purified lichen 
material, 100 µL of P815 cells in Eagles Minimum Essential Media (F 15) and 10% Fetal 
Bovine Serum (FBS) at a final cell concentration of 0.5 x 106 per ml were pipetted into 
96-well plates containing the serially diluted ( 1 :2 dilution, starting concentration of 100 
µM) lichen metabolite. The mycotoxin gliotoxin was used as a reference compound. The 
cells were incubated for 18 hat 37 °C before being pulsed with tritiated thymidine (1 µCi/ 
well) for a further 6 h. Cells were harvested using a Pharmacia Betaplate Liquid 
Scintillation counter. Three replicate wells were used to determine each data point. 
8.2.2 Clonogenic Assay 
The procedure used was a modification of that described by Koya et al. 14 MCF7 (Human 
Breast Carcinoma) cells were seeded in 4 ml of RPMI culture medium supplemented with 
10% FBS at 500 cells/well in 6-well plates. After incubating at 37 °C for 24 h the cells 
were treated with the lichen metabolite or gliotoxin at concentrations ranging from 25 to 
0.01 nM in 1 ml of culture medium. The cells were then incubated for a further 8-10 days 
at 37 °C. Cell colonies were washed with Phosphate Buffered Saline (PBS), stained with 
2% crystal violet in 70% ethanol for 30 min, rinsed several times with PBS and counted. 
The assay was performed in duplicate. 
8.2.3 MCF7 Cell Line 
The adherent cell line was subcultured prior to use. The growth medium was aseptically 
removed and the cell monolayer rinsed with sterile phosphate-buffered saline (PBS) to 
remove FCS. A small volume of sterile trysin-versene was added and the flask incubated 
at 37 °C for 5 min. Growth medium containing FCS (10 ml) was then added to quench 
the action of trypsin and the flask shaken gently to disperse the cells into a single cell 
suspension. 
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8.3 Experimental for Chapter 2 
8.3.1 Lichen Material 
The lichen Lecanora hybocarpa (Tuck.) Brodo was collected on the bark of trees in 
Zwolla, Louisiana in the United States of America, by Dr N. Hamada (Osaka City, Japan) 
on Nov. 26 1995. The voucher specimen was identified by Dr H. T. Lumbsch (Essen, 
Germany) and has been deposited at the Institute of Public Health and Environmental 
Sciences, Osaka City, Japan (registration no. NH 95112689). 
8.3.2 Cultivation and Extraction of Leconora hybocarpa 
The cultivation and extraction of L. hybocarpa was carried out by Dr N. Hamada. 
Cultures of the mycobiont of L. hybocarpa were prepared from spores discharged from 
apothecia on the lichen thallus. These spore cultures were cultivated in 70 test tubes 
containing modified MYlO medium (malt extract 10 g, yeast extract 4 g, sucrose 100 g, 
agar 15 g, water 1 L, pH 7) at 18 °C in the dark. Ultimately the yellow compact colonies 
turned red in colour. After cultivation for 8 months the colonies were harvested and dried 
(yield 6.89 g). This dried material was extracted exhaustively with acetone. The solvent 
was then evaporated and the resultant residue washed with ether and dried (yield 0.16 g). 
8.3.3 Purification of Leconora hybocarpa Mycobiont Extract 
Standardized HPLC9,10 revealed the acetone extracts contained a mixture of the known 
xanthones arthothelin 15 (2.11) (minor) and 6-O-methylarthothelin 16 (2.12) (minor) and 
an orange red pigment, hybocarpone (2.8) (major). The mixture was separated using 
repeated fractional crystallisation and flash chromatography, eluting with ethyl acetate/ 
light petroleum, to yield hybocarpone (2.8) as the major product (45 mg, 0.65%). The 
identities of the two minor xanthones (2.11) and (2.12) were confirmed by comparison 
with authentic, synthetic material (TLC, HPLC, UV and MS). 
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Hybocarpone [ 12a, 12b-diethyl-1,3,4,Sa, 6a, 8,9, 11-octahydroxy-2,10-
dimethyl-Sa, 6a, 12a,12b-tetrahydro-SaH, 6aH, 12aH,12bH-dinaphtho[2,3-
b: 2,3-d]furan-5, 7,12,13-tetraone] (2.8) 
Hybocarpone (2.8) crystallised from aqueous 
methanol as small orange red prisms. 
M.p. 167-168 °C. 
[a]0 - 19.2 (c 0.28, CHCl3). 
UV (MeOH) Amax (log£) 212 (4.41), 258 (4.51), 
320 (4.14), 405 (4.16), 4.19 sh (4.11) nm. 
IR (KBr) Vmax 3382, 2925, 1652, 1632, 1596, 1457, 1437, 1420, 1382, 1282, 1207, 
1137, 1074, 1040, 1011, 944 cm-1. 
1 H NMR (CDC13) 8 0.68 (3H, t, J = 7.4 Hz, CH3CH2), 2.28 (3H, s, ArCH3), 2.31 
(lH, m, CH3CH2), 2.62 (lH, m, CH3CH2),4.90 (lH, s, 5a,6a-OH), 6.57 (lH, s, 3,9-
OH), 10.94 (lH, s, 4,8-OH), 13.13 (lH, s, 1,11-OH). 
13C NMR (CDC13) 8 198.50 (C-12, C-13), 193.41 (C-5, C-7), 157.70 (C-1, C-11), 
150.15 (C-3, C-9), 143.47 (C-4, C-8), 123.31 (C-2, C-10), 108.60 (C-lla, C-13a), 
107.72 (C-4a, C-7a), 99.57 (C-5a, C-6a), 67.30 (C-12a, C-12b), 25.15 (C-16, C-18), 
10.48 (C-17, C-19), 8.90 (C-14, C-15). 
gHMQC (1H- 13C correlations): 8 0.68 - 10.48 (CH3CH2 - C-17,C-19), 2.28 - 8.90 
(ArCH3 - C-14, C-15), 2.31 - 25.15 (CH3CH2, - C-16, C-18), 2.62 - 25.15 (CH3CH2, 
- C-16,C-18). 
gHMBC (1H_l3C correlations): 1,11-OH to (C-1, C-11, -2), (C-2, C-10 -3), (C-1 la, C-
13a - 3); 3,9-OH to (C-2, C-10, -2); 4,8-OH to (C-4, C-8, -2), (C-3, C-9 -3), (C-4a, C-
7a - 3); 5a,6a-OH to (C-5, C-:7, -3), (C-5a, C-6a -2), (C-12a, C-12b - 3); 14,15-H to (C-
l, C-11, -3), (C-2, C-10 -2), (C-3, C-9 - 3); 16, 17-HA to (C-5a, C-6a, -3), (C-12a, C-
12b -2); 16,17-HB to (C-12, C-13, -3), (C-5a, C-6a -3); 18,19-H to (C-12a, C-12b, -3), 
(C-14 -2). 
EIMS m/z [M+] 544 (38), 264 (100), 221 (30). 
HREIMS m/z [M+] 544.1218 (calcd for C26H24O13 544.1217). 
Arthothelin (2.11) 
Arthothelin (2.11) was obtained as a yellow solid: 15 
EIMS m/z 366 (8), 364 (57), 362 (97), 360 (M+, 100). 
Standard TLC5-8 Rt (A) 0.43; Rt (B) 0.40; Rt (C) 0.37. 
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Standard HPLC9,10 tR 29.07 min; RI 0.25. 
6-0-Methylarthothelin (2.12) 
6-O-methylarthothelin (2.12) was obtained as a yellow solid: 16 
EIMS m/z 378 (28), 376 (84), 374 (M+, 100). 
Standard TLC5-8 Rt (A) 0.63; Rt (B) 0.56; Rt (C) 0.60. 
Standard HPLC9,10 tR 32.55 min; RI 0.25. 
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8.4 Experimental for Chapter 3 
8.4.1 Lichen Material 
Specimens of Flavoparmelia euplecta (Stirt.) Hale were collected on exposed rocks in 
pasture on Brigadoon farm, Bunga, 18 km south of Bermagui, New South Wales, 
Australia. A voucher specimen, J. A. Elix 40363, has been lodged in the Australian 
National Herbarium, Canberra (CANB). 
8.4.2 Extraction and Isolation 
The air dried lichen thallus (21. 8 g) was extracted in a Soxhlet extractor with anhydrous 
die thy 1 ether for 26 h. The ethereal solution was then concentrated and permitted to cool. 
The resultant precipitate was filtered and found to comprise predominantly of the 
depsidone protocetraric acid 17 (3.2). The filtrate was evaporated under reduced pressure 
and the residue subjected to radial chromatography over silica gel using ethyl acetate as 
eluant. The faster moving yellow band afforded a mixture of usnic acid15 (3.1) and 
skyrin 18 (3.5) (68 mg). The composition of this mixture was confirmed by HPLC and 
UV spectroscopy. The slower moving orange band contained a mixture of the orange -
yellow pigments (3.3) and (3.4) which were separated by preparative layer 
chromatography over silica gel using 15 % glacial acetic acid/ toluene as eluant. Two 
major yellow-orange bands developed. The faster moving band yielded a mixture of 
euplectin (3.3) and coneuplectin (3.4) (94 mg, 0.43 %) as a yellow-orange solid. 
Repeated crystallisation from chloroform afforded the major co-metabolite, euplectin 
(3.3) (10.5 mg). The mother _liquors, thus enriched in the minor euplectin pigment, were 
concentrated and the residue repeatedly crystallised from chloroform to afford 
coneuplectin (3.4) (3.1 mg). 
Euplectin [S,l l-dihydroxy-2-methylindeno[S,6-h]4H-chromene-4,10-
dione] (3.3) 
Euplectin (3.3) crystallised from chloroform as red-orange 
needles. 0 
M.p. 320 °C (dee.). 0 
UV (MeOH) Amax 219, 246, 280, 328, 433 nm. 
1H NMR (CDC13) 8 2.51 (3H, s, 2-Me), 6.19 (lH, d, J = 5.7 
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Hz, 9-H), 6.27 (lH, s, 3-H), 6.84 (lH, s, 7-H), 6.87 (lH, s, 6-H), 7.49 (lH, d, J = 
5.7 Hz, 8-H), 11.07 (lH, bs, 11-OH), 13.05 (lH, bs, 5-OH). 
13 C NMR (CDCl3) 8 198.44 (C-10), 182.68 (C-4), 167.96 (C-2), 160.31 (C-5), 
156.80 (C-1 lb), 155.63 (C-11), 147.21 (C-8), 144.12 (C-6a), 142.45 (C-7a), 132.27 
(C-9), 115.64 (C-7), 110.32 (C-3), 110.18 (C-4a), 110.05 (C-6), 108.29 (C-1 la), 
107.69 (C-l0a), 20.63 (C-12). 
gHMQC (1H- 13C correlations): 8 2.51 - 20.63 (12-H, C-12), 6.19 - 132.27 (9-H, C-9), 
6.27 - 110.32 (3-H, C-3), 6.84 - 115.64 (7-H, C-7), 6.87 - 110.05 (6-H, C-6), 7.49 -
147.21 (8-H, C-8). 
gHMBC (1H-13C correlations): 3-H to (C-2, 2), (C-4, 2w), (C-4a, 3), (C-5, 4w), (C-
12, 3); 5-OH to (C-4a, 3), (C-5, 2), (C-6, 3), (C-6a, 4w); 6-H to (C-4, 4), (C-4a, 3), 
(C-5, 2), (C-6a, 2w), (C-7, 3), (C-lla, 3); 7-H to (C-6, 3), (C-6a, 2), (C-8, 3), (C-9, 
5w), (C-10, 4), (C-l0a, 3), (C-lla, 3); 8-H to (C-7, 3), (C-7a, 2), (C-9, 2), (C-10, 3), 
(C-l0a, 3), (C-11, 4w); 9-H to (C-7a, 3), (C-8, 2), (C-10, 2), (C-l0a, 3), (C-11, 4w); 
12-H to (C-2, 2), (C-3, 3). 
EIMS m/z 295 (41%), 294 (M,100) 266 (21), 254 (26), 170 (17), 115 (14), 113 (12). 
HREIMS m/z [M+] 294.0535 (calcd for C17H10Os 294.0528). 
Standard TLC RF values: 5-8 Rp (A) 0.53; (B) 0.17; (C) 0.48; (E) 0.15. 
Standard HPLC:9,lO RT 26.13 min; RI 0.26. 
Coneuplectin [S,11-dihydroxy-2-methylindano[S,6-h]4H-chromene-4,10-
dione] (3.4) 
Coneuplectin ( 3. 4) crystallised from chloroform as yellow s 
9 
needles. 0 
M.p. 295 QC (lit.l9 283 QC). 0 
1H NMR (CDC13) 8 2.56 (3H, s, 2-Me), 2.78-2.82 (2H, m, 
9-H), 3.16-3.20 (2H, m, 8-H), 6.31 (lH, s, 3-H), 6.82 ( lH, 
s, 6-H), 7.04 (lH, s, 7-H), 9.60 (lH, bs, 11-OH), 12.89 (lH, bs, 5-OH). 
13C NMR (CDC13) 8 209.57 (C-10), 182.40 (C-4), 167.53 (C-2), 159.04 (C-5), 
158.72 (C-llb), 157.52 (C-11), 152.02 (C-7a), 144.59 (C-6a), 110.91 (C-3), 113.87 
(C-7), 116.38 (C-1 0a), 109 .80 (C-4a), 106.45 (C-6), 106.16 (C-11 a), 36.10 (C-9), 
25.37 (C-8), 20.57 (C-12). 
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gHMQC (1 H- 13C correlations) 8 2.56 - 20.57 (12-H, C-12), 2.78-2.82 - 36.10 (9-H, 
C-9), 3.16-3.20 - 25.37 (8-H, C-8), 6.31 - 110.91 (3-H, C-3), 6.82 - 106.45 (6-H, C-
6), 7.04 - 113.87 (7-H, C-7). 
gHMBC (1H- 13C correlations) 3-H to (C-2, 2), (C-4, 2w), (C-4a, 3), (C-5, 4w), (C-
12, 3); 5-OH to (C-4a, 3), (C-5, 2), (C-6, 3); 6-H to (C-4a, 3), (C-5, 2), (C-7, 3), (C-
l la, 3); 7-H to (C-6, 3), (C-6a, 2), (C-8, 3), (C-l0a, 3), (C-lla, 3); 8-H to (C-7, 3), 
(C-7a, 2), (C-9, 2), (C-10, 3), (C-l0a, 3); 9-H to (C-7a, 3), (C-8, 2), (C-10, 2), (C-l0a, 
3w); 12-H to (C-2, 2), (C-3, 3). 
EIMS m/z 297 (31 %), 296 (M,100). 
HREIMS m/z [M+] 296.0682 (calcd for C17H12Os 296.0685). 
Standard TLC RF values: 5-8 Rp (A) 0.55; (B) 0.17; (C) 0.47; (E) 0.11. 
Standard HPLC:9,10 RT 25.56 min; RI 0.25. 
Usnic acid (3.1) 
Usnic acid (3.1) was obtained as a yellow solid: l5 
EIMS mlz 344 (M+, 80), 260 (70), 233 (100), 217 (20). 
Standard TLC RF values: 5-8 Rp (A) 0.70; (B) 0.66; (C) 0.71; (E) 0.23. 
Standard HPLC:9,lO RT 29.90 min; RI 0.25. 
Protocetraric acid (3.2) 
Protocetraric acid (3.2) was obtained as a colourless solid: 17 
EIMS m/z 374 (M+, 5), 356 (23), 312 (53), 284 (32), 258 (84), 151 (100). 
Standard TLC RF values: 5-8 Rp (A) 0.03; (B) 0.19; (C) 0.05. 
Standard HPLC:9,lO RT 20-.46 min; RI 0.25. 
Skyrin (3.5) 
Skyrin (3.5) was obtained as an yellow-orange solid: 18 
EIMS mlz 410 (M+-128), 398, 370, 342. 
Standard TLC RF values: 5-8 Rp (A) 0.37; (B) 0.32; (C) 0.23; (E) 0.04. 
Standard HPLC: 9,10 RT 29.33 min; RI 0.25. 
I 
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8.5 Experimental J or Chapter 4 
8.5.1 Lichen Material 
The lichen Pseudocyphellaria coronata (Mull. Arg.) Malme was collected on the trunks of 
Nothofagus trees, just south of Mt Cook National Park, South Island, New Zealand, by 
J. A. Elix in 1995. A voucher specimen has been deposited in the herbarium of the 
Australian National Botanic Garden, Canberra, Australia (CANB). 
8.5.2 Extraction of Pseudocyphellaria coronata (Miill. Arg.) Malme 
The extraction of Ps. coronata was carried out by Ms M. Rive. 
The dried lichen material was placed in a Soxhlet extractor and extracted for three 
consecutive 24 h periods with light petroleum (b.p. 60-80 °C), diethyl ether and acetone, 
respectively. The crude mixtures from each extraction were analysed by TLC and the 
unknown pigment was observed to be concentrated in the ethereal extract together with 
significant amounts of the p-terphenylquinone, polyporic acid ( 4.2), 20 and the 
butenolide derivatives, pulvinic acid ( 4.3)21 and pulvinic dilactone ( 4.4)21 . In addition, 
the acetone extract was found to contain the known depsidones stictic acid21 ( 4. 7), 
constictic acid22 ( 4.8), cryptostictic acid23 ( 4.9) and physciosporin24 ( 4.10). The 
ethereal solution was evaporated and the residue (200 mg) was purified by fractional 
crystallisation from toluene, 50% ethyl acetate/ toluene and 20% ethyl acetate/ toluene. 
The least soluble fractions eventually afforded polyporic acid ( 4.2) (90 mg, 0.90 % ) 
identical (TLC, HPLC, 1 H NMR, MS, m.p.) with authentic materiaI.20 The more 
soluble fractions were combined and repeated crystallisation from 10% ethyl acetate -
toluene afforded coronatoquinone (4.1) (12 mg, 0.12%) as deep red prisms. The 
homogeneity of this compound was confirmed by TLC, HPLC and 1 H NMR 
spectroscopy. 
Coronatoquinone [ 1 S,5,8, 1 0-tetrahydroxy-7-methoxy-3-methyl-6,9-
dihydro-1H-naphtho[2,3-c]pyran-6,9-dione] ( 4.1) 
Coronatoquinone (4.1) crystallised from 10% ethyl acetate - toluene as deep red prisms. 
M.p. > 350 °C. 
[a]0 + 684 (c 0.005, CHCl3). 
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UV (MeOH) Amax (log E) 258 (4.21), 369 (3.58), 491 
(3.82), 521 (3.85), 555 (3.70) nm. 
IR (KBr) Vmax 3414, 2954, 1655, 1601, 1444, 1391, 
1285, 1199, 1073, 1017, 954, 776 cm-1. 
CD (CHCl3) Amax 300 (~£, -1.5), 380 (+0.8) and 475 (-0.4) nm. 
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ORD (CHCl3) Amax 372 (<Pmax, +5317), 493 (+7913), 527 (+12857), and 565 (+7317) 
nm. 
1 H NMR (CDCl3) 8 2.16 (3H, s, 3-Me), 4.18 (3H, s, 7-OMe), 6.30 (lH, s, 4-H), 
6.71 (lH, s, 1-H), 12.10 (lH, s, 10-H), 13.09 (lH, s, 5-OH). 
(CD3SOCD3) 8 2.09 (3H, s, 3-Me), 3.87 (3H, s, 7-OMe), 6.20 (lH, s, 4-
H), 6.48 (lH, s, 1-H), 12.65 (lH, s, 10-OH), 13.29 (lH, s, 5-OH). 
13C NMR (CD3SOCD3) 8 184.24 (C-9), 181.15 (C-6), 159.46 (C-3), 157.37 (C-10), 
154.73 (C-5), 148.89 (C-8), 141.92 (C-7), 133.60 (C-4a), 120.75 (C-l0a), 109.95 (C-
5a), 108.06 (C-9a), 94.67 (C-4), 88.33 (C-1), 60.87 (C-12), 20.65 (C-11). 
gHMQC (1H_l3C correlations): 8 2.09 - 20.65 (CH3 - Cl 1), 3.87 - 60.87 (OCH3 -
C12), 6.20 - 94.67 (4-H - C4), 6.48 - 88.33 (1-H - Cl). 
gHMBC (1H_l3C correlations): 1-H to (C-3, -3), (C-4a, -3), (C-10, -3w), (C-l0a, -
2w); 4-H to (C-3, -2), (C-5, -3), (C-10, -4w), (C-l0a, -3) (C-11, -3); 5-OH to (C-4a, -
3), (C-5, -2), (C-5a, -3), (C-9, -5w) (C-l0a, -4w); 10-OH to (C-4a, -4w), (C-6, -5w), 
(C-9a, -3), (C-10, -2) (C-l0a, -3); 11-H to (C-3, -2), (C-4, -3); 12-H to (C-7, -3). 
EIMS mlz [M+] 320 (2), 318 (4), 303 (21), 302 (100), 287 (11) , 259 (12), 256 (11), 
231 (19), 228 (11), 194 (10), 175 (12), 145 (19), 199 (10), 105 (10) 103, (32). 
HREIMS m/z [M+] 320.0528 (calcd for C1sH12Os 320.0533). 
Standard HPLC9,10 tR 23.75 min; RI 0.25. 
Polyporic acid ( 4.2) 
Polyporic acid ( 4.2), deep red solid: 20 
M.p. 304 - 305 °C; lit.20305 °C. 
EIMS mlz 292 (M+, 50), 290 (82), 145 (100). 
Standard TLC5-8 Rt (A) 0.29; Rt (B) 0.29; Rt (C) 0.19. 
Standard HPLC9,lO tR 18.84 min; RI 0.25. 
Pulvinic acid (4.3) 
Pulvinic acid ( 4.3), yellow solid: 21 
EIMS m/z 308 (M+), 290 (100). 
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Standard TLC5-8 Rt (A) 0.09; Rt (B) 0.42; Rt (C) 0.07; Rt (E) 0.10. 
Standard HPLC9,10 tR 18.07 min; RI 0.25. 
Pulvinic dilactone ( 4.4) 
Pulvinic dilactone ( 4.4), yellow solid:21 
EIMS m/z 290 (M+, 85), 145 (100), 89 (94). 
Standard TLC5-8 Rt (A) 0.80; Rt (B) .82; Rt (C) 0.90; Rt (E) 0.81. 
Standard HPLC9,10 tR 25.83 min; RI 0.25. 
Calycin ( 4.5) 
Calycin (4.5), yellow solid: 21 
EIMS mlz 306 (M+, 100), 161 (90). 
Standard TLC5-8 Rt (A) 0.78; Rt (B) 0.79; Rt (C) 0.88 ; Rt (E) 0.40. 
Standard HPLC9,10 tR 31.52 min; RI 0.25. 
Stictic acid ( 4. 7) 
Stictic acid ( 4. 7), colourless solid:21 
EIMS mlz 386 (M+, 57), 368 (27), 193 (75), 83 (100). 
Standard TLC5-8 Rt (A) 0.32; Rt (B) 0.09; Rt (C) 0.18. 
Standard HPLC9,10 tR 17.08 min; RI 0.25. 
Constictic acid ( 4.8) 
Constictic acid ( 4.8), colourless solid: 22 
EIMS m/z 402 (M+, 100). 
Standard TLC5-8 Rt (A) 0.07; Rt (B) 0.01; Rt (C) 0.02. 
Standard HPLC9,lO tR 13.04 min; RI 0.25. 
Cryptostictic acid ( 4.9) 
Cryptostictic acid ( 4.9), colourless solid:23 
EIMS mlz 388 (M+), 370 (100). 
Standard TLC5-8 Rt (A)0. 14; Rt (B) 0.10; Rt (C) 0.10. 
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Standard HPLC9,10 tR 16.64 min; RI 0.25. 
Physciosporin ( 4.10) 
Physciosporin ( 4.10), colourless solid: 24 
EIMS m/z 408 (M+, 34), 407 (20), 406 (100). 
Standard TLC5-8 Rt (A) 0.73; Rt (B) 0.59; Rt (C) 0.78; Rt (E) 0.37. 
Standard HPLC9,10 tR 30.91 min; RI 0.25. 
5,8, 1 0-Trihydroxy-1, 7-dimethoxy-3-methyl-6,9-dihydro-1 H-naphtho 
[2,3-c]pyran-6,9-dione (4.32) 
HO 
Coronatoquinone ( 4.1) (2.5 mg) was dissolved in 
methanol, stood for 16 h and evaporated to dryness. The 
residue crystallised from ethyl acetate/ toluene to give the MeO 
methyl ketal ( 4.32) (2 mg) as deep red crystals. 
M.p. 120 °C. 
[a]o 0. 
0 HO 
0 HO 
OMe 
0 
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1H NMR (CDC13) 8 2.15 (3H, s, 3-Me), 3.60 (3H, s, 1-OMe), 4.16 (3H, s, 7-OMe), 
6.28 (lH, s, 4-H), 6.29 (lH, s, 1-H), 12.08 (lH, s, 10-H), 13.07 (lH, s, 5-OH); 
EIMS m/z [M+] 334 (44), 302 (100), 256 (43), 231 (9), 193 (5), 175 (22), 129 (6), 113 
( 16), 89 (22), 71 (25). 
HREIMS mlz [M+] 334.0684 (calcd for C16H14Os 334.068). 
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8.6 Experimental for Chapter 5 
8.6.1 Lichen Material 
Specimens of the lichen Myeloconis erumpens McCarthy & Elix were collected on the 
trunks of Castano psis trees on a Castano psis acuminatissima dominated ridge ( 1400 m 
alt.), 9 km south of Bulolo, Morobe province, Papua New Guinea by H. Streimann in 
1982. A voucher specimen has been identified by J. A. Elix and deposited in the 
herbarium of the Australian National Botanic Garden, Canberra, Australia (CANB). 
8.6.2 Extraction of Myeloconis erumpens McCarthy & Elix 
The dried lichen material (0.63 g) was placed in a Soxhlet extractor and extracted for 18 h 
with diethyl ether. Evaporation of the ethereal solution yielded an intense yellow crude 
extract (0.11 g). TLC and mass spectrometric analysis of the lichen extract revealed two 
major metabolites - myeloconone A2 (5.1) and the xanthone fragilin (5.2). 21 The 
crude extract was purified using ethyl acetate/ light petroleum as eluant to afford 
myeloconone A2 (5.1) as a bright yellow solid (64 mg, 14.2% ). The homogeneity of 
this compound was confirmed by TLC, HPLC and 1 H NMR spectroscopy. 
Myeloconone A 2 [6, 7,9-trihydroxy-3,8-dimethoxy-4-methyl-lH-phen-
alen-1-one] (5.1) 
Myeloconone A2 (5.1) crystallised from aqueous ethanol as 
intense yellow crystals. 
M.p. > 300 °C. 
1H NMR (CD3SOCD3) 8 2.74 (3H, s, 4-Me), 3.80 (3H, s, 8-
OMe), 3.99 (3H, s, 3-OMe), 6.48 (lH, s, 2-H), 6.80 (lH, s, 5-
H). 
12 
OMe 
OMe 
10 
13C NMR (CD3SOCD3) 8 172.60# (C-1), 169.86# (C-9), 166.24 (C-3), 163.52 (C-6), 
162.37 (C-7), 145.51 (C-4), 132.69 (C-8), 126.77 (C-3b), 116.84 (C-5), 110.70 (C-
3a), 105.21 (C-6a), 103.07 (C-9a), 97.15 (C-2), 59.63 (C-10), 56.19 (C-12), 25.45 (C-
11 ). 
(# may be interchanged) 
gHMQC (1H_l3C correlations) 8 2.74 - 25.45 (CH3 - Cl 1), 3.80 - 60.87 (OCH3 - C-
12), 3.99 - 60.87 (OCH3 - C-10), 6.48 - 97.15 (2-H - C2), 6.80 - 116.84 (5-H - CS). 
1·1 
~ 
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gHMBC (1H- 13C correlations): 2-H to (C-1, -2), (C-3, -2), (C-3a, -3), (C-4, -4w), (C-
9, -4w) (C-9a, -3); 5-H to (C-3a, -3), (C-6 -2w), (C-6a -3), (C-11 -3); 10-H to (C-2, 
-4w), (C-3 -3); 11-H to (C-3, -4w), (C-3a -3), (C-4 -5), (C-5 -3); 12-H to (C-7, -4w), 
(C-8 -3). 
EIMS m/z [M+] 302 (61), 284 (48), 259 (100), 230 (20), 213 (13). 
HREIMS m/z [M+] 302.0790 (calcd for C16H14O6 302.0790). 
Standard HPLC9,10 tR 23.03 min; RI 0.25. 
Fragilin (5.2) 
Fragilin (5.2) crystallised as a yellow solid: 21 
m.p. 265 - 266 QC; lit25 267-268 QC 
EIMS m/z 318 (M+, 65), 284 (100). 
Standard TLC5-8 Rf (A) 0.75; Rf (B)0. 67; Rt (C) 0.82; Rf (E) 0.54. 
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8. 7 Experimental for Chapter 6 
8. 7.1 Synthesis of Butlerin A 
2,5-Dichloro-3,6-di(p-methoxyphenyl)-1,4-benzoquinone ( 6.31) 
p-Anisidine ( 4.89 g), dissolved in a solution of Cl 0 
hydrochloric acid (11 ml) and water (5 ml), was Meo 
diazotised by the dropwise addition of sodium 
nitrite (3.02 g) in water (7 ml) at 0-5 QC. 
0 Cl 
202 
OMe 
Sodium acetate was added portionwise until pH 3-5 was obtained and the diazonium 
chloride solution was then added to a solution of 2,5-dichloro-1,4-benzoquinone ( 6. 33) 
(7 .11 g) in ethanol (800 ml) at 0-5 QC. The resultant dark red solution was left stirring 
overnight. Unreacted quinone (3.02 g) was then collected and the filtrate diluted with 
water. After 3 h the resulting dark red precipitate (3.58 g) was filtered off and extracted 
with boiling methanol. Partial evaporation and aqueous dilution of the methanolic 
solution gave the aryl quinone, 2,5-dichloro-3-(p-methoxyphenyl)-1,4-benzoquinone 
( 1.78 g, 31 % ) as red needles. 
M.p. 135-136 QC (lit. 26 135-137 QC). 
lH NMR (CDC13) 8 3.87 (3H, s, ArOMe), 6.99 (2H, d, J = 8.9 Hz, ArH), 7.22 (lH, 
s, 6-H), 7.29 (2H, d, J = 8.8 Hz, ArH). 
The methanol insoluble residue afforded the title quinone 6. 31 ( 1.62 g, 21 % ) 
recrystallised from ethanol/ ethyl acetate as red brown needles. 
M.p. 258-259 QC (lit.27 258-259 QC). 
1H NMR (CDC13) 8 3.88 (6H, s, ArOMe) , 7.01, 7.35 (8H, 2d, J = 8.9 Hz, ArH). 
2-Chloro-5-hydroxy-3, 6-di-(p-methoxyphenyl )-1,4-benzoquinone ( 6.32) 
A solution of dichloroquinone 6. 31 (202 mg) Cl _O 
in dioxan (75 ml) was treated with potassium MeO 
carbonate (135 mg) in water (6 ml) and the 
resultant solution stirred at reflux for 1 h. 
0 OH 
OMe 
After this time, additional potassium carbonate ( 415 mg) was added portionwise and the 
solution was refluxed for a further 7 h. The solution was acidified, washed repeatedly 
with die thy 1 ether and the combined organic layer shaken with water and dilute ammonia. 
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The basic washings were then acidified, extracted with ethyl acetate, dried (MgSO4) and 
evaporated under reduced pressure. The monohydroxy quinone 6.32 (121 mg, 63%; 
86% from recovered starting material) recrystallised from aqueous methanol as chocolate 
brown needles. 
M.p. 207 - 208 °C. 
1H NMR (CDC13) 8 3.86, 3.87 (6H, 2s, ArOMe), 6.98, 7.01, 7.35, 7.48 (8H, 4d, J = 
8.9 Hz, ArH). 
EIMS mlz 374 (17%), 372 (59), 370 (M, 100), 344 (24), 342 (55), 335 (37), 251 (38). 
Analysis: C20H15O5Cl requires C, 64.8; H, 4.1 %. Found C, 64.8; H, 4.3%. 
2-B enzyloxy-5-chloro-3, 6-di(p-methoxyphenyl )-1,4-be nzoquinone (6.34) 
An excess of ethereal phenyldiazomethane, Cl 0 
prepared using the modified procedure of MeO 
Overberger and Anselme, 28 was added to a 
solution of the enol 6. 3 2 (79 mg) in 
0 OBn 
OMe 
anhydrous ether and the combined solution left to stand overnight. The residue obtained 
after evaporation of the excess phenyldiazomethane and solvent was purified using radial 
chromatography, eluting with 5% - 30% ethyl acetate /light petroleum to give the benzyl 
ether 6. 3 4 as an orange solid (94 mg, 96% ). Crystallisation from ethyl acetate/ light 
petroleum gave bright orange needles. 
M.p. 146 - 147 °C. 
1H NMR (CDC13) 8 3.87 (6H, 2s, ArOMe), 5.09 (2H, s, CH2Ph), 6.95, 7.01 (4H, 2d, 
J = 8.9 Hz, ArH), 7.11 - 7.15 (2H, m, Ph), 7.25 - 7.38 (7H, m, ArH). 
EIMS mlz 464 (11 %), 462 (36), 460 (M, 11), 426 (11), 371 (29), 341, (25), 336 (48), 
91 (100). 
Analysis: C27H21 OsCl requires C, 70.4; H, 4.6%. Found C, 70.5; H, 4.8%. 
5 '-Benzyloxy-2 '-chloro-3 ',4,4 ", 6 '-methoxy-p-terphenyl (6.35) 
The benzyloxyquinone 6.34 (60 mg) was Cl OMe 
dissolved in ether (20 ml) and shaken with a MeO 
fresh solution of sodium dithionite ( 100 mg) in 
water (30 ml). After several minutes, the 
MeO OBn 
OMe 
aqueous layer was drawn off and the near colourless ether solution was washed with 
brine and dried (MgSO4). The filtered solution was treated with an excess of ethereal 
Chapter8 204 
diazomethane and left to stand for 24 h. The residue obtained after removal of the 
diazomethane and evaporation of the solvent was dissolved in dry acetone and treated 
with anhydrous potassium carbonate ( 108 mg) and an excess of methyl iodide. This 
mixture was stirred for 24 h at ambient temperature then poured into dilute hydrochloric 
acid and extracted repeatedly with ethyl acetate. The combined organic phases were 
washed with water, brine and dried. Evaporation of the solvent gave the dimethyl ether 
6.35 (58 mg, 91 %) which crystallised from ethyl acetate/ light petroleum as colourless 
needles. 
M.p. 151 - 153 °c. 
1H NMR (CDC13) 8 3.45 (3H, s, OMe), 3.61 (3H, s, OMe), 3.88, 3.89 (6H, 2s, 4,4"-
OMe), 4.68 (2H, s, CH2Ph), 6.98, 7.02 (4H, 2d, J = 8.8 Hz, ArH), 7.00 - 7.30 (5H, 
m, ArH), 7 .32, 7 .41 ( 4H, 2d, I = 8.8 Hz, ArH). 
EIMS mlz 494 (22%), 492 (59), 490 (M, 100), 401 (32), 399 (64), 364 (100), 285 
( 4 5), 91 ( 100). 
Analysis: C29H27O5Cl requires C, 70.9; H, 5.5%. Found C, 70.7; H, 5.5%. 
2,5-Dimethoxy-3,6-di-(p-methoxyphenyl)phenol ( 6.37) 
The benzyloxychloro-p-terphenyl 6.35 (45 mg) 
was dissolved in a solution of formic acid (85%, MeO 
1 ml) and dimethylformamide (5 ml). 10% 
palladized charcoal (50 mg) was added and the 
Meo 
OMe 
OH 
OMe 
mixture stirred at reflux for 24 h. After cooling, the catalyst was filtered off and washed 
with ethyl acetate. The filtrate was then diluted with water and extracted repeatedly with 
ethyl acetate. The combined _organic phases were washed with water, saturated sodium 
bicarbonate solution, brine, dried (MgSO4) and evaporated under reduced pressure to 
give a mixture of 4-chloro-2,5-dimethoxy-3,6-di-(p-methoxyphenyl)phenol [1H NMR 
(CDC13) 8 3.35 (3H, s, 2'-OMe), 3.45 (3H, s, 5'-OMe), 3.87, 3.88 (6H, 2s, ArOMe), 
7.01, 7.01, 7.36, 7.46 (8H, 4d, J = 8.8 Hz, ArH)] and 2,5-dimethoxy-3,6-di-(p-
methoxyphenyl)phenol (6.37) in a ratio of approx. 2: 1. 
Further hydrodehalogenation was carried out by adding 10% palladized carbon ( 50 mg) to 
a solution of ammonium formate (18 mg) in water (0.5 ml) and ethanol (5 ml). The 
mixture of phenols (51 mg) was then dissolved in absolute ethanol (30 ml), added to the 
mixture and stirred at reflux for 48 h. The reaction mixture was then cooled and the 
~ 
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catalyst filtered off and washed with ethyl acetate. Dilution of the filtrate with water was 
followed by repeated extraction with ethyl acetate. The combined organic phases were 
washed with water, saturated sodium bicarbonate solution, brine, dried (MgSO4) and 
evaporated under reduced pressure to afford the title phenol 6.37 as a off-white solid (32 
mg, 88%). 
M.p. 183 - 184 °C, (lit. 29 181 - 182 °C). 
1H NMR (CDC13) 8 3.45 (3H, s, 2'-OMe), 3.75 (3H, s, 5'-OMe), 3.85, 3.87 (6H, 2s, 
4,4"-OMe), 6.45 (lH, s, 4'-H), 7.00, 7.00, 7.41, 7.59 (8H, 4d, J = 8.7 Hz, ArH). 
Butlerin A [3',4,4",6'-Tetramethoxy-p-terphenyl-2'-yl acetate] (6.16) 
A solution of the phenol 6. 3 7 · ( 15 mg) in acetic OMe 
anhydride (2 ml) and pyridine ( 1 ml) was stirred MeO 
at room temperature for 18 h. The solution was 
then diluted with water and extracted repeatedly 
MeO OAc 
OMe 
with ethyl acetate. The organic extract was washed with dilute hydrochloric acid, 
saturated sodium bicarbonate, water, brine and dried (MgSO4). Evaporation of the 
solvent under reduced pressure yielded butlerin A (6.16) (16 mg, 97%) as a white solid. 
M.p. 147 - 148 °C. 
1H NMR (CDC13) 8 2.08 (3H, s, 2'-COMe), 3.41 (3H, s, 3'-OMe), 3.75 (3H, s, 6'-
OMe), 3.85, 3.86 (6H, 2s, 4,4"-OMe), 6.81 (lH, s, 5'-H), 6.95, 6.98, 7.28, 7.58 (8H, 
4d, J = 8.9 Hz, ArH). 
EIMS mlz 408 (74%), 367 (41), 366 (M, 100), 351 (54), 320 (24), 243 (30). 
8. 7.2 Synthesis of Butlerin B 
2,5-Di-(p-methoxypheny 1)-1,4-benzoq uinone ( 6 .25) 
This compound was synthesised by a 
modification of the method of Pummerer and MeO 
Pren.30 
1,4-Benzoquinone (32.4 g, 0.30 mol) ( 6.24) 
0 
0 
OMe 
was partially dissolved in a solution of carbon disulfide (300 ml) and anisole ( 49.8 g, 
0.90 mol). The mixture was cooled to O °C and stirred vigorously while anhydrous 
aluminium chloride (80.4 g, 0.60 mol) was added portionwise over 0.5 h. The straw 
coloured solution became deep blue in colour and then slowly turned green-black. After 3 
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h the reaction mixture was poured into a stirred mixture of ice (600 g) and concentrated 
hydrochloric acid (75 g). The black precipitate, a mixture of the substituted quinone, 
hydroquinone and quinhydrone, was filtered and washed with hot water. The wet 
precipitate was dissolved in hot glacial acetic acid (900 ml) and the undissolved residue 
filtered off. The filtrate was oxidised by refluxing with anhydrous ferric chloride ( 102 g, 
0.36 mol) for 5 min. On cooling 2,5-di-(p-methoxyphenyl)-1,4-benzoquinone (6.25) 
precipitated as a red-brown solid (22.7 g, 24% ). This crude material was sufficiently 
pure to use in further preparations. A single recrystallisation using ethyl acetate and 
toluene gave the pure quinone 6.25 as red-brown crystals. 
M.p. 231-232 °C (lit.30 m.p. 231 °C). 
1H NMR (CDC13) 8 3.87 (6H, s, ArOMe), 6.91(2H, s, H3, H6), 6.98 (4H, d, J = 8.9 
Hz, 4H ArH), 7.55 (4H, d, J = 8.9 Hz, ArH). 
2,5-Di-(p-methoxyphenyl)benzene-1,4-diol (6.41) 
This compound was prepared by a modification OH 
of the procedure of Shildneck and Adams.31 Meo OMe 
A mixture of the quinone 6.25 (4.5 g), HO 
stannous chloride (9.0 g), concentrated hydrochloric acid (9.0 ml) and acetone (130 ml) 
was stirred for 2 h at room temperature. An exothermic reaction followed and the colour 
of the solution changed from red to a bluish-green to a pale khaki. The hydroquinone 
6.41 ( 4.1 g, 90%) precipitated as a colourless solid. 
M.p. 208-209 °C (lit.3 1 m.p. 210 °C). 
1H NMR (CDC13) 8 3.86 (6H, s, ArOMe), 6.86 (2H, s, H3, H6), 7.03 (4H, d, J = 8.8 
Hz, ArH), 7.44 (4H, d, J = 8..7 Hz, ArH). 
2,5-Dibromo-3,6-di-(p-methoxyphenyl)-1,4-benzoquinone ( 6.40) 
This compound was synthesised by a tjr_ 0 
modification of the method of Shildneck and MeO OMe 
Adams. 31 0 Br 
A solution of the hydroquinone 6.41 (4.0 g) in 
glacial acetic acid (2 L) was prepared by gentle heating and stirring. The warm solution 
was cooled to 25 °C. A solution of bromine (2.56 ml, 4 equivalents) in glacial acetic acid 
(20 ml) was then added with stirring over a period of 1 h. After stirring overnight, the 
resulting 2,5-dibromo-3,6-di-(p-methoxyphenyl)benzene-1,4-diol, was obtained as a 
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colourless solid, 1H NMR (CDC13) 8 3.89 (6H, s, ArOMe), 7.06 (4H, d, J = 8.8 Hz, 
ArH), 7 .29 ( 4H, d, J = 8.8 Hz, ArH). This compound was then oxidised to the 
corresponding quinone 6.40 by adding ferric chloride (2.0 g) and refluxing for 3 h. The 
solution was cooled and the product left to precipitate overnight. The solid was filtered, 
then water (200 ml) was added to the filtrate and a second batch of crystals was filtered 
and the combined product air dried. 2,5-Dibromo-3,6-di-(p-methoxyphenyl)-1,4-
benzoquinone 6.40 was obtained as polymorphic reddish brown crystals (2.86 g, 58% ). 
M.p. 285-288 °C (lit.31 m.p. 282-283 °C). 
lH NMR (CDC13) 8 3.88 (6H, s, ArOMe), 7.01 (4H, d, J = 8.9 Hz, ArH), 7.34 (4H, 
d, J = 8.9 Hz, ArH). 
2-Bromo-5-hydroxy-3,6-di-(p-methoxyphenyl)-1,4-benzoquinone (6.42) 
A solution of dibromo quinone 6.40 (210 mg) Br. 0 
in dioxan (7 5 ml) was treated with potassium MeO 
carbonate (140 mg) in water (6 ml) and the 
resultant solution stirred at reflux for 1 h. After 
0 OH 
OMe 
this time, additional potassium carbonate ( 430 mg) was added portion wise and the 
solution was refluxed for a further 6 h. The solution was acidified, washed repeatedly 
with die thy 1 ether and the combined organic layers shaken with water and dilute ammonia. 
The basic washings were then acidified, extracted with ethyl acetate, dried (MgSO4) and 
evaporated under reduced pressure. The monohydroxy quinone 6.42 (93 mg, 51 %; 
89% from recovered starting material) recrystallised from aqueous methanol as chocolate 
brown needles. 
M.p. 215 - 217 °C. 
1H NMR (CDC13) 8 3.86, 3.87 (6H, 2s, ArOMe), 6.98, 7.01 (4H, 2d, I= 9.0 Hz, 
ArH); 7.33, 7.48 (4H, 2d, J = 8.9 Hz, ArH). 
EIMS mlz 418 (26%) 416 (100), 414 (M, 81), 388 (36), 386 (36), 372 (32), 370 (35), 
335 (51), 251 (59). 
HREIMS mlz M+ 414.0105 (calcd for C20H1sOs79Br 414.0103). 
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5-Bromo-3,6-di-(p-methoxyphenyl)-l,4-benzoquinone-2-yl acetate (6.43) 
A mixture of the hydroxyquinone 6.42 (75 
mg), acetic anhydride ( 4 ml) and concentrated MeO 
sulfuric acid ( 1 drop) was stirred at room 
temperature overnight, then diluted with water 
0 
OMe 
OAc 
and extracted repeatedly with ethyl acetate. The organic extract was washed in tum with 
water, dilute sodium hydrogen carbonate solution, brine and dried (MgSO4). 
Evaporation of the solvent under reduced pressure afforded the title acetate 6.43 as an 
orange solid (76 mg, 92% ). Crystallisation from ethyl acetate/ light petroleum gave bright 
orange needles. 
M.p. 195 - 196 °C. 
1H NMR (CDC13) 8 2.25 (3H, s, COMe), 3.86 (3H, 2s, ArOMe), 6.98, 6.99 (4H, 2d, 
J = 8.l Hz, ArH), 7.32, 7.33 (4H, 2d, J = 8.9 Hz, ArH). 
EIMS mlz 460 (3%), 458 (5), 456 (M, 3), 418 (20), 416 (100), 414 (81), 388 (22), 386 
(22), 372 (20), 370 (32), 335 (30). 
HREIMS mlz M+ 456.0204 (calcd for C22H17O679Br 456.0208). 
Butlerin B [3 ',4,4 ",S '-Tetramethoxy-p-terphenyl-2 '-yl acetate] (6.17) 
10% Palladized charcoal (40 mg) and OMe 
triethylamine (20 µl) were added to a solution of MeO OMe 
the acetate 6.43 (45 mg) in ethyl acetate (15 ml) AcO OMe 
and the reaction mixture stirred in an inert 
atmosphere of hydrogen for 48 h. The catalyst was removed by filtration and washed 
with ethyl acetate. The filtrate was then washed with water, brine, dried (MgSO4) and 
evaporated under reduced pressure to give a mixture of 3',5'-dihydroxy-4,4"-dimethoxy-
p-terphenyl-2'-yl acetate (6.39) [1H NMR (CDCl3) 8 2.13 (3H, s, 2'-COMe), 3.85, 
3.87 (6H, 2s, 4,4"-OMe), 6.60 (lH, s, 6'-H), 6.94, 7.09, 7.38, 7.39 (8H, 4d, J = 8.9 
Hz, ArH)] and 3',6'-dihydroxy-4,4"-dimethoxy-p-terphenyl-2'-yl acetate (6.38) [1H 
NMR (CDC13) 8 2.05 (3H, s, 2'-COMe), 3.86, 3.87, (6H, 2s, 4,4"-OMe), 6.84 (lH, s, 
5'-H; 7.01, 7.03, 7.30, 7.47 (8H, 4d, J = 8.9 Hz, ArH)] in a ratio of approx. 9:1. The 
mixture of dials [6.38 and (6.39] was immediately dissolved in anhydrous ether, treated 
with an excess of ethereal diazomethane and left to stand overnight. The residue obtained 
after evaporation of the residual diazomethane and solvent was dissolved in dry acetone 
(20 ml) and treated with anhydrous potassium carbonate ( 40 mg) and an excess of methyl 
I 
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iodide. The reaction mixture was stirred at room temperature for 24 h then poured into 
dilute hydrochloric acid and extracted repeatedly with ethyl acetate. The organic phase 
was washed with brine, dried (MgSO4) and evaporated under reduced pressure to give 
butlerin B (6.17) as an off white solid (37 mg, 93%). Recrystallisation from ethyl 
acetate/ light petroleum gave colourless crystals. 
M.p. 163-164 °C. 
1H NMR (CDC13) 8 2.16 (3H, s, 2'-COMe), 3.36 (3H, s, 3'-OMe), 3.76 (3H, s, 5'-
OMe), 3.85, 3.86 (6H, 2s, 4,4"-OMe), 6.72 (lH, s, 6'-H), 6.97, 6.98, 7.41, 7.42 (SH, 
4d, J = 8.9 Hz, ArH). 
EIMS mlz 408 (47%), 378 (54), 366 (100), 348 (10), 336 (89), 321 (21), 306 (26), 
291 (16), 132 (17). 
8. 7.3 Second Synthesis of Butlerin B 
2 ,5-Dihydroxy-3 ,6-di-(p-methoxypheny 1)-1,4-benzoq uinone ( 6.45) 
This compound was synthesized according to HO 0 
the general directions of Shildneck and MeO-</ \)--(/ 1)--{t \)-OMe 
Adams. 31 
0 OH 
A solution of the dibromo-benzoquinone 6. 4 0 
(2.00 g) in methanol (200 ml) and 10% sodium hydroxide (200 ml) was stirred at room 
temperature for 48 h. The purple sodium salt of the required dihydroxyquinone was 
filtered off and separated from the unreacted starting material by dissolving it with water 
(500 ml). The permanganate coloured filtrate was acidified with glacial acetic acid and 
heated to reflux. The golden-brown flocculent precipitate was filtered under gentle 
suction and washed with hot water to give the quinone 6.45 (1.16 g, 78%), as a bronze 
solid. 
M.p. 297-299 °C (lit.3 1 m.p. 297-298 °C). 
lH NMR (CDC13) 8 3.86 (6H, s, ArOMe), 7.00 (4H, d, J = 8.5 Hz, ArH), 7.53 (4H, 
d, J = 8.5 Hz, ArH), 8.13 (2H, s, 2,5-OH). 
3, 6-Di-(p-methoxyphenyl)-1,4-benzoquinone-2,5-diyl acetate ( 6.46) 
Concentrated sulfuric acid (2 drops) was added AcO 0 
to a stirred mixture of the dihydroxyquinone MeO 
6.45 (0.57 g) in acetic anhydride (8 ml). 
Within minutes the acetylated product 6 . 4 6 
0 OAc 
OMe 
·~ 
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began precipitating as a bright orange solid. Stirring was continued overnight to ensure 
complete conversion. The suspension was diluted with water and filtered under vacuum 
to yield 3,6-di-(p-methoxyphenyl)-1,4-benzoquinone-2,5-diyl acetate (6.46) (0.64 g, 
91 % ) as a bright orange solid. The product was recrystallised from ethyl 
acetate/cyclohexane to give bright orange needles. 
M.p. 224-226 °C. 
1H NMR (CDC13) 8 2.24 (6H, s, OCOMe), 3.85 (6H, s, ArOMe), 6.96 (4H, d, J = 9.0 
Hz, ArH), 7.32 (4H, d, J = 8.9 Hz, ArH). 
EIMS mlz 438 (M+2, 3% ), 436 (1), 394 (12), 352 (100), 324 (22), 267 (6), 203 (6), 
148 (8), 119 (13). 
Analysis: C24H2oO8 requires C, 66.05; H 4.62%. Found C, 66.25; H, 4.44%. 
3-Hydroxy-4, 4, 6-trimethoxy-2, 5-di-(p-methoxyp he ny l )-2, 5-
cyclohexadie none (6.44) 
A mixture of the diacetoxyquinone 6.46 (0.50 
g) and 1 M methanolic potassium hydroxide MeO 
(10 ml) was stirred for 2 h at room 
temperature. The resultant dark brown-green 
MeO 0 
OMe 
solution was acidified using dilute hydrochloric acid. The red-brown solid which 
precipitated out of the solution was filtered and air-dried. Recrystallisation from ethyl 
acetate/cyclohexane gave 3-hydroxy-4, 4, 6-trimethoxy-2, 5-di-(p-methoxyphenyl )-2, 5-
cyclohexadienone (6.44) (0.37 g, 78%) as yellow orange prisms. 
M.p. 167 °C, dee. 204 °C. 
1H NMR (CDC13) 8 3.27 (6:fl, s, 6-OMe), 3.69 (3H, s, 2-OMe), 3.84 (3H, s, ArOMe), 
3.86 (6H, s, ArOMe), 6.38 (lH, s, 4-OH), 6.82 (2H, d, J = 9.0 Hz, ArH), 6.97 (2H, d, 
J = 9.0 Hz, ArH), 7.38 (2H, d, J = 8.9 Hz, ArH), 7.71 (2H, d, J = 9.0 Hz, ArH). 
EIMS mlz 412 (6%), 397 (9), 382 (92), 352 (100), 335 (49), 323 (14), 309 (64), 281 
(84), 267 (17), 251 (14), 238 (26), 223 (31), 191 (18), 176 (25), 159 (17), 147 (25), 
135 (20), 119 (34). 
Analysis: C23H24O7 requires C, 66.98; H 5.87%. Found C, 67.09; H, 5.90%. 
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2,4-Dimethoxy-3, 6-di-(p-methoxyphenyl)phenol ( 6.4 7) 
A solution of the acetal 6.44 (188 mg) in ether 
(30 ml) was added slowly to a stirred MeO 
suspension of lithium aluminium hydride ( 15 
mg) in ether (10 ml). After the addition was 
HO 
211 
OMe 
OMe 
OMe 
complete the mixture was refluxed for 1 h. Dilute ammonium chloride (20 ml) was added 
dropwise to the cooled suspension followed by dilute hydrochloric acid (20 ml). The 
ether phase was separated, washed with water, brine, dried (MgSO4) and evaporated. 
Preparative layer chromatography was used to purify the crude product. The major band 
obtained was recrystallised from ethyl acetate/cyclohexane to give the title phenol 6. 4 7 
(96 mg, 57%) as colourless prisms. 
M.p. 139-140 °c. 
1 H NMR (CDC13) 8 3.37 (3H, s, 2'-OMe), 3.72 (3H, s, 4'-OMe), 3.87 (3H, s, 
ArOMe), 5.74 (lH, s, 1-OH), 6.71 (lH, s, 5'-H), 6.99, 7.01 (4H, 2d, I= 8.0 Hz, 
ArH), 7.43, 7.61 (4H, 2d, J = 8.9 Hz, ArH). 
EIMS mlz 366 (100%), 351 (10), 336 (21), 320 (16), 305 (10), 291 (16), 288 (11), 
24 3 ( 11), 18 3 ( 13). 
Analysis: C22H22Os requires C, 72.1; H 6.1 %. Found C, 71.9; H, 6.2%. 
Butlerin B [3' ,4,4" ,5'-Tetramethoxy-p-terphenyl-2'-yl acetate] (6.17) 
The phenol 6. 4 7 (81 mg) was stirred in a OMe 
solution of acetic anhydride (2 ml) and pyridine MeO 
( 1 ml) for 24 h. The solution was then diluted 
with water and extracted repeatedly with ethyl 
AcO OMe 
OMe 
acetate. The organic extract was washed with dilute hydrochloric acid, dilute sodium 
hydrogen carbonate solution, brine and dried (MgSO4). Evaporation of the solvent 
yielded butlerin B (6.17) (82 mg, 99%) as a buff coloured solid. The crude product was 
recrystallised from ethyl acetate/ cyclohexane to give fine colourless needles. 
M.p. 164-165 °C, identical (TLC, 1H NMR, EIMS, m.p.) with synthetic sample 
obtained above. 
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8. 7.4 Synthesis of Butlerin C 
2-Bromo-3,6-di(p-methoxyphenyl)-l,4-benzoquinone (6.52) 
2-chloro-3,6-di(p-methoxyphenyl)-l,4-benzoquinone (6.53) 
A solution of 2,5-di-(p-methoxyphenyl)benzene- 0 
1,4-diol (6.41) (1.88 g) in glacial acetic acid (1 Meo 
L) was prepared by gentle heating and stirring. 
After cooling, a solution of bromine ( 1.02 g) in 
0 X X = Br, Cl 
212 
and 
glacial acetic acid ( 15 ml) was added over a period of 1 h and the solution stirred 
overnight. Ferric chloride (3 .45 g) was added and the solution was then refluxed for 2 h, 
cooled and diluted with water. The reddish brown needles which precipitated out of 
solution were filtered off and air dried to give a mixture of 2-bromo-3,6-di-(p-
methoxyphenyl)-1,4-benzoquinone ( 6.52) and 2-chloro-3,6-di-(p-methoxyphenyl)-1,4-
benzoquinone (6.53) in a ratio of approx. 2: 1 (1.09 g). 
2-Bromo-3 ,6-di-(p-methoxypheny 1)-1,4-benzoquinone ( 6.52): 
lH NMR (CDC13) 8 3.87 (3H, s, ArOMe), 6.94 (lH, s, 5-H), 6.98, 7.00, 7.31, 7.54 
(8H, 4d, J = 8.9 Hz, ArH). 
EIMS rn/z 402 (52%), 400 (80), 398 (M, 54), 319 (100) 288 (71). 
HREIMS mlz M+ 398.0152 (calcd for C20H15O479Br 398.0154). 
2-Chloro-3,6-di-(p-methoxyphenyl)-1,4-benzoquinone (6.53): 
1H NMR (CDCl3) 8 3.87 (3H, s, ArOMe), 6.94 (lH, s, 5-H), 6.99, 7.01, 7.34, 7.55 
(8H, 4d, J = 8.9 Hz, ArH). 
EIMS rn/z 358 (38%) 356 (92), 354 (M, 78), 319 (100) 288 (71). 
HREIMS mlz M+ 354.0647 (calcd for C20H1sO435Cl 354.0659). 
2-Benzyloxy-3, 6-di(p-methoxyphenyl )-1,4-benzoquinone (6.55) 
A solution of the haloquinone mixture [ 6. 5 2, 0 
6.53] (110 n1g) in anhydrous dimethyl MeO 
sulfoxide (5 ml) was added to a stirred solution 
of sodium (10 mg) dissolved in benzyl alcohol 
0 OBn 
OMe 
(2 ml, freshly distilled) under an atmosphere of dry nitrogen. The reaction mixture was 
stirred for 15 h and diluted with ethyl acetate. The solution was then washed with 10% 
! 
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hydrochloric acid, brine, dried (MgSO4) and the solvent removed by evaporation under 
reduced pressure. The residue obtained was purified using radial chromatography 
(SiO2), eluting with 2.5% - 30% ethyl acetate/ light petroleum to give the benzyl ether 
6.55 (67 mg, 27% from 6.41) as bright red orange crystals. 
M.p. 176 - 178 °C. 
1H NMR (CDC13) 8 3.86, 3.87 (6H, 2s, ArOMe), 5.06 (2H, s, OCH2Ph), 6.83 (lH, 
s, 5-H), 6.95, 6.98 (4H, 2d, J = 8.8 Hz, ArH) 7.14 - 7.28 (SH, m, C6H5), 7.30, 7.51 
( 4H, 2d, J = 8.8 Hz, ArH). 
EIMS mlz 426 (M, 50%), 337 (53), 307 (100), 252 (46), 91 (100). 
Analysis: C27H22Os requires C, 76.0; H 5.2%. Found C, 76.0; H, 5.2%. 
3 '-Benzyloxy-4,4 "-methoxy-p-terphenyl-2 ',5'-diyl diacetate (6.56) 
The benzyloxyquinone 6.55 (20 mg) was OAc 
dissolved in ether (20 ml) and shaken with a MeO 
fresh solution of sodium dithionite (7 5 mg) in 
water (30 ml). After a few minutes, the aqueous 
AcO OBn 
OMe 
layer was drawn off and the near colourless ether solution was washed with brine and 
dried (MgSO4). The residue obtained on evaporation of the solvent was stirred in a 
solution of acetic anhydride (3 ml) and pyridine (2 ml) for 20 h. The solution was then 
diluted with water and extracted repeatedly with ethyl acetate. The organic extract was 
washed with dilute hydrochloric acid, saturated sodium bicarbonate, water, brine, and 
dried (MgSO4). Evaporation of the solvent under reduced pressure yielded the diacetate 
6.56 (21 mg, 87%) as an off white solid. Crystallisation from ethyl acetate /light 
petroleum gave the diacetate 6.56 as colourless needles. 
M.p. 113 - 115 °C. 
lH NMR (CDC13) 8 2.01 (3H, s, 2'-COMe), 2.05 (3H, s, 5'-COMe), 3.86, 3.87 (6H, 
2s, 4,4"-OMe), 4.48 (2H, s, 3'-OCH2Ph), 6.97 (lH, s, 6'-H), 6.95 (2H, d, J = 8.6 Hz, 
ArH), 6.98 (2H, d, J = 8.3 Hz, ArH), 7.03 - 7.09, 7.23 - 7.28 (SH, 2m, C6Hs), 7.39 
(2H, d, J = 8.3 Hz, ArH), 7 .40 (2H, d, J = 8.5 Hz, ArH). 
EIMS mlz 512 (27%), 470 (6), 428 (34), 337 (100), 91 (44). 
HREIMS mlz M+ 512.1843 (calcd for C31H2sO7 512.1835). 
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Butlerin C [3' ,4,4 "-Trimethoxy-p-terphenyl-2' ,6' -diyl diacetate] (6.18) 
10% Palladized charcoal (20 mg) was added to a OAc 
solution of the diacetate 6.56 (13 mg) in ethyl MeO 
acetate (15 ml) and the reaction mixture stirred in 
an inert atmosphere of hydrogen. The 
Meo OAc 
OMe 
hydrogenolysis was monitored by TLC and after 20 mins the catalyst was removed by 
filtration and the filtrate evaporated under reduced pressure to give a mixture of 3 ' -
hydroxy-4,4"-dimethoxy-p-terphenyl-2',5'-diyl diacetate 6.57 (approx. 60%) [1H NMR 
(CDCl3) 8 1.98 (3H, s, 5'-COMe), 2.16 (3H, s, 2'-COMe), 3.86 (6H, 2s, 4,4"-OMe), 
6.74 (lH, s, 6'-H), 6.94, 7.01, 7.31, 7.39 (8H, 4d, J = 8.9 Hz, ArH)] and 3'-hydroxy-
4,4"-dimethoxy-p-terphenyl-2',6'-diyl diacetate 6.58 (approx. 40%) [1H NMR (CDC13) 
8 1.98 (3H, s, 6'-COMe), 2.05 (3H, s, 2'-COMe), 3.86 (6H, 2s, 4,4"-OMe), 6.74 (lH, 
s, 5'-H), 6.93, 7.01, 7.23, 7.47 (8H, 4d, J = 8.9 Hz, ArH)] as a colourless solid (11 
mg, 99% ). The isomeric mixture was then dissolved in anhydrous ether, treated with an 
excess of ethereal diazomethane and left to stand overnight. The residue obtained after 
evaporation of the residual diazomethane was dissolved in dry acetone (20 ml) and stirred 
with anhydrous potassium carbonate ( 40 mg) and an excess of methyl iodide at room 
temperature for 24 h. The reaction was then poured into dilute hydrochloric acid and 
extracted repeatedly with ethyl acetate. The organic phase was washed with brine, dried 
(MgSO4) and evaporated under reduced pressure. Preparative TLC using 20% ethyl 
acetate/ light petroleum as eluant yielded two major bands. The slower moving band 
afforded a mixture (11 mg, 92%) of 3',4,4"-trimethoxy-p-terphenyl-2',5'-diyl diacetate 
(6.59) (approx. 70%) and butlerin C (6.18) (approx. 30% ). 
The less polar band contained 4,4",5',6'-tetramethoxy-p-terphenyl-2'-yl acetate (6.60) 
as a colourless oil (1 mg, 8% ): 
1H NMR (CDC13) 8 1.99 (3H, s, 2'-COMe), 3.65 (6H, 2s, 5',6'-OMe), 3.86 (3H, 2s, 
4,4"-OMe), 6.86 (lH, s, 3'-H), 6.95, 6.96, 7.29, 7.51 (8H, 4d, J = 8.5 Hz, ArH). 
EIMS mlz 408 (55%), 366 (100), 351 (32). 
HREIMS mlz M+ 408.1578 (calcd for C24H24O6 408.1573). 
Repeated preparative thin-layer chromatography using high performance plates with 15% 
ethyl acetate/ light petroleum as eluant was used to separate the mixture of isomers 6 .18 
~: 
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and 6. 5 9. Recrystallisation of the fas test moving band from dichloromethane /light 
petroleum yielded butlerin C (6.18) as colourless crystals: 
M.p. 160 - 161 °c, (lit.32 169 - 170 °C). 
1 H NMR (CDC13) 8 1.99 (3H, s, 6'-COMe), 2.07 (3H, s, 2'-COMe), 3.45 (3H, s, 
3'-OMe), 3.85 (6H, 2s, 4,4"-OMe), 6.92, 6.96 (4H, 2d, J = 8.8 Hz, ArH), 7.0l(lH, s, 
5'-H), 7.22, 7.56 (4H, 2d, J = 8.7 Hz, ArH). 
8. 7.5 Synthesis of 3 ',4,4 ''-Trimethoxy-p-terphenyl-2 ',5 '-diyl diacetate 
2-M ethoxy-3, 6-di(p-methoxyphenyl)-1,4-benzoquinone (6.61) 
Sodium in methanol (63.5 mM, 2.65 ml) was 0 
added dropwise with stirring to a solution of the MeO 
halides [6.52, 6.53] (50 mg) in methanol (300 
ml) and the resultant solution stirred at room 
0 OMe 
OMe 
temperature for 30 min. Evaporation of the solvent to incipient separation and cooling 
afforded the methoxyquinone (6.61) [41 mg, 44% overall from diol (6.41); three steps] 
as red needles. 
M.p. 155-156 °C (lit. 29 155-156 °C). 
1H NMR (CDC13) 8 3.81 (3H, s, 2-OMe), 3.85, 3.86 (6H, 2s, ArOMe), 6.85 (lH, s, 
5-H), 6.97, 6.98, 7.32, 7.53 (8H, 4d, J = 9.0 Hz, ArH). 
3 ',4,4 "-Trimethoxy-p-terphenyl-2 ',5 '-diyl diacetate ( 6.59) 
10% Palladized charcoal (20 mg) was added to a 
solution of the methoxy quinone 6. 61 (33 mg) MeO 
in ethyl acetate (20 ml) and the reaction mixture 
stirred in an inert atmosphere of hydrogen for 24 
AcO 
OAc 
OMe 
OMe 
h. The catalyst was filtered off and the residue obtained on evaporation of the solvent 
was stirred in a solution of acetic anhydride (3 ml) and pyridine (2 ml) for 24 h. The 
solution was then diluted with water and extracted repeatedly with ethyl acetate. The 
organic extract was washed with water, dilute hydrochloric acid, saturated sodium 
hydrogen carbonate solution, brine and dried (MgSO4). Evaporation of the solvent under 
reduced pressure yielded the title p-terphenyl 6.59 (44 mg, 97%) as a white solid. 
Crystallisation from dichloromethane/light petroleum gave the pure p-terphenyl 6. 5 9 as 
colourless needles. 
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M.p. 141-142 °c. 
1 H NMR (CDC13) 8 2.01 (3H, s, 2'-COMe), 2.17 (3H, s, 5'-COMe), 3.39 (3H, s, 
3'-OMe), 3.85 (6H, s, 4,4"-OMe), 6.92 (lH, s, 6'-H), 6.94, 6.95, 7.33, 7.38 (8H, 4d, 
J = 8.9 Hz, ArH). 
EIMS mlz 436 (45%), 394 (27), 352 (100). 
Analysis: C2sH24O7 requires C 68.8; H 5.5%. Found C 69.0; H, 5.7%. 
I 
i 
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8.8 Experimental for Chapter 7 
8.8.1 Lichen Material 
The foliose lichen Xanthoparmelia scabrosa (Taylor) Hale was collected from the head of 
a coastal cliff face in Lilli Pilli, south east of Batemans Bay, New South Wales, Australia 
in 1996 by J. A. Elix and the author. A voucher specimen is deposited in the herbarium 
of the Australian Botanic Garden Herbarium, Canberra. 
8.8.2 Extraction and Isolation 
The air dried lichen thallus ( 105 g) was separated from adhering soil and rock and 
extracted in a Soxhlet extractor with anhydrous ether (2 L) for 68 h. Evaporation of the 
ethereal solution under reduced pressure to one quarter of the initial volume afforded a 
pale green solid (0.98 g). Flash chromatography of a portion of the crude mixture (508 
mg) using toluene/ acetic acid (85: 15) as eluent yielded the known cortical pigment usnic 
acidl5 (7.10) (222 mg), a number of fractions containing scabrosin esters (7 .5) - (7 .9) 
(274 mg) and the known depsidone norlobaridone21 (7 .11) (9 mg). Further flash 
chromatography of the scab rosin mixture eluting with ethy 1 acetate/ light petroleum ( 1: 1) 
afforded scabrosin dibutyrate (7.7) (37 mg), scabrosin acetate hexanoate (7 .8) (81 mg), 
scabrosin acetate butyrate (7.6) (120 mg) and scabrosin diacetate (7.5) (12 mg). A fifth 
previously unknown scabrosin ester, scabrosin butyrate hexanoate (7 .9) (1 mg), was 
also obtained from the crude scabrosin mixture using preparative TLC. 
Scabrosin diacetate [(laS ,2S ,4aR ,6aS ,6bR, 7aS ,8S ,lOaR ,12aS ,12bR)-
la,2,6a,6b, 7 a,8, 12a, 12-octahydro-5,11-dioxo-5H, 11H-4a, 1 Oa-epidithio-4 
H, 1 OH-bisoxireno[g,g' ]pyrazino [ 1,2-a: 4,5-a' ]diindol-2,8-diy l 
(7.5) 
acetate] 
Scabrosin diacetate (7 .5) was obtained as a Me~O 
14 I 3 
white solid. oy~ 
M.p. 260 °C dee (lit.33 m.p. 262°C). 
1H NMR (CDCl3) 8 2.15 (6H, s, OCOCH3), 
2.82 (2H, d, J = 16.5 Hz, 4,10-H), 3.64 (2H, 
t, J = 4.3 Hz, la,7a-H), 3.71 (2H, dd, J = 
4 
7a 
8 
9~0 
10 9 I 15 
00Me 16 
I 
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1.9, 16.5 Hz, 4,10-H), 4.35, (2H, d, J = 3.3 Hz, 6b,12b-H), 4.44 (2H, bs, 6a,12a-H), 
5.69 (2H, t, J = 5.5 Hz, 2,8-H), 5.91 (2H m, 3,9-H). 
EIMS m/z [M+-S2] 440 (60), 380 (26), 320 (35), 318 (100), 302 (46), 160 (52). 
Scabrosin acetate butyrate [(laS ,2S ,4aR ,6aS ,6bR, 7aS ,SS ,lOaR ,12aS, 
12bR )-8-(acetyloxy)-la,2,6a,6b, 7a,8,12a,12-octahydro-5,ll-dioxo-SH, 11 
H-4a,1 Oa-epidithio-4H, lOH-bisoxireno[g,g' ]pyrazino[l,2-a :4,5-a' ]diindol 
-2-yl butyrate] (7.6) 
Scabrosin acetate butyrate (7.6) 
recrystallised from benzene/ ethanol as 
colourless needles. 
M.p. 216 - 217 QC (lit.33 m.p. 216.5 -
217.5 QC). 
CD (CHCl3) Amax 223 (~£, -610) and 260 
(+228) nm. 
~o 
1b 14 r 3 
0 .... 2 ./"~ 4 
10 
1 H NMR (CDCl3) 8 0.96 (3H, t, J = 7 .5 Hz, OCOCH2CH2CH3), 1.66 (2H, sext, l = 
7.5 Hz, OCOCH2CH2CH3), 2.10 (3H, s, OCOCH3), 2.35 (2H, dt, J = 1.5, 7.5 Hz, 
OCOCH2CH2CH3), 2.85 (2H, d, J = 16.65 Hz, 4,10-Ha), 3.59 (2H, d, J = 3.4, 4.6 
Hz, la,7a-H), 3.72 (2H, dd, J = 0.8, 2.6, 16.5 Hz, 4,10-H~), 4.26, (2H, d, J = 3.4 Hz, 
6b,12b-H), 4.41 (2H, bs, 6a,12a-H), 5.65 (2H, m, J = 4.6, 5.7 Hz, 2,8-H), 5.91 (2H 
m, J = 2.6, 2.8, 5.7 Hz, 3,9-H). 
13C NMR (CDC13) 8 172.71 (C-13), 170.08 (C-17), 162.49 (C-5, C-11), 137.32 and 
137.27 (C-3a, C-9a), 119.79 and 119.65 (C-3, C-9), 75.61 (C-4a, C-l0a), 64.63 and 
64.39 (C-2, C-8), 55.84 and 55.80 (C-6a, C-12a), 54.57 (C-6b, C-12b ), 50.66 and 
50.61 (C-la, C-7a), 36.43 (C-4, C-10), 35.36 (C-14), 20.16 (C-18), 18.06 (C-15), 
13.00 (C-16). 
gHMQC (1H-13C correlations): 8 0.96 - 13.00 (OCOCH2CH2CH3 - C-16), 1.66 -
18.06 (OCOCH2CH2CH3 - C-15), 2.10 - 20.16 (OCOCH3 - C-18), 2.35 - 35.36 
(OCOCH2CH2CH3 - C-14), 2.85 - 36.43 (4,10-Ha - C-4,10), 3.59 - 50.61/50.66 
(la,7a-H, C-la,7a), 3.72 - 36.43 (4,10-H~ - C-4,10), 4.26 - 54.57 (6b,12b-H - C-
6b,12b), 4.41 - 55.80/55.84 (6a,12a-H - C-6a,12a), 5.65 - 64.39/64.63 (2,8-H - C-
2,8), 5.91 - 119.65/119.79 (3,9-H - C-3,9). 
gHMBC (1H-13C correlations): 8 la,7a-H to (C-2, C-8 -2), (C-3, C-9 -3); 2,8-H to (C-
3, C-9 - 2), (C-3a, C-9a -3), (C-13, C-17 -3); 3,9-H to (C-la, C-7a - 3), (C-4, C-10 -3), 
I 
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(C-12a, C-6a -3); 4,10-Ha to (C-3a, C-9a - 2), (C-4a, C-l0a - 2) , (C-3, C-9 -3), (C-12a, 
C-6a -3); 4,10-H~ to (C-3a, C-9a - 2), (C-4a, C-l0a - 2), (C-3, C-9 -3), (C-5 , C-11 -3); 
6a,12a-H to (C-6b, C-12b - 2), (C-7a, C-la - 3), (C-9, C-3 -3), (C-9a, C-3a -3); 6b,12b-
H to (C-6a, C-12a - 2), (C-9a, C-3a - 3); 14-H to (C-13 -3) , (C-15 -2), (C-16 -3); 15-H 
to (C-13 -3), (C-15 -2), (C-16 -3); 16-H to (C-14 -3), (C-15 -2); 18-H to (C-17 - 2). 
COSY (1H-1H correlations): 8 la,7a-H to (2,8-H -3), (12b,6b-H -3); 2,8-H to (la,7a-H 
-3), (3,9-H -3); 3,9-H to (2,8-H -3), (4,10-H~, -4), (12a,6a-H -4); 4,10-Ha to (4,10-
H~, -2), (12a,6a-H, -4w); 4,10-H~ to (3,9-H, 4), (4,10-Ha, -2), (12a,6a-H, -4); 12a,6a-
H to (3,9-H - 4), (4,10-Ha - 4), (4,10-H~ -4w); 12b,6b-H to (12a,6a-H - 3); 14-H to 
(15-H -3); 15-H to (14H -3), (16H -3); 16-H to (15-H - 3). 
NOESY (1H-1H correlations): la,7a-H to (2,8-H), (12b,6b-H); 2,8-H to (la,7a-H), 
(3,9-H); 3,9-H to (2,8-H), (4,10-Ha); 4,10-Ha to (4,10-H~), (3,9-H); 4,10-H~ to (4,10-
Ha); 12a,6a-H to(-); 12b,6b-H to (la,7a-H); 14-H to (15-H); 15-H to (14H), (16H); 16-
H to (15-H). 
SERF (1H-1H correlations): 311a-H,2-H 4.65 Hz, 312-H,3-H 5.69 Hz, 4J3-H,12a-H 2.82 Hz, 
3112a-H 12b-H 0.80 Hz. 
' 
gHMBC (1H-15N correlations): 4,10-Ha to (N-6 -3); 6b,12b-H to (N-6 -3). 
EIMS m/z [M+-S2] 468 (100), 446 (18), 408 (12), 380 (34), 320 (20), 149 (79). 
Scabrosin dibutyrate [ (laS ,2S ,4aR ,6aS ,6bR, 7aS ,8S ,lOaR ,12aS ,12bR )-
la,2,6a,6b, 7 a,8, 12a,12b-octahydro-5, 11-dioxo-SH, 11H-4a, 10a-epidithio-
4H, lOH-bisoxireno[g,g' ]pyrazino[l,2-a :4,5-a' ]diindol-2,8-diyl butyrate 
(7.7) 
Scabrosin dibutyrate ( 7. 7) recrystallised H7C3'f O 
3 
from benzene/ ethanol as colourless needles. or 
M.p. 197-198 °C (lit.33 m.p. 196-197 °C). 
1H NMR (CDCl3) 8 0.98 (6H, t, I= 7.5 
Hz, OCOCH2CH2CH3), 1.69 ( 4H, sext, I= 
7 .4 Hz, OCOCH2CH2CH3), 2.38 ( 4H, dt, I 
4 
10 
= 2.3, 7.5 Hz, OCOCH2CH2CH3), 2.82 (2H, d, J = 16.5 Hz, 4,10-H), 3.64 (2H, d, 
4.4 Hz, la,7a-H), 3.71 (2H, dd, J = 1.7, 16.3 Hz, 4,10-H), 4.35, (2H, d, J = 3.6 Hz, 
6b, 12b-H), 4.44 (2H, bs, 6a, 12a-H), 5.69 (2H, mt, J = 5.7 Hz, 2,8-H), 5.90 (2H m, 
3,9-H). 
I 
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EIMS m/z [M+-S2] 496 (25), 408 (11), 320 (12), 318 (35) , 302 (22), 160 (17). 
Scabrosin acetate hexanoate [(laS,2S,4aR,6aS,6bR,7aS,8S,10aR,12aS, 
12bR )-8-(acetyloxy)-la,2,6a,6b, 7a,8,12a,12-octahydro-S,l l-dioxo-SH, 11 
H-4a, 1 Oa-epidi thio-4H, 1 OH-bisoxireno [g,g'] pyrazino[ 1,2-a: 4,5-
a' ]diindol-2-yl hexanoate] (7.8) 
Scabrosin acetate hexanoate (7 .8) was H11Csy0 
obtained as a white solid. 0 ~ 2 
M.p. 209 QC (lit. 33 m.p. 213 QC). 
1 H NMR (CDCl3) 8 0.92 (3H, t, J = 6.9 
Hz, OCO(CH2)4CH3), 1.29 - 1.34 ( 4H, m, 
OCO(CH2)2CH2CH2CH3), 1.62 - 1.70 (2H, 
4 
10 
m, OCO(CH2CH2(CH2)2CH3), 2.15 (3H, s, OCOCH3), 2.35 - 2.41 (2H, m, 
OCOCH2(CH2)3CH3), 2.81 (2H, d, J = 16.5 Hz, 4,10-H), 3.62 (2H, t, J = 3.8 Hz, 
la,7a-H), 3.70 (2H, dd, J = 1.7, 16.5 Hz, 4,10-H) , 4.34, (2H, d, J = 3.5 Hz, 6b,12b-
H), 4.43 (2H, bs, 6a,12a-H), 5.67 (2H, t, J = 4.9 Hz, 2,8-H), 5.89 (2H m, 3,9-H). 
EIMS m/z [M+-S2] 496 (100), 436 (11), 380 (37), 320 (36), 318 (16), 160 (38). 
Scabrosin butyrate hexanoate [(laS,2S,4aR,6aS,6bR, 7aS,8S,10aR,12aS, 
12b R)-8-( 1-oxobutoxy )-1 a,2, 6a,6b, 7 a,8, 12a,12-octahydro-S,11-dioxo-5 H 
, 11 H-4a, 1 Oa-epidithio-4H,1 OH-bisoxireno[g,g ']pyrazino[ 1,2-a:4,5-a 'Jdiin 
dol-2-yl hexanoate] (7.9) 
Scabrosin butyrate hexanoate (7. 9) was H11 Csy O 
3 
obtained as a white solid. 0~ 
M.p. 139-141 QC. 
1 H NMR (CDCl3) 8 0.90 (3H, t, J = 7 .3 
Hz, OCO(CH2)4CH3), 0.98 (3H, t, J = 7 .3 
Hz, OCO(CH2)2CH3), 1.30 - 1.35 ( 4H, m, 
4 
10 
OCO(CH2)2CH2CH2CH3), 1.64 - 1.72, (4H, m, OCOCH2CH2CH3 and 
OCO(CH2CH2(CH2)2CH3), 2.35 - 2.41 (4H, m, OCOCH2CH2CH3 and 
OCOCH2(CH2)3CH3), 2.82 (2H, d, J = 16.5 Hz, 4,10-H), 3.63 (2H, t, J = 3.4 Hz, 
la,7a-H), 3.71 (2H, d, J = 16.5 Hz, 4,10-H), 4.35, (2H, d, J = 3.3 Hz, 6b,12b-H), 
4.44 (2H, bs, 6a,12a-H), 5.69 (2H, t, J = 5.6 Hz, 2,8-H), 5.90 (2H m, 3,9-H). 
Chapter8 
EIMS mlz [M+-S2] 524 (16), 437 (3), 408 (6), 320 (11), 318 (22), 160 (11). 
HREIMS m/z [M+-S2] 524.2150 (calcd for C2sH32N2Os 524.2159). 
Usnic acid (7 .10) 
Usnic acid (7.10) was obtained as a yellow solid: 15 
EIMS m/z 344 (M+, 80), 260 (70), 233 (100), 217 (20). 
Standard TLC RF values: 5-8 Rp (A) 0.70; (B) 0.66; (C) 0.71; (E) 0.23. 
Norlobaridone (7.11) 
Norlobaridone (7.11) was obtained as a colourless solid:34 
221 
EIMS m/z 398 (M+, 100), 370 (59), 341 (30), 313 (22), 236 (20), 221 (19), 220 (5). 
Standard TLC RF values: 5-8 Rp (A) 0.40; (B) 0.36; (C) 0.20; (E) 0.18. 
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Appendices 
Appendix A 
Crystal Data for Hybocarpone (2.8) 
0305 
0304i 
Empirical Formula 
Formula Weight 
Crystal Colour, Habit 
Crystal Dimensions 
Crystal System 
C54Hs602s 
1153.02 
orange, rod 
0.14 X 0.07 X 0.04 mm 
monoclinic 
225 
0404 
Appendices 
Lattice Type 
No. of Reflections Used for Unit 
Cell Determination (2 e range) 
Omega Scan Peak Width at Half-height 
Lattice Parameters 
Space Group 
Z value 
Deale 
Fooo 
µ(CuKa) 
Primitive 
25 (50.2 - 84.0°) 
0.39° 
a= 10.903 (3) A 
0 b = 12.431 (6) A 
0 
c = 19.457 (3) A 
p = 98.25° 
V = 2610(2) A3 
P21 (#4) 
2 
1.467 g cm-3 
1208.00 
10.31 cm- 1 
226 
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Appendix B 
Crystal Data for 3-Hydroxy-4,4,6-trimethoxy-2,5-di(p-methoxyphenyl) 
cyclohexa-2,5-dien-1-one (6.44) 
C14~ 
Cl5A 
Empirical Formula 
Formula Weight 
Crystal Colour, Habit 
Crystal Dimensions 
Crystal System 
Lattice Type 
No. of Reflections Used for Unit 
Cell Determination (2 e range) 
Omega Scan Peak Width at Half-height 
Lattice Parameters 
C23H24O7 
412.44 
yellow, prism 
0.40 X 0.16 X 0.12 mm 
triclinic 
Primitive 
21 (53.7 - 62.4°) 
0.38° 
0 
a= 9.741(3) A 
b = 9.787(2) A 
0 
c = 23.067(4) A 
a = 96.42(2) 0 
~ = 97.64(2) 0 
y = 107 .40(2) 0 
06A 
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V = 2053.0(8) A3 
Space Group Pl (#2) 
Z value 4 
Deale 1.334 g cm-3 
Fooo 872.00 
µ(CuKa) 0.92 cm -1 
Appendices 
Appendix C 
Crystal Data for scabrosin dibutanoate (7.7) 
Empirical Formula 
Formula Weight 
Crystal Colour, Habit 
Crystal Dimensions 
Crystal System 
Lattice Type 
No. of Reflections Used for Unit 
Cell Determination (2 0 range) 
Omega Scan Peak Width at Half-height 
Lattice Parameters 
Space Group 
Z value 
Deale 
Fooo 
µ(CuKa) 
C26H2sN 20sS2 
560.64 
yellow, plate 
0.24 x 0.08 x 0.03 mm 
monoclinic 
Primitive 
17 (20.4 - 28.6°) 
0.58° 
0 
a= 9.681 (2) A 
0 
b = 7.879 (3) A 
0 
c = 17.134 (3) A 
~ = 94.63(2) 0 
V = 1302.6(6) A3 
P21 (#4) 
2 
1.429 g cm-3 
588.00 
23.15 cm- 1 
229 
